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1. INTRODUCTION: 
This thesis is concerned with thymus-de rived 
lymphocytes (T cells) and in particular the nature of their 
receptor for antigen and their role in cellular collaboration. 
1.1 The T cell receptor 
The reaction of antigen with lymphocytes is highly 
specific and is believed to involve special receptors on the 
surface of the lymphocyte. The chemical nature of these 
receptors on T cells is probably the most controversial issue 
in cellular immunology at present. The view that immunoglo-
bulin (Ig) is the receptor, as it appears to be for bone-
marrow (or bursa)-derived lymphocytes (B cells) has been 
challenged by the failure of many investigators to demonstrate 
Ig directly on the surface of T cells or to inhibit various T 
cell responses with anti-lg reagents. The first part of this 
thesis is concerned with the presence and functional signi-
ficance of Ig on T cells. 
1.1.1 Immunoglobulin on T cells: Is it there? 
Does it have a functional significance? 
In 1972, when the work described in this thesis was 
commenced, these questions were being vigorously debated. The 
most common method used to detect Ig on T cells, direct 
visualization by reaction of cells with labelled anti-Ig (e.g. 
with fluorescent chromophores, radioiodinated, hybridized with 
anti-viral antibody coupled with ferritin or enzyme conjugated 
- see Warner, 1974) led to the conclusion that there was very 
much less Ig on T cells than on B cells. (Raff, 1970a; 
Rabellino et al., 1971; Unanue et al., 1971; Lamelin et al., 
1972; Matter et al., 1972; Nossal et al., 1972; Gonatas et al., 
1972.) Sensitive methods (e.g. radioautography with long 
exposures) (Bankhurst and Warner, 1971; Nossal et al., 1972) 
revealed approximately 500 molecules of Ig on thymus cells 
compared to 20,000 or more molecules on B cells. Ig was more 
readily demonstrated on peripheral T cells in lymph node or 
spleen (Hammerling and Rajewsky, 1971) or activated T cells, 
for example T cells from thoracic duct lymph of F1 animals 
given parental thymus cells (T-TDL) (Bankhurst et al., 1971). 
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However, some workers found no significant di f ference between 
labelling cells in thymus and peripheral T cells (Grey et al., 
1972a) or T-TDL (Nossal et al., 1972). Nevertheless, the 
theory developed that Ig was present on T cells but that it 
was somehow "buried" in the membrane and inaccessible to the 
anti-Ig reagents in resting T cells till, upon activation, it 
became exposed and was therefore more readily detected. 
Support for this theory grew. Greaves (1970) had 
shown that splenic T cells could be prevented from binding SRBC 
by pretreatment with anti-Fab antiserum but not by anti-heavy 
chain sera. Later, however,Hogg and Greaves (1972) found that 
some anti-µ chain sera could inhibit the binding. These were 
shown to be sera directed against the "hinge" region deter-
minants of theµ heavy chain. Other anti-µ chain sera or other 
anti-heavy chain sera were not effective at blocking rosette 
formation. These data implied that the IgM antigen receptor 
molecules on the T cell were only partially exposed. (Greaves 
and Hogg, 1971.) A similar interpretation was give n by 
Marchalonis and coworkers (1972a, b, c; Marchalonis and Cone, 
1973). They used a lactoperoxidase iodination technique to 
label cell surface proteins and then examined cell extracts 
for labelled Ig. They concluded that T cells had significant 
amounts of IgM on their outer surface, of the same order as on 
B cells. Electron microscopic studies of the outer membrane of 
T and B cells revealed a thick glycocalyx layer present on T 
cells but not nearly so obvious on B cells. (Santer et al., 
1972) and this was taken as more evidence for the inaccess-
'ibility of T cell Ig on intact cells to anti-lg reagents. 
Evidence for a functional role for Ig on T cells came 
from the ability of anti-Ig sera to block antigen binding 
(Dwyer et al., 1972), and to block other expressions of T cell 
recognition, such as graft versus host reactions (GVH) (Mason 
and Warner, 1970; Greaves et al., 1969; Rouse and Warner, 19 72), 
mixed lymphocyte reactions (MLC) (Greaves et al., 1971), 
delayed hypersensitivity (0TH) (Theis and Thorbecke, 1972), 
suicide by radioactive antigen (Basten et al., 1971; Cooper 
and Ada, 1972), and T-B co-operation (Lesley et al., 1971; 
Cheers et al., 1971). In addition, experiments by Feldmann and 
Basten (1972b) and Feldmann (1972c) characterized a specific 
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collaborative factor released from activated thymus cells 
(ATC) as an IgM-like molecule of size 7-Bs. This provided 
perhaps the most telling argument that activated T cells 
possessed functionally active IgM and most probably had recep-
tors that were essentially similar to those on B cells. 
However, other groups had failed to find hidden or 
inaccessible Ig on the T cell membrane. Grey et al. (1972b) 
solubilized cells in detergent, urea-acetic acid or by freeze-
thawingand assayed cell extracts for Ig using a quantitative 
inhibition assay. They concluded that T cells did not have 
large amounts of Ig bound on the cell membrane. A similar 
conclusion was reached by Vitetta et al. (1972) using the same 
detection technique as Marchalonis and later by a third group. 
(Lisowska - Bernstein et al., 1973). By adding known numbers 
of B cells to thymocyte suspensions Vitetta et al. (1972) 
calculated that if thymocytes had any IgM, it would be less 
than 250 molecules per cell. This calculation was close to 
other estimates determined by Nossal et al. (1972) and Grey et 
al. (1972a) using different surface labelling techniques. 
Lisowska - Bernstein et al. (1973) showed that Ig synthesis by 
activated thymus cell populations was due to contamination of 
these cells by IgM containing plasma cells. 
There were al s o reports of unsuccessful attempts to 
block T cell function with anti Ig sera. Probably the most 
thorough of these was the work on GVH reactions in chickens by 
Simonsen's group who concluded that Ig was not the receptor 
for this type of recognition. (Crone et al., 1972.) Other 
research groups also failed to block GVH reactions (Iva~i et 
al., 1970), or cytotoxic T cells, derived from the thymus, in 
either the sensitization (Feldma n et al., 1972;) or the 
effector stage (Chapuis and Brunner, 1971; Feldman et al., 
1972) with anti-Ig. Some of these investigators, however, 
(Crone et al., 1972; Feldman et al., 1972) showed that though 
anti-Ig sera were ineffective at blocking the T cell function, 
antisera directed at other me mbrane components, such as 
histocompatibility antigens, were effective. They postulated 
that the positive results obtained by other g~oups may be due 
to contamination of the anti - lg reagents with antibody directed 
against membrane components other than Igor that the anti-lg 
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reagents acted via steric hindrance. 
Another controversial issue concerning Ig on T cells 
was whether the amounts detected were in fact synthesized by 
the T cells or acquired passively. Nobody had definitely 
demonstrated that pure T cells could synthesize Ig. Surface 
Ig had been detected on some malignant cell lines, apparently 
of T cell origin (Marchalonis et al., 1972a) and synthesis of 
Ig by these cell lines had been reported (Harris et al., 1972), 
but malignant cells cannot be regarded as normal T cells. In 
addition, other evidence had been published which suggested 
that tumour cells could acquire Ig cytophilically (Grey et al., 
1972b). 
Some evidence that Ig was not acquired passively by 
T cells came from the work of Basten et al. (1972). Using the 
sensitive radioautographic technique, they showed that 
125 1 
labelled antigen-antibody complexes did not bind to T cells 
from several sources, including activated thoracic duct cells, 
although they bound to B cells. They concluded that B, but not 
T cells, possess a receptor for the Fe portion of Ig. Cline 
et al. (1972) also found activated T-TDL unable to form rosettes 
with antibody coated erythrocytes. However, other workers, 
(Yoshida and Andersson, 1972) detected 2-5% Fe rosettes in 
normal thymus and about 70% of T cells activated to histocom-
patibility antigens from spleen or lymph nodes gave Fe rosettes. 
This rosette formation could not be significantly inhibited 
by free mouse Ig but could be inhibited by mouse antigen-
antibody complexes. They concluded that antigen activated 
mouse T cells did have receptors for antigen complexed Ig. Thus, 
whether T cells possessed a receptor for Fe was still being 
debated. There had been no reports of functionally active T 
cells possessing an Fe receptor. 
Some of these controversial issues concerning Ig on 
T cells and its functional significance were considered (see 
1.3) and results are reported in Chapters 2 and 5. 
1.2 Role of the T cell in cellular collaboration 
The s cond part of this thesis is concerned with 
collaboration between T and B cells in the induction of anti-
body synthesis.Collaboration was first suggested by the 
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experiments of Claman et al . (1966) in which it was shown that 
irradiated mice given both thymus and bone marrow cells made 
a far greater primary response to SRBC than recipients which 
received either thymus or bone marrow cells alone. Subsequent 
work (Davies et al., 1967; Miller and Mitchell, 1968; Nossal 
et al., 1968) clearly demonstrated that T cells had a "helper" 
role and B cells produced the antibody. Co-operation between 
T and B lymphocytes has now been observed in vitro as well as 
in vivo, in both primary and secondary humoral responses and 
has been demonstrated for a variety of antigens. Hapten-
carrier antigens have been studied most. The two antigenic 
components, hapten and carrier, are thought to represent 
separate sites of functional recognition by T and B lymphocytes, 
with haptens binding to Ig receptors on B cells and the carrier 
being recognized by T cells. (Mi tchison et al., 1970; 
Mitchison, 1971.) This phenomenon is known as the "carrier" 
effect. Carrier effects are not confined to hapten-protein 
conjugates. They can be demonstrated for example, with the sub-
units of protein molecules (Rajewsky et al. , 1967) or with 
separate determinants on erythrocytes . (Cunningham and 
Sercarz, 1971). Hapten carrier antigens have provided a 
valuable tool for looking at T-B collaboration because the two 
functional antigenic determinants can be separately identified. 
Collaboration between T and B cells has been extensively 
discussed in recent reviews. (Basten and Howard, 197 3; 
Bullock and Moller, 1974; Claman and Chaperon, 1969; Davies, 
1969; Feldmann and Nossal, 1972; Katz and Benacerraf, 1972; 
~Playfair , 1971; Playfair, 1973; Miller, 1972; Miller and 
Mitchell, 1969; Miller et al., 1971a; Mitchell, 1974.) However, 
the mechanisms by which T and B cells collaborate are not 
definitely known. Models that have been proposed may be broadly 
classified into the Contact models and the Factor models. 
Contact models propose:-
a) that antigen is more efficient at activating B 
c lls when exposed as an ord red array on the T 
c 11 surf c - "local concentration hypothesis" 
(Mitchison, 1969; Moller, 1970). 
or 
b) that as T cells recognize foreign antigen on the 
B cell surface they release non-specific 
activating factors which stimulate B cells 
directly - "T cell surveillance hypothesis" 
(Kreth and Williamson, 1971). 
or 
c) that cell-cell contact via an antigen bridge 
allows a surface membrane interaction between 
T and B cells resulting in B cell activation. 
(Katz et al., 1973a) 
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Evidence cited in favour of these contact models is that:-
a) chemical linkage between the hapten and the 
carrier determinant is required for the anti-
hapten response; (Mitchison, 1971; Kettman and 
Dutton, 1971). 
b) T independent antigens are antigens which have 
repeating antigenic determinants. For example, 
the response to polymeric flagellin (POL) is T 
independent in mice, whereas the response to 
monomeric flagellin (MON) is dependent on the 
presence of MON primed T cells. (Feldmann and 
Basten, 1971). 
c) the "allogeneic effect", (i.e. abnormal induction 
of B cells by allogeneic T cells - Katz et al., 
1971a, b) is only obtained when hapten primed B 
memory cells represent the targets for the 
allogeneic aggressor cells. No activation 
occurs when the precursor cells for anti-hapten 
antibody production are "innocent bystanders", 
i.e. part of the allogeneic population (Rajewsky 
et al., 1972) 
d) T-B collaboration is restricted to histocompatible 
cells. (Katz et al. 197 3 a and b) . 
However, against the contact models are that:-
a) the T cell does not appear to have merely the 
passive role of antigen presentation. Feldmann 
and Basten (1972a) showed that protein and RNA 
synthesis were required for collaboration. In 
addition, other cell types coated with antigen or 
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antigen coated inert particles or non-reactive 
T cells coated with antigen could not collaborate 
with B ~ells. (Unanue, 1970; Katz et al., 1970; 
Miller et al., 1971b). 
b) two relatively rare specific T and B cells would 
need to contact each other and T cells have been 
shown to enhance the response of antigens in 
vivo, even when B cells outnumber them by a ratio 
of 1000:l (Rajewsky et al., 1972). 
c) T cell co-operation with B cells has been shown 
to occur across a cell impermeable membrane 
(Feldmann and Basten, 1972b). 
These latter objections have led to the Factor models 
for T-B collaboration. Factor models propose:-
a) T cells upon contact with antigen are activated 
to secrete non-specific B cell mitogenic products; 
or 
b) T cells upon contact with antigen secrete antigen 
specific activating substances; 
or 
c) both a) and b) occur. 
Production of non-specific T cell replacing factors 
has been reported by many workers (e.g. Davies et al., 1967; 
Kennedy et al., 1970; Ekapaha-Mensah and Kennedy, 1971; Dutton 
et al., 1971; Doria et al., 1972; Rubin and Coons, 1972a, b; 
Rubin et al., 1973; Schimpl and Wecker, 1972, 1973; Britton, 
1972; Gorczynski et al., 1972a, b, 1973; Feldmann and Basten, 
1972c; Sjoberg et al., 1972; Rosenthal et al., 1973; Watson, 
1973; Gisler et al., 1973; Geha et al., 1973; Waldmann and 
Munro, 1973, 1974; Waldmann et al., 1973; Armerding and Katz, 
1974). Factors were obtained from primed T cells cultured 
with the inducing antigen, (e.g. Rubin and Coons, 1972a, b; 
Waldmann and Munro 1973, 1974; Waldmann et al., 1973; Geha et 
al., 1973; Gisler et al., 1973), or from allogeneic cell super-
natants, (e.g. Schimpl and Wecker 1972, 1973; Gorczynski et al., 
1972a, b, 1973; Feldmann and Basten, 1972c; Armerding and 
Katz, 1974) or from mitogen activated T cells (Sjoberg et al., 
1972) and even from unprimed spleen cells cultured with SRBC 
(Doria et al., 1972). However, in most reports the evidence 
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for T cell production of the factor was not conclusive. 
Waldmann and Munro (1973) showed that addition of adherent cells 
to activated thymus cells led to a dramatic increase in 
production of their T cell replacing factor. Thus the poss-
ibility existed that T cells activated by antigen may cause 
macrophages to liberate a T cell replacing factor. In addition, 
the site of action of the factor is an important consideration. 
Most workers studied the effect of the factor in stimulating 
the response of ATXBM spleen cells or normal spleen cells 
cultured with antigen. Thus whether the factor was acting 
directly on B cells or was causing expansion of a small residue 
of T cells or T cell precursors which could then help in the 
response was unknown. Schimpl and Wecker (1972) and Askonas, 
Schimpl and Wecker (1974) demonstrated the existence of two 
factors - 1) a T cell expanding factor (TEF) which stimulated 
the proliferation of T cells and thus led to functional 
replenishment of the T cell pool, in systems partially deprived 
of T cells, and 2) a T cell replacing factor (TRF) which 
actually replaced T cells in their co-operation with B cells. 
They used anti-8 treated nude (congenitally athymic) mouse 
spleen cells to demonstrate that TRF acted as a differentiation 
signal favoring Ig production by an antigen activated B cell. 
They showed that reduction of T cells by treatment with anti-8 
serum abolished TRF production whereas reducing the number of 
macrophages of a mixed lymphocyte culture after 14h (before 
TRF appearance) did not affect the yield of TRF. 
Thus, non-specific factors, presumably produced from 
T cells, can replace the collaborative role of T cells in 
vitro. However, it must be postulated that these factors are 
short range in action to explain, for example, the requirement 
for hapten-carrier linkage for an anti-hapten response, and 
the in vivo experiment of Rajewsky et al. (1972) where there 
was no antibody production when the antibody precursor cells 
were "innocent bystanders" during a GVH reaction. 
Specific T cell replacing factors have also been 
reported (Feldmann and Basten, 1972b, c and d; Yu and Gordon, 
1973; Gisler et al., 1973; Taussig, 1974; Taussig and Munro, 
1974). In most cases these have been produced by activated 
thymus cells (ATC) i.e. cells obtained from splee ns of 
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irradiated recipients given thymus cells and antigen 7 days 
previously. Two groups have attempted to characterize these 
specific factors and disagree as to their nature. Feldmann 
(1972c) and Feldmann et al. (1973) showed that their factor 
was similar to monomeric IgM complexed with antigen. It was 
cytophilic for macrophages and formed a functional irrununogen 
on their surface which could activate B cells of the appropriate
 
specificity. Taussig and Munro (1974), however, claimed that 
their factor could not be removed by a sheep anti-mouse Ig 
absorbent, but was removed completely by congenically raised 
anti-H-2 antibodies. This coincided with a similar character-
ization by Tada et al. (1973) of a specific T cell suppressive 
factor and is consistent with there being H-2 requirements 
for T-B collaboration. (Katz et al., 1973b), unlike Feldmann's 
factor which would seem to allow effective co-operation between 
allogeneic cells. 
Active synthesis of specific collaborative factors 
by T cells has not been demonstrated, and the possibility that 
some may be from B cells contaminating the ATC preparations 
or B cell products on the surface of activated thymus cells 
(Hunt and Williams, 1974; Sprent and Hud s on, 1973; Hudson et 
al., 1974) must be considered. Antibody mediated enhancement 
of an inunune response is a well established phenomenon (e.g. 
see Henry and Jerne, 1968; Dennert, 1971; Pincus et al ., 1971, 
1973; Rubin 1972a, b; Taussig and Lachmann, 1972; Brody et al., 
1967; Walker and Siskind , 1968; McBride and Schierman, 1970, 
1973; Terres and Morrison, 1967; Murgita and Vas, 1972; 
Janeway and Paul, 1973; Janeway , 1973), but the mechanism by 
which specific antibody can augment antibody responses is not 
known. Recently, Playfair et al. (1974) have suggested that 
the receptor for antigen on T helper cell s is adsorbed antibody,
 
and that antibody given to animals passive ly augments antibody 
responses by arming T cells with specific receptors. They 
claim this could explain some of the controversy regarding Ig 
on T cells, discussed in 1.1. J.F.A.P. Miller has also 
suggested that B cells present in the ATC population are 
responsible for production of the specific collaborative 
factor, (personal conununication). 
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Hence it is clear that there are still many 
questions regarding mechanisms of T-B collaboration and the 
nature, role and in vivo significance of non-specific and 
specific T cell replacing factors. Some questions are answered 
and others raised by the data presented in the second part of 
this thesis, where collaboration between cells in an anti-
hapten response in vitro were examined. 
1.3 Outlines of Thesis 
Initially, thymus cells were examined for surface Ig 
by reacting them with a purified 125r-labelled anti-light 
chain antibody. This reagent was one which had been previously 
shown to block suicide of the DTH reaction to flagellin by 
125r-labelled flagellin (Cooper and Ada, 1972). Thymus cells 
were also examined for total Ig by solubilizing the cells and 
assaying the Ig present in cell extracts by a quantitative 
rnicroprecipitin technique (Chapter 2). Chapter 3 describes 
a plaque assay for measuring anti-DNP plaque-forming cells 
and characterization of in vitro culture systems for obtaining 
good anti-hapten responses to DNP-haemocyanin (DNP-HCY), DNP-
human garruna globulin (DNP-·HGG) and DNP-f lagellin (DNP-MON) . 
During characterization of these responses, spleen cells from 
the congenitally athymic "nude" mouse mutant were used as 
negative controls to establish the T cell dependent nature of 
the responses. However, nude spleen cells gave excellent 
responses to DNP-MON. This discrepancy was resolved when nude 
mice were shown to have a small proportion of functionally 
active T cells able to collaborate in the anti-hapten response 
and give a delayed type hypersensitivity reaction to MON 
injected into the hind footpad (Chapter 4). 
In Chapter 5, a method for obtaining pure populations 
of mouse T and B cells by fractionating cells on Isopaque/ 
Ficoll was adapted in collaboration with C.R. Parish, from a 
cell separation procedure he had worked out for rat lympho-
cytes and was characterized with the techniques described in 
Chapters 2 and 3. Also, the procedure was modified to detect 
Fe rosetting cells and used to see whether Fe receptors were 
present on any functional T cells. 
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The in vitro techniques and cell separation procedure 
were combined to study T-B collaboration to DNP-MON and the 
role of soluble factors (Chapters 6 and 7). 
Results of these studies are discussed in relation to those of 
other investigators in Chapter 8. 
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2.1 INTRODUCTION 
The aim of the experiments reported in this chapter 
was to examine thymus cells for surface inununoglobulin and 
try to quantitate this. The reagent used in these studies 
was an anti-light chain irrununoglobulin which could block 
inactivation of T cell function (Cooper and Ada, 1972). First 
the amount of reagent which bound to cells was assayed both 
by total counts and by examining cells individually by radio-
autography. Second, thymus cells were compared with B cells 
by assaying the total Ig present in extracts of the two classes 
of cells. 
2.2 MATERIALS AND METHODS 
2.2.1 Animals 
Unless otherwise stated, CBA/J mice were used in the 
experiments described in this chapter. 
CBA/J, CBA/H, Balb c, (CBA x C57 Bl)F1 were obtained from 
breeding colonies in this School. 
ATxBM (Adult thymectomized, irradiated, bone marrow 
reconstituted) mice were thymectomized at 7 weeks of age, 
lethally irradiated (850 rads) two weeks later and reconstituted 
by i.v. injection of 2 x 10 7 bone marrow cells. 
2.2.2 Sources of lymphoid cells 
Thymus and spleen cell suspensions were prepared by 
cutting these organs into small pieces with scissors and 
gently teasing the pieces through a stainless steel sieve into 
cold Dulbecco's balanced salt solution (DBSS) (Dulbecco et al., 
·1954) containing 10% foetal calf serum (FCS). Special care 
was taken when removing thymuses to have a minimum of blood 
contamination and to exclude nearby lymph nodes. All surround-
ing fatty areas were cleaned from the thymus routinely before 
cell suspensions were prepared. Bone marrow cells were 
obtained by flushing out the femurs and tibias with medium 
using a syringe and 26G x ~" needle. Cell clumps were broken 
up by gently aspirating the cells through the syringe. 
White blood cells (WBC) were obtained from whole 
blood using a ficoll flotation method described by Noble et 
al. (1968). All cell suspensions were thoroughly washed 3 
times in medium and counted using a haemocytometer. Viability 
was judged by trypan blue dye (0.05%) exclusion and in most 
cases was greater than 95%. 
2.2.3 Immunoglobulin reagents 
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2.2.3.1 Rabbit anti-CBA mouse light chain globulin (anti-
mouse L chain Ig) 
This antibody was prepared by Mrs. B.J. Howlett and 
full details are given elsewhere (Cooper and Ada, 1972). 
Briefly, serum globulins from rabbits made hyperimmune to a 
Balbcmouse myeloma IgA were recycled through a s epharose 
column containing mouse IgG until most anti-L-chain activity 
had been adsorbed. The antibody was then eluted from the 
column with lN propionic acid and neutralized by dialysis 
against DBSS. 
2.2.3.2 Rabbit anti-sheep light chain globulin (anti-sheep 
L chain Ig) 
This reagent was kindly donated by Dr. P.L. Ey. It 
was prepared similarly to the anti-mouse reagent. Details of 
its preparation and specificity are given elsewhere (Ey, 1973). 
2.2.3.3 Anti-6 globulin 
The reagent used was a concentrate of an ammonium 
sulphate (50%) precipitate of an anti- 6 ascitic fluid. The 
latter was prepared in AKR/J mice which were given 10 
intraperitoneal injections of 5-10 x 107 CBA thymocytes at 
weekly intervals. The first injection was given with 1 x 109 
B. pertussis organisms (C.S.L., Melbourne). Three days before 
the final dose of thymocytes, the mice were injected intra-
peritoneally with 0.2 ml of a 10% suspension of sarcoma 180 
cells in saline (Tikasingh et al., 1966). The ascitic fluid 
was harvested 7 days after the final thymocyte injection. 
Uninununized AKR/J mice were used as donors of control ascitic 
fluid and a similar ammonium sulphate precipitate of this used 
as a control for the anti- 8 globulin. Undiluted, the anti- e 
globulin had a cytotoxicity of >98% for thymocytes. 
2.3.2.4 Anti-B-anti-macrophage 
The preparation and specificity of this reagent, 
(an antiserum from rabbits immunized with thioglycollate 
induced macrophages) kindly donated by Dr. R.V. Blanden, has 
been described elsewhere (Blanden and Langman, 1972). After 
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adsorption with 5 x 108 CBA thymocytes/ml it was found to be 
cytotoxic for B but not T cells. 
2.3.2.5 Anti-heavy chain sera 
Anti-µ and anti-y chain sera, prepared by P.L. Ey 
(Ey, 1973), were obtained from the hyperinunune sera of 
rabbits injected with purified mouse (CBA) IgM and IgG 
respectively. Anti-light chain activity was removed by passing 
the sera through sepharose-mouse IgG and IgM columns. The 
specificity of these reagents for heavy chains was shown by 
microprecipitin tests. 
2.2.4 Labelling o f the anti-light chain reagent with 125r 
The anti-light chain reagent was labelled with 
carrier-free [125r] iodide (IMS3: The Radiochemical Centre, 
Amersham, U.K.) by direct oxidation with chloramine-T (Byrt 
and Ada, 1969). Labelling efficiencies were usually 70-90% 
and the specific activity of the protein was in the range 30-
4o µC/µg protein. For radioactive anti-light chain suicide 
the specific activity was in the range 150-200 µC/µg. 
2.2.5 Reaction of cells with rad i oactive protein 
Cells were incubated (30 min, o0 c) at a concentrat-
ion of 2 x 107 cells/0.2 ml of DBSS containing 10% FCS and 
15mM sodium azide, with 125r -anti-light chain IgG, 200 ngs 
being the "standard dose", but this varied in some experiments 
from 180-250 ngs . The cells were then washed by centrifuging 
through 2 gradients of FCS to remove unreacted anti-light chain 
Ig and the final cell pellet resuspended in a drop of FCS and 
smeared onto gelatin-coated slides for radiouutography. The 
cell smears were fixed in methanol or acid methanol . 
2.2.6 Radi oautographic procedure 
Full details of this t e chnique are described by 
Byrt and Ada, (1969). Briefly, fixed slides were dipped in 
Kodak NTB-2 photographic emulsion, dried vertically, boxed 
in light-proof boxes containing "drierite" and stored at 4°c 
for 2-5 days when they were developed (Kodak D-19) and stained 
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with 5% Giemsa, mounted in DPX mounting medium and scanned 
for labelled cells. 
Between 50000-100000 cells were scanned . Labelled 
cells were classified into four categories according to the 
number of grains associated with them:-
'L': <25 grains, 'M': 25-50 grains, 'H': >50 grains, 
'HH': "hedgehog" - cell obscured by density of grains. The 
criterion for a labelled cell was that there were at least ten 
grains above background level, which in most cases was very 
low (2-3 grains per cell area). 
2.2.7 Carbon-black visualization of parathymic lymph nodes 
Pelikan black ink was centrifuged for 15 min at 
2000 g and the supernatant diluted twofold with DESS, and 0.2 
ml injected intraperitoneally into mice 30 min before they 
were killed and thymuses removed. 
2.2.8 Cortisone treatment 
Mice were injected subcutaneously with 5 mg (0.2 ml) 
of cortisone acetate (Rousel, England) 24 hours before thymuses 
were removed. 
2.2.9 Cytotoxicity Assay 
Lymphoid cells were incubated (30 min , 37°C) at a 
concentration of 4 x 10 6 cells/0.2 ml with dilutions of the 
antiserum under test. They were then washed twice, resuspended 
in 0.2 ml of a twofold dilution of reconstituted guinea pig 
complement (CSL, Melbourne, Australia). The complement had 
been adsorbed previously on agarose (80 mg/ml complement) for 
1 hour at o0 c and incubated for a further 30 min at 37°c. 
After this incubation the tubes were placed in ice and 0.2 ml 
ice-cold Trypan blue (0.1%) added. Aliquots of cells were 
counted for viability irrunediately in a haemocytometer. 
2.2.10 Treatment of anti-l i ght cha in bindi ng cells with 
various antisera and complement 
Basically the same procedure as above was used, but 
the initial incubation with the antisera was done for one hour 
at o0 c in order to minimize the risk of loss of label from 
the cells at 37°c. The 30 min incubation with C' was carried 
out at 37°c, but the c' was diluted twofold with medium 
containing azide. 
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2.2.11 Nigrosin staining technique for differentiation of 
live and dead cells 
This technique was adapted from that described by 
Claesson et al. (1969). Cells (2 x 107 ) were resuspended in 
0.1 ml chilled 0.9% sodium chloride in 0.25M sucrose and 
0.1 ml 0.1% nigrosin in isotonic saline was added. After 
10 min at 4°c the mixture was centrifuged through an FCS 
gradient and the cell pellet smeared for radioautography as 
usual. Slides were fixed in methanol. The staining procedure 
withstood the radioautographic procedure. The Feulgen counter 
stain, suggested by Claesson et al. was found to be unsatis-
factory for radioautographs, as many of the silver grains 
dissolved during the HCl digestion. A one minute counter 
stain in Giemsa proved satisfactory - live cells staining a 
very pale blue, dead cells a dark purplish-blue. 
2.2.12 Microprecipitin inhibition technique 
Known numbers of lymphoid cells, ranging from 2-5 
x 108 cells were solubilized in 0.5 ml 5% NP-40 containing 5% 
FCS and 0.1% azide at o0 c for more than one hour with occasional 
vortexing. They were spun for 15 minutes at 2500 g at 4°c 
and the supernatants used in microprecipitin inhibition assays. 
The diluent used also contained 5% NP-40, 5% FCS and 0.1% 
azide. Doubling dilutions of each cell extract and known IgM 
and IgG standards were made over an appropriate range to yield 
·a final volume of 100µ1. Both IgM and IgG were assayed in 
each cell extract. Appropriate amounts of specific anti-µ or 
anti-y sera (20µ1) were added to the cell extract dilutions, 
and kept at 4°c overnight with intermittent shaking. Samples 
(50µ1) of the mixtures were then assayed in a microprecipitin 
test. 
125 1 -IgG or 12 51 -IgM, (5ng amounts in O.lM Tris 
HCl pH 7.2, 10% NRS, 15mM azide) in a final volume of 50µ1 
were added to the inhibitor mixtures. The contents of the tubes 
were mixed thoroughly, incubated for 3 hours at 37°c and kept 
overnight at 4°c. They were then centrifuged (11000 g for 1 
hour), and 50µ1 of supernatant counted in a ganuna spectrometer. 
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The amount of IgM and IgG present in the cell extract dilutions 
could be judged by comparison with the known IgM and IgG 
standards at the 50% end-point. From this an estimate of the 
average amount of Ig present per cell could be gained. 
2.2.13 Enumeration of plaque-forming cells 
Anti-SRBC PFC were counted using the technique of 
Cunningham and Szenberg (1968). To detect anti-DNP PFC, 
SRBC were coated with dinitrophenylated rabbit anti-SRBC Fab, 
as described by Strausbauch et al. (1970) and in Chapter 3. 
2.3 RESULTS 
2.3.1 Anti-light chain binding cells in different tissues -
evidence for specificity 
In the first set of experiments, labelled anti-mouse 
light chain immunoglobulin was reacted with cells from bone 
marrow, spleen and thymus. 
The results were expressed , both as counts of radio-
activity associated with the cell pellet after the reaction, 
and as the proportion of cells labelled. There were consist-
ently gross differences in both respects among these three 
different cell populations. In the experiment reported in 
Table 2.1, 40-50% of spleen cells, 10-15% of bone marrow cells 
and less than 1% of thymus cells bound anti-mouse light chain 
Ig. 
The cell populations could be further distinquished 
by the proportion of cells in different categories when this 
~was plotted according to the number of grains associated with 
cells (see Figure 2.1). Bone marrow and thymus showed a 
rather similar profile in which there was about the same 
proportion of heavy to lightly labelled cells; this pattern 
was different from that shown by spleen where there was a much 
higher proportion of lightly labelled cells. 
As a control for the specificity of this reaction, 
cells were treated under the same conditions with labelled 
anti-sheep light-chain Ig. Although radioactivity was still 
found with the cell pellet, negligible numbers of labelled 
cells were detected. As a further test of specificity, cells 
were pre-exposed to an excess (40x) of either unlabelled anti-
Table 2.1: Anti-light chain binding cells in different 
tissues - evidence for specificity 
Anti-light 
chain 
reagent a) 
1251-anti-mouse 
1251-anti-sheep 
Unlabelled 
Anti-mouse 
+ 125r-anti-
mouse 
Unlabelled 
Anfi-sheep 
+ 25r-anti-
mouse 
Tissue 
B.M.c) 
Spl 
Thy 
B.M. 
Spl 
Thy 
B.M. 
Spl 
Thy 
B.M. 
Spl 
Thy 
Percentage 
bound 
(Bulk 
counts) 
2.0 
6.7 
0.3 
0.5 
0.9 
0.2 
0.7 
4.7 
0.1 
2.1 
6.4 
0.2 
Percentage of 
labelled cells 
(Radioautography)b) 
13 
44 
0.1 
<0.3 
<0.3 
<0.002 
6 
38 
<0.002 
11 
41 
0.08 
a) 250ng specific activity= approx. 30 µc/µg. 
b) Radioautographs were exposed for 3 days. 
c) B.M.: bone marrow, Spl.: spleen, Thy: thymus. 
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Figure 2.1 Evidence for specificity of anti-light 
chain binding. 
The solid lines show the proportion of anti-CBA light 
chain binding cells of different grain distribution 
in the tissues examined . The dotted lines show the 
effect of pre-exposure to cold anti-mouse light chain 
(left) or cold anti-sheep light chain (right) on these 
anti-light chain binding cells. 
'L' : < 25 grains; 'M' : 25-50 grains; 'H' : > 50 grains; 
'HH' : "hedgehog" - cell obscured by density of grains. 
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sheep L-chain Igor unlabelled anti-mouse L-chain Ig before 
treatment with the labelled reagents. Table 2.1 shows that 
pre-exposure of cells to the unlabelled anti-sheep reagent 
did not affect either the amount of radioactivity associated 
with the cell pellet or the numbers of labelled cells found. 
Furthermore, the distribution of cells in the different grain 
categories did not appreciably change. Pre-exposure of cells 
to excess (40x) unlabelled anti-mouse light-chain decreased 
both the density of grains over cells and the total numbers of 
labelled cells seen. The number of labelled spleen cells 
detected was only slightly decreased but most were now in the 
lightly labelled category. Numbers of labelled bone marrow 
cells were substantially decreased and no labelled thymus cells 
were detected. 
2.3.2 Morphology 
The anti-light chain binding cells in the thymus were 
heterogeneous in morphology and could be divided broadly into 
cells which were small lymphocyte-like cells and those which 
were not. Cells in the two groups occurred at approximately 
the same frequency. The small lymphocyte-like cells ranged 
in size from 2.5-6µ in diameter and were generally heavily 
labelled (>50 grains). The other cells were a variable group, 
often 10µ and greater in diameter, with varying proportions 
of basophilic cytoplasm. They were generally more lightly 
labelled. (Figure 2.2.) 
In contrast to the variety of morphological types 
found in thymus, all the binding cells in bone marrow were 
about 5-6µ in diameter and many were heavily labelled. They 
were very similar in appearance to the heavily binding cells 
in the thymus. In spleen, most of the labelled cells were 
typical small lymphocytes with diameters 5µ and upwards, and 
some had a visible rim of cytoplasm. The binding cells in 
blood were relatively uniform being typical lymphocytes 
approximately 7.5µ in diameter; most were heavily labelled. 
(Figures 2.3 and 2.4.) 
2.3.3 Nature of the binding cells found in thymus 
In view of the very small proportion of cells which 
reacted with the anti-mouse light-chain Ig the first question 
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Anti-light chain binding cells in the thymus. 
(a) small (<6µ), heavily labelled lymphocytes. 
(b) larger (6-12µ) more lightly labelled cells. 
(c), (d), (e) large cells (6-14µ) of varying morphology 
generally lightly labelled. 
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Anti-light chain binding cells in 
(a) spleen 
(b) thymus 
(c) blood 
(d) bone marrow. 
Anti-light chain binding was carried out under "standard" conditions, 
described in the text and radioautographs exposed for 24 hours. 
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Figure 2.4 
Higher magnification of anti-light chain binding cells in 
(a) spleen 
(b) thymus 
(c) bone marrow, 
reacted under "standard" conditions, after 4 days' exposure. 
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which arose' was whether these cells were merely contaminants 
and not an intrinsic thymic population. 
2.3.3.l The possibility of contamination with lymph node cells 
There are small lymph nodes on the dorsal side of 
the thymus adherent to the capsule, and unless care is taken 
they may also be excised when thymuses are removed from mice1 
(Blau and Gaugas, 1968 ). Leckband and Boyse, (1970) have 
shown that these parathymic lymph node cells can be readily 
located following injection of carbon black. Suspensions of 
carbon black were injected i.p. and 30 minutes later the mouse 
thymus exposed and excised (see Figure 2.5). All dyed tissue 
and fat were removed from one lobe of each thymus. Cell 
suspensions were prepared as usual from each lobe and reacted 
under standard conditions with 1251 -anti-mouse light-chain 
Ig. 
Results of radioautography are s ummariz e d in 
Table 2.2. The "cleaned" thymus cell population had at least 
as many labelled cells as in the untouched population. However, 
there was some variation in the proportion of labelled cells 
in the different samples, particularly in the "cleaned" 
population. This degree of variability was greater than was 
normally found in subsequent experiments. 
2.3.3.2 Possible contamination of the thymus with blood 
borne cells 
A second possible source of contamination of thymus 
is anti-light-chain binding cells present in the blood. It was 
found that about 40% of WBC in adult blood label with anti-CBA 
L-chain Ig. As the ratio o f RBC:WBC in CBA mice is 1 700:l 
(Russel and Bernstein, 1966), it can be calculated that the 
expected ratio of RBC to labelled WBC would be 4250:1 if the 
presence of these cells in thymus was due to simple blood 
contamination. The ratio found was consistently less than 40:1, 
thus arguing against the above possibility. 
It can be further argued that the thymus would need 
to contain 10-20% of its weight in blood if the calculated 
content of labelled WBC (3 x 10 4/thymus) were due to blood 
present in the organ and this is not the case. There might, 
of course, be preferential accumulation of WBC in the thymus. 
Figure 2.5 : Carbon black visualization of parathymic 
lymph nodes 
(a) A thymus from which all surrounding dyed tissue and 
fat was removed - "cleaned" thymus. 
(b) and (c) Thymuses showing fatty tissue and parathymic 
lymph nodes (arrowed) adhering to the capsule. 
Table 2.2: Evidence for intrinsic nature o f anti-light 
chain binding cells in thymus: I 
Possible lymph node contamination 
Percentage of labelled cells 
Thymus (a) Cleaned (b) Untouched 
lobe lobe 
1 0.027 0.027 
2 0.057 0.023 
3 0.155 0.042 
4 0.034 0.022 
Table 2.3: Evidence for intrinsic nature of anti-light 
chain binding cells in thymus: II 
Injection of labelled lymphocytes into mice 
Time after 
injection 
10 min 
20 min 
40 min 
60 min 
120 min 
Overnight 
Percentage of 
labelled cells in 
smears 
Spleen Thymus 
0.02 <0.001 
0.03 <0.001 
0.06 <0.001 
0.08 <0.001 
0.07 <0.001 
<0.005 <0.001 
Average no. of cells 
per cross siction 
(approx. 10 cells)a) 
Spleen Thymus 
61 0 
43 0 
58 0 
94 0.2 
116 0 
0.3 0 
a) 5 Sections through different levels of each tissue 
were counted. 
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Figure 2.6 
(a) Labelled WBC present in the blood of recipient mice a few 
minutes after their injection. Scale in microns. 
(b) A low power (approximately 40x magnification) of a typical 
thymus section, 10 minutes to 120 minutes after inoculation 
of labelled WBC. No labelled cells were apparent. 
(c) and (d) Higher power view of spleen sections (approximately 200x 
magnification) 20 minutes and 60 minutes after inoculation 
of labelled WBC. Labelled cells (arrowed) were seen in 
blood vessels. 
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2.3.3.3 Injection of labelled lymphocytes into mice 
A further approach to this problem was to see if 
WBC pre-labelled with radioactive anti-light-chain Ig and 
injected i.v. into mice would be recovered in the thymus. 
WBC were isolated, labelled with anti-mouse light 
chain IgG and about 2 x 106 WBC (i.e. 8 x 10 5 labelled cells) 
in 0.2 ml were injected i.v. into recipient mice. This 
represents 5-10% of the WBC circulating in the mouse. At 
various time intervals thereafter (10 mins - 24 hours) the 
mice were killed and thymuses and spleens removed. One lobe 
of each thymus and half of each spleen were fixed in formalin 
and sections cut and examined by radioautography. In each 
case five sections through different levels of the organ were 
obtained. Single cell suspensions of the other portions of 
the organs were prepared and smears of these also subjected to 
radioautography. The presence (or absence) of labelled cells 
in the sections a nd smears is r_corded in Table 2.3. 
Labelled cells were found in both smears and sections 
of spleen at all times up to 2 hours. In the sections, these 
cells appeared to be present in the blood vessels. No 
unequivocally labelled cells were found in either smears or 
sections of the thymus (Figure 2.6 ). Thus there was again 
no evidence to suggest that the anti-light chain binding cells 
in the thymus were due to simple blood contamination. 
2.3.4 Reproducibility 
In many separate experiments in which the reaction 
of thymocytes with 125 r -labelled anti-mouse light chain was 
studied under comparable conditions ("standard conditions") 
approximately the same percentage of labelled cells was 
consistently observed, the mean value being 0.036% ± 0.005, 
range : 0.02 - 0.1%. 
2.3.5 Proportion of anti-light chain binding cells in thymuses 
of different mouse strains 
The thymuses of mice of different strains were 
found to contain similar proportions o f cells binding anti-L 
chain IgG (Table 2.4). 
Table 2.4: Incidence of anti-light chain binding cells 
in thymuses of different mouse strains 
Strain a) Percentage of labelled cells b) 
CBA/J 0.01, 0.02 
CBA/H 0.03, 0.02 
C57/BL 6J 0.05, 0.02 
(C57 /BL X CBA/J)F 1 0.05, 0.04 
BALB c 0.09, 0.08 
a) In all cases mice were 7-9 weeks of age. 
b) Duplicate samples. 
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2.3.6 Reaction of thymocytes with 12 51 -Fab of anti-light 
chain Ig 
The same proportion of labelled cells (approx. 
0.03%) was also found when the Fab portion of the anti-light 
chain IgG (papain digest) (Porter, 1959) was labelled and bound 
to CBA thymocytes under standard conditions. This binding was 
also inhibited by pre-treatment with cold anti-mouse light 
chain Ig but not by pre-treatment with cold anti-sheep light 
chain Ig. (Figure 2. 7.) 
2.3.7 The dose dependence of anti-light chain binding cells 
in different tissues 
Spleen, bone marrow and thymus cell suspensions were 
incubated with concentrations of 125 1 -anti-light chain Ig 
varying from 43-2200 ng per 2 x 10 7 cells, and radioautography 
carried out as usual (Table 2.5 ). 
The results indicated clearly that whereas the 
number of binding cells found in spleen and bone marrow was 
only slightly dose dependent, there was a marked effect with 
thymus, the numbers of labelling cells increasing up to 50 
times as the concentration of the reagent increased 50 fold; 
i.e. 2-5 times the number obtained under standard conditions. 
A further substantial difference between spleen and 
bone marrow, on the one hand, and thymus on the other was 
shown if the frequency of grains over cells seen with the high-
est dose of anti-light chain was plotted (Figure 2.8). The 
majority of cells in both spleen and bone marrow were heavily 
labelled whereas the majority of cells in thymus were lightly 
labelled, thus altering the pattern seen with the "standard" 
dose of anti-light chain (Figure 2.1). 
2.3.8 The ag_ incidence of anti-light chain binding cells 
in different tissues 
The proportion of anti-light chain binding cells 
found in the bone marrow, spleen, blood and thymus of mice of 
varying ages - 6-7 weeks , 3 weeks, 1 week and 3-4 days - are 
summarized in Table 2.6 and Table 2.7. In the case of spleen 
and blood , and particularly with bone marrow, there was a 
sharp drop in the number of anti-light chain binding cells in 
very young mice compared to older mice. Results for the thymus 
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Figure 2.7 Reaction of thymocytes with 125 r-Fab of 
anti-light chain lg. 
(a) The proportion of labelled cells which reacted 
with the Fab reagent (0.04%). 
(b) The proportion of labelled ce!ls following pre-
treatment with cold anti-sheep light chain (0.04%). 
(c) The proportion of labelled cells found following 
pre-treatment with cold anti-mouse light chain 
(0. 0008%). 
'L' : < 25 grains; 'M' : 25-50 grains; 'H' : >0 50 
grains; 'HH' : "hedgehog" - cell obscured by density 
of grains. 
Ta ble 2.5: Dos e dep e nde nce of a nti-light c hai n binding 
c ells in d iffe r e nt tissues 
Dose of 125 r-anti CBA Percentage of cells labelled 
light chain Ig per 
standard conditions (ng) Spleen B.M. thymus 
Expt. 1 Expt. 1 Expt. 1 Expt. 
43 0.01 
80 38.8 8.7 0.047 0.05 
220 0.08 0.12 
430 0.27 
700 47.3 18.8 
860 0.49 
2200 52.8 18.2 0.43 0.26 
2 
a) 
a) This apparent fall-off is probably due to the difficulty 
in detecting lightly labelled cells in slides with high 
background. 
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Figure 2.8 Frequency of grains over cells from different 
tissues seen with the highest dose of anti-light chain lg 
(2200ng). 
'L' : " 25 9rc-:1ins; ' M' · 25-50 grains; ' II' : ,,, 50 grains; 
' HII ' : 11 hedychog" - ce 11 obscured by d e nsity of grains. 
Table 2.6: The age incidence of anti-light chain binding 
cells in various tissues 
Percentage of labelled cells a) 
Age 
Bone Marrow Spleen Blood 
6-7 weeks 19 (15-22) 48 (45-51) 41 (39-42) 
3 weeks 12 (9-15) 32 (30-33) 31 (29-32) 
1 week 10 ( 8-12) 31 (30-32) 43 (40-43) 
3-4 days 2 (1.3-3.6) 16 (15-20) 18 (14-21) 
a) Mean value of triplicate samples, the range given 1n 
brackets. 
Table 2.7: The age incidence of anti-light chain binding 
cells in thymus 
Age 
Percentage of labelled cells 
Expt. 1 Expt. 2 
6-7 weeks 0.01, 0
.02 
3 weeks 0.01, 0.04 0.0
5 
1 week 0. 0 4, 0.03 
0.03 
3-4 days 0.02, 0.04 0.01 
a) Duplicate smears. 
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are variable, in part due to the small numbers of labelled 
cells involved, but no such trend is apparent. 
2.3.9 The effect of cortisone treatment on the proportion 
of anti-light chain binding cells in thymus 
Treatment of mice with cortisone causes rapid 
involution of the thymus. The total numbers of cells 
recovered 24 hours after injection of cortisone was 3% of the 
normal number of cells, and after longer periods as few as 1% 
of cells were recovered (Figure 2.9). 
However, the numbers of anti-L chain binding cells 
were enriched by this cortisone treatment i.e. as a fraction 
of the total cells recovered their numbers increased about 10 
fold (Table 2.8). 
Again the ratio of RBC to labelled cell on the 
radioautographs was 10-100 times lower than expected if 
simple blood contamination were to explain the increase. 
2.3.10 The effect of various antisera on the anti-light 
chain binding c lls in thymus 
Although the evidence so far indicated that the 
binding cells in the thymus were not contaminating B cells, 
more evidence of their thymic origin was required. Therefore 
cells pre-labelled with anti-light chain were treated with 
anti-8 globulin or with an anti-B cell serum and complement. 
The cortisone resistant cell population was mainly studied 
because of the greater frequency of binding cells. Cells 
lysed by the antisera were detected on radioautographs by a 
nigrosin staining procedure. 
2.3.10.1 ?u1ti-8 globulin 
The effect of anti-8 on thymocytes and the cortisone 
resistant thymocytes is shown in Figure 2.10. About 1% of 
thymus cells were found to be resistant to anti- 8 , and in the 
cortisone resistant fraction this proportion increased to about 
10% of the cell population. Radioautographs of labelled 
(12 5r -anti-light chain Ig), and stained, nigrosin cell smears 
indicated that although about 20% of the cells were lysed the 
majority of labelled cells were resistant to the anti- 8 treat-
ment under these conditions. Most of the labelled cells in 
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Figure 2.9 
Involution of the thymus following treatment of mice with cortisyl 
acetate. 
Upper: 
Lower: 
the numbers of viable lymphocyte like cells recovered 
from the thymus at different time intervals after 
treatment (each point is the arithmetic mean of 3 values ). 
the macroscopic appearance of the thymus at 
a) O, b) 12 and c) 24 hours after cortisone treatment. 
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Table 2.8: Anti-light chain binding to cortisone resistant 
thymus cells 
Time after 
Cortisone 
Treatment 
Total cells 
recovered 
Percentage of labelled cells 
Untreated 
24 hours 
>36 hours a) 
(x 10-6 ) 
150 
4 
1.5 
Expt. 1 
0.02 
0.3 
0.2 
Expt. 2 
0.03 
0.3 
a) Pool of cells from mice treated with cortisone 
36, 48 and 72 hours previously. 
Expt. 3 
0.03 
0.4 
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cortisone resistant 
thymocytes 
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normal thymocytes 
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Figure 2.10 
2 4 8 
reciprocal dilution 
of anti-theta globulin 
16 
The cytotoxicity of anti- 6 globulin for 
normal thymocytes (dotted line) and cortisone resistant 
thymocytes (solid line) under conditions described in 
the text. 
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the susceptible population were of the lightly labelled, 
larger category, described previously. It is importa nt to 
point out that there were many (up to 10 %) unlabelled cells 
which were also resistant to the anti- 8 reagent. Hence these 
cells were either not T cells or were cells with very little 
theta antigen which were not being lysed by the anti- 8 
globulin. 
2.3.10.2 Anti-B serum 
The efficiency of this antiserum was estimated on 
a source of B cells from an ATxBM spleen. Up to 80% of cells 
from such a spleen cell population were found to bind the anti-
light-chain Ig reagent (Figure 2.11). Under the conditions 
described, the anti-B serum lysed up to 70% of these labelled 
cells and the total cell population. When tested on the 
cortisone resistant thymus cells, less than 4% of the anti-
light chain binding cells were lysed. Thus an overwhelming 
majority of these cells were more resistant to the reagent 
than were most of the binding cells in ATxBM spleen. Hence, 
the c labelling c 1 lls w re not typicul B culls and the 
po3sibllity of their leing T cells with low theta antigen was 
reinforced. 
2.3.10.3 Anti-heavy chain sera 
The effect of pre-treatment (1 hour, o0 c) of ATxBM 
spleen cells and cortisone resistant thymocytes with 
specific anti-µ chain and anti-y chain sera on the anti-light 
chain binding cells was investigated. Both antisera inhibited 
the binding in both cell populations, decreasing the overall 
number of labelled cells and the density of grains over the 
remaining labelled cells. The anti-y chain serum was 3x more 
effective than the anti-µ chain serum in blocking the anti-
light chain binding (Figure 2.12). Three additional experiments 
showed that anti-µ pretreatment of cortisone resistant 
thymocytes decreased the total proportion of labelled cells 
from 0.48 to 0.39%. 
2.3.11 Estimation of total immunoglobulin present in 
thymocytes 
The possibility remained that many more thymus cells 
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Figure 2.11 
Comparison of anti-light-chain binding cells in 
(a) ATxBM spleen and 
( b) normal thymus. 
(" Standard" conditions , 3 days ' expo s ure.) 
Up to 80 % of c e lls from ATXBM splee n were labelled . 
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Figure 2.12 The effect of pre-treatment with anti-
heavy chain sera on the anti-light chain binding cells 
found in ATxBM spleen and the cortisone resistant thymus 
population. 
(a) C lls pre-treated with normal rabbit serum. 
(b) Cells pre-tr•at_d with anti-µ chain serum. 
(c) Cells pre-treated with anti-y chain serum. 
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detected by the above procedure, contained significant amounts 
of Ig, possibly held in the plasma membrane in such a manner 
that the appropriate groups were not accessible to the anti-L-
chain reagent, although still accessible to antigen. There-
fore thymocytes were dissolved in 5% NP-40, and the amount of 
Ig in these extracts determined by the microprecipitin tech-
nique, as described, using both anti-µ and anti-y chain sera. 
The results of several such experiments are 
presented in Figure 2.13 and Figure 2.14 and summarised in 
Table 2 . 9. The ratio of Ig present in the thymus population 
compared to the spleen population was repeatedly 1:50, despite 
variations in the total amounts of Ig detected between 
individual experiments. In brief, the results were consistent 
with the radioautographic data suggesting that the thymus 
cell population contained a small proportion of cells having 
Ig at about the same density per cell as B cells, while the 
majority of cells had none, or very small amounts, of Ig. 
2 . 3.12 Functional significance of anti-light chain binding 
cells in thymus 
Two attempts were made to investigate the functional 
significance of the anti-light chain binding cells in thymus. 
2 . 3 . 12 . 1 Effect of 125 1 -anti-light-chain suicide on the 
ability of thymus cells to collaborate in an 
anti-SRBC response in vivo 
Spleen, bone marrow and thymus cells were reacted 
with 1251-labelled anti-light chain reagent of high specific 
activity as described by Cooper and Ada (1972). The cells 
·Were then injected into syngeneic irradiated (850 rads) 
recipients . Mice were challenged 2 days later with 2 x 10 8 
SRBC and given a secondary challenge on day 5. On day 8 
spleens were harvested and assayed for anti-SRBC PFC. 
Results of two such experiments are summarized in 
Table 2.10. While there was a marked decrease in the re sponse 
when spleen and bone marrow cells were suicided, thymus 
activity was completely unaffected under the experimental 
conditions used. 
2.3 . 12 . 2 The effect of removal of Ig positive rosette forming 
cells on the ability of thymus cells to collaborate 
in an anti-hapten response in vitro 
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DECREASING DILUTIONS of CELLS or INHIBITOR 
9 10 
Microprecipitin inhibition curves for spleen and thymus NP-40 
cell extracts. (Experiment 1). 
The total amount of lg present in spleen and thymus was in this 
experiment measured by the ability of cell extracts and an IgM 
standard to interfere with the precipitation of 1251-IgM by 
anti-light chain serum. 
Dilution 1 is equivalent to the extract from 5.6 x 106 cells 
(spleen and thymus) and 177 ng IgM standard. 
The 50% end-points (arrowed) were: 
(i) IgM standard: 4ng 
(ii) Spleen: equivalent to the extract from 1.5 x 10 6 
cells. 
(iii) Thymus: well below the level of detection. 
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Figure 2.14 
Microprecipitin inhibition curves for spleen and thymus NP - 40 cell 
extracts (Experiment 2). 
(a) The amount of IgM present in cell extracts was quantitated 
by its ability, r e lative to a known IgM standard, to 
inte rfere with the precipitation of 125 r-IgM (Sng) by 
specific anti-µ chain serum. 
Dilution 1 is equivalent to the 
spleen cells, 8.2 x 107 thymus 1 
extract from 3.1 x 107 
cells, 7.7 x 107 thymus 2 
cells and 275 ng IgM standard. 
The 50% end-points (arrowed) are: 
(i) IgM standard: 4ng. 
(ii) 
(iii) 
Spleen: 
Thymus 1: 
cells. 
equivalent to extract from 2 x 106 cells. 
equivalent to extract from 8.2 x 107 
(iv) Thymus 2: just below the level of detection. 
(b) The amount of IgG present in cell extracts was quantitated by 
its ability, relative to a known IgG standard to interfere 
with the precipitation of 1251 - IgG (Sng) by specific anti-
y chain serum. 
Dilution 1 is equivalent to the extract from 3.1 x 107 spleen 
cells, 8.2 x 10 7 thymus 1 cells, 7.7 x 107 thymus 2 cells 
and 275 ng IgG standard. 
The 50% end points (arrowed) are: 
(i) IgG standard : 17ng . 
(i i ) Spleen : equivale nt to e xtract from 4 x 105 cells . 
(iii ) 
(iv) 
Thymus l : equival e nt to 0xtract from 2 x 10 7 cells. 
Thymus 2 : equivalent to extract from 2.2 x 107 
cells . 
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Table 2.9: Estimation of immunoglobulin in spleen and thymus 
NP-40 extracts (Microprecipitin inhibition) 
Sample ng per 10 6 cells Molecules 7s Percentage Ig 
per cell on Thy/Spl 
(a) IgM 
G.Pig spleen 0.25 
Mouse spleen 1.85 8000 2.6% 
Mouse thymus 0.05 210 
{b) IgG 
G.Pig spleen <l 
Mouse spleen 42.5 170000 2.0% 
Mouse thymus 0.85 3400 
The microprecipitin inhibition tested the ability of cell extracts to interfere 
with the precipitation of (a) 5 ng 1251-IgM by anti-µ (b) 5 ng 1251-IgG + anti-y. 
Values given are a composite of 2 experiments - average of 3 values for thymus. 
Guinea pig spleen cell extracts were included as a specificity control. 
Table 2.10: The effect of suicide with 125r- anti-light chain reagent of higb specific activity on 
the anti-SRBC response in vivo. 
Cells transferred a) 
127r treated spleen b) 
125r treated spleen b) 
127r treated bone marrow 
12 5r treated bone marrow 
127r treated thymus 
125r treated thymus 
127r treated bone marrow 
+ 127r treated thymus 
125r treated bone marrow 
+ 127r treated thymus 
127r treated bone marrow 
+ 125r treated thymus 
125r treated bone marrow 
+ 125r treated thymus 
No cells 
Anti-SRBC PFC 
Expt. 1 
4820 ± 720 
30 ± 17 
n.d. d ) 
n.d. 
n.d. 
n.d. 
1480 ± 420 
760 ± 100 
1940 ± 660 
800 ± 97 
20 ± 8 
per spleen c) 
Expt. 2 
n.d. 
n.d. 
186 ± 70 
162 ± 28 
160 ± 20 
24 ± 14 
1664 ± 420 
96 ± 20 
1106 ± 480 
166 ± 40 
60 ! 20 
a) In experiment 1, approximately 2 x 107 spleen, 1.3 x 107 bone marrow and 8.5 x 107 thymus cells were 
transferred i.v. in 0.3 ml of medium into syngeneic mice which had been lethally irradiated (850 rads) 
24 hours previously. 
In experiment 2, approximately 1.9 x 10 7 bone marrow and 1.2 x 108 thymus cells were transferred. 
b) Cells were incubated (0°c, 30 min) at 5 x 107 - 1 x 10 8 perm~ in medium containing 15 mM sodium 
azide and 5-10 µg/ ml of iodinated anti-light chain reagent. 1 7r is the non-radioactive isotope. 
125r is the radi oactive isotope. The specific activity of the anti-light chain reagent used was 
in the range 150-200 µC/ ug. The cells were spun through 2 FCS gradients and incubated in medium 
for 14-19 hours at 4°c before transfer. 
c) Anti -SRBC PFC were assayed on day 8 after cell transfer following antigenic challenges with 2 x 10 8 
SR.BC on days 2 and 5 after cell transfer. 
d) Not done. 
Table 2.11: The effect of removal of Iq positive rosette forming cells on the ability of thymus cells 
to collaborate in the anti-hapten response to DNP-flagellin ip vitro 
Cells cultured a) 
Untreated spleen cells 
Anti- 8 ascitic fluid and C' treated spleen 
Anti- 8 treated spleen 
+ Thymus cells control rosetted 
Anti- 8 treated spleen 
+ Thymus cells depleted of Ig rosette-forming 
cells 
Thymus, control rosetted alone 
Thymus, Ig depleted alone 
c) 
Anti-DNP PFC per culture b) 
1703 ± 93 
443 ± 44 
806 ± 30 
716 ± 77 
<S 
<5 
a) 5 x 106 viable untreated and anti- 8 treated spleen cells and 2.5 x 10 6 Ig depleted and control 
rosetted thymus cells were cultured per well (final volume, 2.5 ml) as above, with purified, 
oxidized DNP-MON at a final concentration of 100 ng/ml.CBA/H mice were used in this experiment. 
b) Anti-DNP PFC were measured on day 3 after culture. Each value is the arithmetic mean of 4 
cultures± the standard error of the mean. 
c) Rosettes were formed with the Ig positive cells and were separated from the non-rosetting lympho-
cytes by centrifugation on Isopaque/ Ficoll. The rosettes sank with the red cells and the non-
rosetting cells floated . The procedure was >97% efficient at removing the Ig bearing cells 
detected by radioautography (Chapter 5 ). 
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A separation procedure for depleting lymphoid 
populations of Ig positive rosette forming cells will be 
described in Chapter 5 and in Chapters 3 and 4 an in vitro 
anti-hapten response to DNP-flagellin (DNP-MON) is character-
ized. The response to DNP-MON is T cell dependent, and anti- 8 
treated cells give a 3-7 fold lower response compared to 
untreated spleen cells. The response of an anti- 8 treated 
spleen population is partially restored, by addition of thymus 
cells (3.3.2.3.B). This was confirmed in the experiment 
reported in Table 2.11 and the effect of removal of the Ig 
positive rosette forming cells from thymus cells on their 
ability to restore the anti-DNP PFC response was investigated. 
No decrease in their ability to help in the anti-DNP response 
was observed (Table 2.11). 
2.4 DISCUSSION 
The question posed initially in this chapter was: 
Do thymus cells contain Ig and if so, how much? The answer 
was that only a small proportion of thymus cells (<1%) appeared 
to contain a detectable amount of Ig and within this small 
proportion there was a hierarchy of anti-light chain-binding 
cells. Most of the positive cells bound only small amounts 
of the anti-light chain reagent but a few bound as much as 
peripheral B cells. 
This conclusion was reached using three complementary 
techniques:-
a) An estimation of the total amount of 1251-anti-light 
chain Ig, which bound to intact cells by counting in 
a spectrometer. 
b) Radioautography of normal and cortisone resistant 
thymus cell populations after reaction with the 
radioactively labelled anti-mouse reagent. 
c) An estimation of the total amount of Ig present in 
cells, using a quantitative microprecipitin 
inhibition technique in which the inhibitor was total 
Ig present in cell extracts. 
The validity of the conclusion drawn from the first 
two approaches depends upon the availability of membrane 
bound lg to the anti-light chain reagent. For this purpose, 
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a reagent which had been shown previously to interfere with 
the specific "suicide" of peripheral T cells by radioactive 
antigen was used. 
The third approach depends on the efficiency of the 
detergent, nonidet-P-40 to extract and solubilize Ig present 
in or on the cells. Use of NP-40 by us and by Ey (1973) on 
preparations of B lymphocytes yielded an estimate of the 
amount of Ig present on B cells which was comparable to those 
obtained by other workers using different techniques (Unanue 
et al., 1971; Eskeland et al., 1971). In addition, Grey et 
al. (1972b) compared the efficiencies of various procedures 
for extracting Ig from thymocytes and concluded that solubil-
ization with NP-40 was the most efficient technique of those 
tried, which included freeze-thawing and urea/acetic acid 
treatment. However, there are contrary claims (Marchalonis 
and Cone, 1973). 
Attempts to use deoxycholate as an alternative 
solvent to NP-40 were unsuccessful for technical reasons 
associated with the microprecipitin inhibition technique used. 
The small proportion of Ig positive cells found were 
looked at in some detail. The first question asked was 
whether they were intrinsic to the thymus or merely casual 
contaminants. 
Evidence presented indicated that they were present 
in all strains of mice tested at various ages and were not 
casual contaminants from blood or from parathymic lymph nodes. 
The possibility of their selective accumulation in the thymus 
' from the blood was not excluded. 
Secondly, what were the nature and properties of these 
cells? Morphologically, the more heavily labelled cells were 
small lymphocyte-like cells. The lightly labelled cells were 
a heteroge ne ous group of larger cells, some with a high 
proportion, relative to the nucleus, of basophilic cytoplasm. 
Some of these may have been plasma cells, but this kind of 
cell was rare and greatly outnumbered by the other Ig positive 
cells. 
A small proportion (20%) mainly the lightly labelled 
cells were lysed by anti- 8 plus complement. A ne gligible 
proportion only wa s lysed by an anti-B cell, anti-macrophage 
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antiserum. This antiserum was able to kill 95% of splenic 
plaque-forming cells and hence it seems likely that few, if any, 
of the Ig positive cells were plasma cells. It is of interest 
that Vitetta et al. (1973) have found that synthesis and 
secretion of Ig by cells in the thymus can be inhibited by 
an anti-plasma cell serum, suggesting the presence of plasma 
cells in thymus. In addition Perkins et al. (1972) using 
electron microscopy radioautography have reported finding 
small numbers {1/300) of Ig positive cells in thymus which in 
contrast to splenic B cells had unique morphological character-
istics which included fewer ribosomes and a higher cytoplasmic 
to nuclear ratio (1:3). 
Thus the identity of the majority of binding cells 
is uncertain, although it is known that a proportion of 
peripheral T cells are rather resistant to anti-8 antibody 
(Raff and Cantor, 1971). 
What is the role of these cells in the thymus? They 
were considerably enriched in the cortisone resistant fraction 
which is known to contain most of the immunocompetent cells 
for activities such as graft vs. host reaction, (Warner, 1964; 
Blomgren and Andersson, 1969 ) and helper function (Cohen and 
Claman, 1971). One possibility is that they are the end 
product of a differentiation process concerned with the 
maturation of thymus cells for the peripheral T population. 
The absence of large amounts of Ig on peripheral T cells 
argues against this, however, as do the experiments designed 
to investigate the functional significance of the Ig positive 
. cells. Their removal by an Ig rosette forming cell depletion 
procedure did not impair the ability of the remaining cells 
to collaborate in the response to DNP-flagellin in vitro, 
nor did their removal by radioactive anti-light chain suicide 
destroy their ability to help in an anti-SRBC response in 
VlVO. 
Another possibility is that they are incoming cells 
from the bone marrow which apparently differentiate in such 
a way as to lose most of their surface Ig and gain the 8 
antigen. Henuningson {1972) has shown that bursal cells can 
migrate to the thymus. This would explain the lack of sus-
ceptibility of the heavy binding cells to anti- 8 and the 
susceptibility of the lightly labelled cells. 
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A third possibility, that the Ig detected is 
cytophilic for a minor cell population cannot be discounted 
(Chapter 5), particularly as a substantial amount appeared 
to be IgG. 
Although it is not possible to quantitate the radio-
autographic data when such a pronounced hierarchy of binding 
cells is observed, consideration of the data from the three 
approaches leads to a consistent picture. This is, that the 
majority of cells in the thymus contain little Ig, but that 
there is a minor sub-population which does contain demonstrable 
Ig. Of this sub-population, a small proportion contain large 
amounts of Ig, comparable to that present on B cells. It is 
of interest that of a number of thymomas examined recently 
(Harris et al., 1973) some were found to contain large amounts 
of Ig, others little if any. The Ig positive subpopulation 
present in thymus will be discussed further in Chapter 8. 
2.5 SUMMARY 
Thymus cells were examined for Ig by exposing them 
to purified anti-mouse light chain Ig labelled with 125 I and 
examining the amount of reagent bound by bulk counting and 
radioautography. In addition cell extracts were assayed for 
total Ig using a quantitative microprecipitin inhibition 
technique. It was concluded that the majority of cells in 
thymus contained little Ig but that there was a minor sub-
population, of varying morphology, which did contain demon-
strable Ig. This small proportion of cells ( ~1%) appeared to 
be intrinsic to the thymus and dose response data indicated 
that there was a hierarchy of Ig positive cells. They were 
enriched for in the cortisone resistant fraction. The 
majority were resistant to both anti -8 and an anti-B-anti-
macrophage serum, leaving their identity in doubt. Some 
further properties and attempts to attribute a functiona l 
significance to such cells were described. 
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3.1 INTRODUCTION 
Following failure to find large amounts o f Ig on 
thymus cells (Chapter 2), systems for measuring f unctional 
activity of peripheral T cells were investigated. It was 
planned to use such systems for looking further at properties 
of T cells, the nature of the T cell receptor and the 
significance of Ig on the T cell surface. In vitro assay 
systems were pre f erred as they had a number of advantages over 
in vivo systems. 
For example: a) fewer animals were required for each 
experiment; b) results were obtained more quickly (3-4 days 
compared to weeks); c) systems were more open to analysis in 
vitro; and d) variables in the experiments were more easily 
controlled. 
Several major biological activities have been 
attributed to T cells:-
a) the r e j e ction of " f ore ign" cells, which may be grafted 
cells, tumours or altered cells (e.g. virus infected 
cells). 
b) the elaboration of a variety of non-antigen specific 
factors (lymphokines) on activation by antigen; e.g. 
migration inhibition factors (MIF), chemotactic 
factors, cytotoxic factors and mitogenic factors. 
Many of these factors affect the behaviour of macrophages 
or their precursors. 
c) collaboration with B cells either to enhance or suppress 
antibody formation. 
These functions of T cells were considered for in vitro assay 
systems. 
In vitro cytotoxic assays provide the only direct 
measure of T cell function. Assays for measuring the activity 
of cytotoxic T cells for viral infected target cells were 
developed and chara cterized by workers i n this school (Gardner 
et al., 1974 a, b; Dohe rty et al., 1974a, b). T cells 
activated to ectromelia v i rus or lymphocytic choriome ningitis 
virus in vivo were able to rele as e 51cr f rom viral infected 
target c e ll s . The re l ease appeared t o be v i ra l s pecific,as 
~ c l l s rcti v a ed o n e v ·rus would only release Slcr fro m 
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targets infected with the same virus. Attempts were made 
(in collaboration with A. Hapel) to set up a cytotoxicity assay 
for a simpler virus, the Group A arbovirus, Semliki Forest 
virus. This virus consists of 3 proteins, all of which can be 
readily purified. However, no reproducible, specific lysis 
above levels obtained by immune spleen cells primed to a 
heterologous virus could be obtained on a number of target 
systems tested. Also, the nature of the specificity of the 
killing systems (i.e. whether the T cell recognises the virus 
or a virus-induced altered H-2 region or both, Zinkernagel 
and Doherty, 1974) and the relevance of these systems to the 
in vivo activity of the T cell is not yet clear. 
T-B collaboration in antibody formation has, 
however, been clearly demonstrated both in vivo and in vitro 
(see 1.2) and is a well recognized and important T cell 
function even though measurement of T activity is indirect,as 
it is based on the final activity of other cells. In addition, 
one of the strongest pieces of evidence that Ig is the 
functional T cell receptor has come from the work of Feldmann 
and colleagues (1972c, 1973) who claimed that a soluble Ig-
antigen complex released from T cells could substitute for 
the helper function of T cells in the response to hapten-
carrier antigens in vitro. In this chapter, therefore, in 
vitro anti-hapten responses to DNP-HCY, DNP-HGG and DNP-MON 
are described and two of these, the response to DNP-HCY and 
DNP-MON are characterized in some detail. Future chapters 
report experiments using both these culture systems to 
characterize a procedure for separating mouse T and B lymph-
ocytes (Chapter 5) and to investigate mechanisms of T-B 
collaboration (Chapters 6 and 7). 
3.2 MATERIALS AND METHODS 
3.2.1 Animals 
CBA/J mice were purchased from Jackson Laboratories, 
Bar Harbour, Maine, U.S.A. Other mice used were obtained from 
breeding colonies in this School. Nude mice were from both 
heterozygous (nu+ x nu+) and homozygous (nu+ x nu/nu) matings 
of mice obtained originally from Dr. M. Holmes of the Walter 
and Eliza Hall Institute, Melbourne. The heterozygous nudes, 
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originally outbreds, had been backcrossed in CBA/H and Balb c 
mice. Mice were used at 7-9 weeks of age. ATxBM (adult 
thymectomized, irradiated, bone marrow reconstituted) mice 
were thymectomized at 7 weeks of age, lethally irradiated 
(850 rads) 2 weeks later and reconstituted by i.v. injection 
of 2 x 10 7 bone marrow cells. Unless otherwise stated CBA/H 
mice were used throughout. Outbred New Zealand rabbits 6-12 
months of age were used for raising antisera. 
3.2.2 Irradiation of mice 
Groups of 5 mice were placed in cylindrical plastic 
containers (diameter 9.5 cm, height 4.5 cm) on rotating 
stages 15 cm from a 60co rod source and given 850 rads 
whole body gamma irradiation, over a period of 20-25 min. 
3.2.3 Antigens 
Monomeric flagellin {MON), molecular weight 40000, 
was prepared from the flagella of Salmonella typhimurium SL 
870 (Ada et al., 1964) and oxidized to prevent repolymerization 
(Parish and Stanley, 1972). 
Haemocyanin (HCY), a pentamer of molecular weight 
450000, was crystallized from the haemolymph of the South 
Australian crayfish, Jasus lalandii. (Moore et al. , 196 8 ), 
Human gamma globulin {HGG), Fraction II, was purchased from 
CSL, Melbourne and bovine serum albumin (BSA), Fraction V 
from Armour Pharmaceutical Co., England. These proteins were 
dinitrophenylated, according to the method of Eisen, (1964). 
Conjugation ratios used were DNP 0 . 2 5 MON to DNP2.s MON, 
~ DNP4s HCY, DNP20 HGG and DNP20 BSA. SRBC were obtained from 
a single sheep in this school, and were stored in Alsever's 
solution and washed 4x in saline prior to use. 
Mice were primed with 10 µg MON in saline . l. V. , 
1 week to 1 month before use, 1 mg IICY or 500 µg alum 
precipitated HGG, with 109 B. pertussi s organisms (Commonwealth 
Serum Laboratories (CSL), Melbourne) in 0.2 ml saline, 1.p., 
1 week before use; or 500 ~g alum precipitated DNP-BSA and 
pertussis i.p., as above, 2 to 4 months before use. 
3 , • 4 _P;;...r,....."~-.. ~....;,,.;;;.·i ;;...;;00.._n,., ... _.;o f: <:. l J~~.~-s ' on E._ 
Spleen and thymus cell suspcng'ona we a pr p ~ed 
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in tissue culture medium, under sterile conditions as 
described earlier (2.2.2). The viability of such cell 
suspensions was generally >90%. Cortisone resistant thymocytes 
were prepared from the thymuses of mice which had received 
cortisyl acetate (5mg/0.2ml) s.c. 24 hours previously (2.3.9). 
3.2.5 Tissue culture 
Eagle's minimal essential med i um (F 15) (Grand 
Island Biological Co., Grand Island, New York) buffered with 
sodium bicarbonate and supplemented with 10% foetal calf serum 
(CSL, Melbourne), 100 µg/ml streptomycin, 100 units/ml 
penicillin G, and 10-4 M mercaptoe thanol was used for cell 
culture. Cells were cultured with antigen in this medium 
(5-6 x 10 6 cells/well in a final volume of 2.5 ml) in 16 nun 
Linbro trays (Linbro Chemical Co., New Haven, Connecticut, 
U.S.A.). 
Cultures were placed in a humidified incubator at 
37°c in an atmosphere of 10% co2 , 7% 02 in N2 , for three days, 
and then harvested and assayed for plaque-forming cells. 
3.2.6 3HTdr uptake in vitro 
Cells (5 x 10 6;2.Sml) were incubated in culture 
me dium, as above , f or 3-5 days with antige n 3HTdr (Radio-
chemical Centre, Ame rsham, U.K.) was the n adde d for 5 hand 
the uptake into DNA measured both by bulk counting and by 
radioautography. 
3.2.7 Radioautographic procedure 
See 2.2.6 
3.2.8 Preparation of hyperinunune anti-SRBC antiserum 
Rabbits were injected i.v. (ear) twice a week with 
1ml of a suspension of washed SRBC with a concentration 
gradually increasing from 10 up to 50 per cent SRBC in saline. 
Seven days after the sixth injection, the animals were bled 
and serum collected. Anti-SRBC antibody titres were assayed 
by a haemagglutination procedure (Langman, 1972) and were 
generally greater than 1:1500. 
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3.2.9 Precipitation of anti-SRBC globulin 
Globulins were precipitated from the immune serum 
by ammonium sulphate precipitation (35% saturation). After 
washing and reprecipitation the globulins were dissolved in 
O.lM phosphate, 0.002M EDTA buffer and dialyzed against the 
same overnight. 
3.2.10 Preparation of anti-SRBC Fab 
Anti-SRBC globulins prepared as above, were digested 
with papain (2x crystallized Cat. No. P3125 Sigma Chemical 
Co.) for 2-4 hat 37°c according to Porter (1959). The 
reaction was stopped by addition of solid iodoacetamide and 
the mixture cooled in ice and then dialysed (overnight at 4°c) 
against Dulbecco's balanced salt solution (DBSS) (Dulbecco 
and Vogt, 1954). This procedure allowed most of the Fe piece 
to precipitate. 
3.2.11 Removal of undigested IgG from Fab preparation 
As the reaction with papain was not 100% efficient, 
there was still some undigested IgG present in the Fab reagent. 
It was necessary to remove this as the Fe portion of the IgG 
was able to fix guinea pig complement and cause lysis of the 
coated SRBC in the plaque assay. The Fab reagent was purified 
in two ways - either by centrifugation on preparative (36 ml) 
sucrose gradients (10-30% sucrose in DBSS + 15mM NaN 3 , 55K, 
24-30h), or by passage through a G-200 column (approx. 90 
cm long with an internal diameter of 2.5 cm). Both procedures 
achieved good separations and enabled the Fab reagent to be 
obtained in pure form. 
3.2.12 Dinitrophenylation of the anti-SRBC Fab 
The Fab reagent was dinitrophenylated, as for the 
protein antigens, using 2, 4-dinitrobenzene sulphonate 
(Eastman Organic Chemicals, N.Y.) as described by Strausbauch 
et al., (1970). An average number of 3 DNP groups per Fab 
molecule was determined spectrophotornctrically (Eisen, 1964). 
3.2.13 Reaction of SRBC with anti-SRBC Fab-DNP 
The anti-SRBC Fab-DNP was reacted at various 
concentrations with 10% SRBC in DBSS (lh, 37°c) ~ followed by 
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2 washes in DBSS. The optimum dilution of reagent was the 
one which detected the greatest number of clear, regular 
plaques. 
3.2.14 Enumeration of plaque-forming cells 
Plaque forming cells (PFC) were detected using the 
technique of Cunningham and Szenberg, (1968). To detect anti-
DNP PFC, SRBC were coated with the dinitrophenylated rabbit 
anti-SRBC Fab as described above. Indirect plaques were 
developed using a rabbit anti-mouse Ig serum. This was 
prepared by injecting rabbits with 1 mg of mouse Ig (40% (NH4 ) 2 
so4 precipitate of normal mouse serum) in FCA into the flanks 
at 4 sites. Four weeks later the rabbits received a second 
challenge in FIA (1 mg, 4 sites in flanks) and one week later 
serum was obtained and tested. The optimum dilution of 
developing antiserum (i.e. the one which detected most 
indirect plaques) was obtained by titrating it in a plaque 
assay. 
The tissue culture response was largely IgM in 
nature, so only direct plaques were measured in the in vitro 
experiments. 
3.2.15 Preparation of anti- 8 reagent 
Anti- 0 ascitic fluid was prepare d in AKR/J mice 
which were give n up to 10 intraperitoneal injections of 5-10 
x 107 CBA thymocytes at weekly intervals. The first injection 
was given with 10 9 B. p e rtussis organisms . Three days before 
the f inal dos e o f thymocytes , the mice were injected intra-
. pcritoneally with 0.2 ml of a 10 % su s p e n s ion of sarcoma 180 
cells in saline (Tikasingh et al., 1966). The ascitic fluid 
was harvested 7 days after the final thymocyte injection. Un-
immunized AKR/J mice were used as donors of control ascitic 
fluid. The anti- 8 ascitic fluid was cytotoxic for >98% of 
thymus cells and for 20 to 30% of spleen cells. 
3.2.16 Treatment of cells with anti- 8 and complement 
Cells were incubated (37°c, 30 min) at a concent-
ration of 5 x 10 7 - 1 x 10 8 cells/ml with a 1:2 dilution of 
anti- 8 ascitic fluid, washed and resuspe nded in a 1:2 
dilution of guinea pig serum, adsorbed previously on agarose 
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(80 mg/ml, o0 c for 1 hour) and checked for anti-mouse activity, 
as even after this adsorption some batches of complement were 
found to have considerable toxicity for mouse thymus cells. 
Cells were then incubated for a further 20 min at 37°c, washed 
and recounted. Viability was judged by trypan blue (0.05%) 
dye exclusion. 
3.2.17 Treatment of cells with anti-Ig serum and complement 
Anti-IgM serum was kindly donated by P.L. Ey 
(2.3.2.5 }. After adsorption with thymocytes (5 x 108 cells/ml} 
this antiserum was cytotoxic for 40-50% of spleen cells and 
less than 10% thymus cells were affected. Cells were treated 
with this antiserum as per 3.2 •. 16. After the reaction dead 
cells were removed by mixing cells with 20 times their volume 
of isotonic glucose and passing them through cotton wool. 
Cells recovered were >95% viable. 
3.2.18 Fractionation of spleen cells on Isopague/Ficoll 
Spleen cells were depleted of irrununoglobulin bearing 
cells by the one-step fractionation method developed by 
Parish and Hayward (1974) for the rat. The procedure for the 
mouse is described in detail in a later chapter (Chapter 5). 
3.2.19 Footpad assay of delayed type hypersensitivit~ (DTH) 
Mice were injected subcutaneously behind the left 
and right shoulders with antigen in a total of 0.2 ml saline 
or 0.2 ml complete Freund's adjuvant (Difeo, Detroit, 
Michigan, U.S.A.) and their hind footpads were assayed for DTH 
. reactivity 6 days after this injection. The dorso-ventral 
thickness of each hind footpad was measured in tenths of a 
millimetre ( ±0. 0 5 rrun) with a dial gauge caliper ("Schnell taster", 
H.C. Kroplin, Hessen, West Germany) before and after the sub-
cutaneous injection of antigen and saline into the right and 
left footpads respectively, using a micrometer syringe and 
the mean percentage increase in footpad thickness calculated 
( Cooper , 19 7 2 a ) . 
3.3 RESULTS 
3.3.1 Measurement of anti-DNP antibodx 
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3.3.1.1 Preliminary remarks 
Before in vivo or in vitro systems for measuring T 
cell helper function in an anti-hapten response could be set 
up, it was necessary to have a reproducible, reliable and 
quick method for assaying anti-hapten antibody. The most 
common method for measuring serum anti-hapten antibody 
involved modifications of the Farr assay (Brownstone et al., 
1966; Mitchison, 1971; Roelants and Askonas, 1971; Hamaoka et 
al., 1973). This method relied on reaction of the serum under 
test with 125 r-labelled DNP peptides, followed by precipitation 
of the antigen-antibody complexes with ammonium sulphate and 
subsequent counting of the supernatants. For measuring anti-
DNP PFC, DNP had to be coupled to SRBC. This could be done 
either directly by chemical means (Layson and Sehon, 1967; 
Yamada and Yamada, 1969; Havas and Hraba, 1969; Trump, 1972), 
or indirectly using a dinitrophenylated rabbit anti-sheep 
reagent (e.g. Strausbauch et al., 1970; Miller and Segre, 1972) 
or a chicken anti-sheep reagent (Silver, et al., 1971). 
The chicken anti-sheep reagent had the advantage that chicken 
IgG did not fix guinea pig complement so that the antiserum 
could be coupled directly with the hapten and used at a sub-
agglutinating dose for coating SRBC. With the rabbit reagent, 
however, unless very low doses of reagent could be used 
(Miller and Segre, 1972) the Fab of the Ig had to be made to , 
prevent lysis of the SRBC by guinea pig complement during the 
plaque assay. 
All the above methods yielded similar results as 
regards the kinetics of the anti-DNP response in vivo, but the 
overall number of plaques detected varied. The indirect 
coating methods seemed more efficient at detecting anti-DNP 
PFC. In addition, indirectly coated cells had the advantage 
of being stable for longer periods after coating. 
A direct method for coating SRBC, described by 
Trump, (1972) in which SRBC were reacted with FDNB was tried 
with success. The method had the advantage that large 
numbers of coated SRBC could be prepared at one time. However, 
the method had a number o f disadvantages : 
a) the coating proc e dure was not reliably r e producible and 
seemed to depend quite critically on parameters such as 
38 
the temperature of the reaction (room temperature 
variations) and the state, e.g. age, of the SRBC being 
coated; 
b) the coated cells were not reproducibly stable. Some 
batches would last no more than 1-2 days while others 
could be stable for a week or more; 
c) no indirect plaques were ever detected using these 
directly coated cells under conditions known to detect 
indirect plaques for the anti-SRBC response. 
An indirect method of coating SRBC with DNP using 
anti-SRBC-Fab-DNP was much more successful and satisfied 
criteria of being quick, r_producible and reliable. Details 
of the method are described by Strausbauch et al., (1970) 
and in the Materials and Methods section of this chapter. The 
procedure had the advantages that:-
a) the numbers of plaques detected were consistent with 
those described by others using indirect procedures 
(i.e. of the order of 105 PFC per spleen at the peak 
of response); 
b) plaques were clearly defined, regular and easy to count; 
c) indirect plaques were readily detected with developing 
antiserum; 
d) coated SRBC were reliably stable for 1-2 weeks. 
This method was thus adopted and used in all future experiments 
where anti-DNP PFC were measured. 
3.3.1.2 Properties of the anti-DNP PFC detected using anti-
SRBC Fab-DNP coated SRBC 
A. Appearance of anti-DNP PFC 
Plaques obta i ned with the optimal dilution of anti-
SRBC Fab-DNP were clear, circular (l-3 rrun diameter) and 
easily counted. Under high magnification a central lymphoid 
cell was clearly visible and RBC ghosts could be seen in the 
plaque. 
B. Stability of the coated SRBC 
The same number of background anti-SRBC PFC (around 
100 per spleen) were obtained on both DNP coated and normal 
SRBC. 
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c. Specificity of the anti-DNP PFC 
When dilutions of DNP-BSA were incorporated into 
the plaque assay an inhibition of the anti-DNP PFC response 
was observed (Table 3.1 ). This inhibition was not due to 
any toxic properties of the DNP-BSA for PFC as at the same 
dilutions at which it was inhibitory for the anti-DNP PFC 
response it had no effect on the ability of an immune anti-
SRBC spleen cell suspension to form plaques on SRBC. 
Dilution of the anti-DNP immune spleen cell 
suspension caused a corresponding decrease in the number of 
plaques observed. 
D. Kinetics of the response and detection of indirect PFC 
Unimmunized mice gave only background numbers of 
plaques (100-200 per spleen}. Following immunization with 
500 µg of alum precipitated DNP-BSA and 109 B. pertussis 
organisms i.p., anti-DNP PFC increased in number through to 
the 6th day and were found in decreasing numbers in the 
spleen after the 7th day. Indirect plaques were found in 
low numbers (10-60% of the direct response) from day 4 onwards. 
The secondary response was predominantly indirect and tended 
to peak at day 4 after challenge (Table 3.2). 
3.3.2 Characterization of in vitro anti-hapten responses 
Systems for obtaining in vitro anti-DNP responses 
to hapten-carrier antigens, DNP-HCY, DNP-HGG and DNP-MON were 
set up and two of these, the responses to DNP-HCY and DNP-
MON, were characterized in some detail. 
3.3.2.1 Characterization of the anti-hapten response to 
DNP-HCY 
A. Kinetics o f the r ·seonse 
When spleen cells from normal CBA/H mice were 
cultured with DNP-HCY only a minimal response was observed 
unless cells primed to both the hapten and carrier were used. 
Initially, hapten primed cells (2 x 10 6 per well) were 
cultured with increasing numbers of carrier primed cells 
(1 x 10 6 - 4 x 10 6 per well) and the response compared with 
hapten primed cells cultured with 4 x 10 6 normal (i.e. 
umprimed) spleen cells. Within each group there were four 
~~~-3~._l : Specificity of the anti-DNP PFC 
Inhibitor (DNP-BSA) Anti DNP PFC Anti SRBC PFC 
present in plaque per spleen per spleen 
assay a) b) c) 
No inhibitor 2440 2620 
Inhibitor undilut e d 180 1880 
Inhibitor 1/2 dilution 200 2160 
Inhibitor 1/5 dilution 760 2280 
Inhibitor 1/10 dilution 720 2680 
a) 1 drop of inhibitor or the appropriate dilution was 
added to the plaque mixture (0.1 ml spleen cells, 2 
drops medium, 2 drops SRBC , 1 drop C' where 1 drop was 
equivalent to 0.01 ml). 
bJ Sple 1ns w~re taken on day 3 a fter 1° challenge (500 µg 
DNP-BSA alum precipitated+ 10 9 B. pertussis organisms 
i.p.). 
c) Spleens were taken on day 3 after primary challenge 
with 2 x 10 8 SRBC i.v. 
Only direct plaques were measured. 
Table 3 .2: Dcveloprn _. nt of indirect anti-DNP PFC 
D V loping antiserum present Anti-DNP PFC per spleen 
in plaqu assay a) Primary b) Secondary 
response response 
No developing serum 840 2160 
s rum 1/20 360 12080 
S •rum 1/40 1260 1344 0 
S _; rum 1/80 1240 11520 
Sr2rum 1/160 1120 6160 
Serum 1/320 860 3960 
Serum 1/640 790 2360 
Serum 1/1280 820 2280 
a) 1 drop of deve loping sc rum or appropriate dilution per 
pl quc ass,y. 
b) Spleens were taken on day 5 after primary challenge 
(500 pg alum precipitated DNP-BSA + 10 9 B. pertussis 
organisms i .p. ). 
c) 
c) Spleens were taken on day 5 after 2° challenge (as for 1°). 
Dilution 1/40 was optimal for developing indirect plaques. 
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replicate wells. Cultures were set up in triplicate so that 
the response could be followed on three successive days, 
days 3, 4 and 5 after culture. DNP-HCY was at a final 
concentration of 2 µg/ml, a fortuitous choice as the optimum 
concentration of antigen was later found to be between 2-3 
µg/ml (Table 3.3). The anti-DNP response of such cultures is 
summarized in Figure 3.1. 
The wells which received carrier primed cells showed 
significantly higher anti-DNP responsescompared to those which 
received unprimed cells,on all 3 days of culture. The 
optimal PFC response and difference occurred on day 4, (open 
circles and triangles), the background plaques (i.e. where 
no carrier primed cells were added) remaining at the same 
level on days 3 and 4, whereas cultures which received HCY 
primed cells continued to show an increase in the anti-DNP 
PFC. By day 5 the PFC response had severely declined in all 
groups. 
B. Optimum culture conditions 
The difference in anti-DNP PFC response between 
cultures receiving carri •r primed cells rather than normal 
spleen c lls was only 2~ fold, and it was hoped that by 
investigating parameters of the tissue culture system larger 
differences might be obtained. Three such parameters were 
antigen dose, replenishment of culture medium and the time 
between carrier priming and cell culture. 
Antigen dose 
Hapten primed cells (2 x 10 6 per well) were cultured 
with carrier primed (4 x 10 6 per well) or unprimed spleen 
cells (4 x 10 6 per well) with varying concentrations of DNP-
IICY and assayed for anti-DNP PFC on day 4. The results are 
shown in Table 3.3. The optimal antigen dose was clearly 
2.5 µg/ml where again a 2~ fold increase in the anti-DNP 
response was obtained in the presence of carrier primed cells. 
Effect of change of medium during culture 
The effect of replenishing the culture medium on the 
anti-DNP PFC response was investigated. Cells were cultured 
as usual and either left untouched during culture or were 
PFC per CULTURE 
900 
800 DAY 4 
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DAY 3 
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300 f 
200 
DAY 5 
I 
0 1 2 3 4 
6 CARRIER PRIMED CELLS per WELL (XlO ) 
Figure 3.1 The in vitro anti-DNP r~sponse to DNP-HCY. 
Hapten primed cells (2xlo6 per well) were cultured with 
increasing numbers of carrier primed cells (6 days after 
priming - lxlo6 - 4xlo6 per well) (Circles), or with 
normal, unprimed spleen cells (4xl06 per well) (triangles). 
The response to DNP was measured on days 3, 4 and 5 
fter cultur . DNP-HCY was at a final concentration of 
2µg/ml. 
Medium and antigen were replaced on days 2 and 4 of 
culture. Each point represents the arithmetic mean of 
four wells± the standard error of the mean. 
Table 3.3: Effect o f conce ntration of DNP-HCY on the anti-
DNP response l ll vitr~ 
Cells cultured 
a) 
DNP primed 
+ HCY primed 
DNP primed 
+ unprime d 
DNP primed 
+ HCY primed 
DNP primed 
+ unprimed 
DNP primed 
+ HCY primed 
DNP primed 
+ unprimed 
__ ,__,,_ ___ ~--·---· 
Concentration 
of antigen 
( µg/ml) 
l 
Anti-DNP PFC per 
culture b) 
522 ± 51 
300 ± 30 
--·-~-___...,....- -~--__,.,..,,. _______ _ 
681 ± 39 
2.5 
258 ± 39 
- -.. ·----··--·-------
228 ± 24 
5 
186 ± 3 
·---I"'-..._~-~'·------------------
a) 2 x 10 6 DNP primed cells were cultured with 4 x 10 6 carrier 
primed (6 days previously) or unprimed cells. Medium and 
antigen were replaced on day 2. 
b) Cultures were assayed on day 4 of culture. Each value 
represents the arithmetic mean of 4 wells± the standard 
error of the mean. 
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given a change of medium with fresh antigen on day 2 or a 
change of medium without antigen on day 2 or day 3. Results 
are given in Table 3.4. There was little difference in the 
overall anti-DNP response or the response over background 
levels following any of these procedures. 
Effect of time of carrier priming on the anti-DNP response 
To investigate when the carrier primed population 
was most efficient at helping in the anti-DNP response, 
spleen cells from mice which had been primed at intervals 
from 3 to 36 days prior to culture were added to DNP primed 
cells and cultured with DNP-HCY as usual. The responses of 
two such experiments are shown in Table 3.5. There was some 
slight trend towards increased help at longer periods after 
priming but differences above background were still no more 
than 3 fold. 
C. Dose response of carrier primed cells and specificity 
of the help effect 
The optimum number of carrier primed cells in the 
culture was investigated by adding increasing numbers (1 x 
106 to 8 x 106) of carrier primed or unprimed spleen cells 
to hapten primed cells (2 x 10 6 ) and culturing them under 
optimal conditions (3.3.2.1 B). At the ratio of 2 x 10 6 hapten 
primed cells to 5 x 10 6 carrier primed cells the best response 
was observed - a 3 fold difference above the background level 
(Figure 3.2). It is of interest that hapten primed cells and 
carrier primed cells, in the absence of antigen (open 
·triangles), gave a background anti-DNP response of the same 
order as that of the unprimed cells. It was thus likely that 
all the response above background was a specific help effect. 
To show that it was a specific effect and not just 
a conseyuanc! of recent prlming, allowing, for example, more 
efficient handling of antigen, the experiment shown in Figure 
3.2 was repeated. This time, however, heterologously primed 
spleen cells were included as well as normal cells as a 
specificity control for the help effect. Results are given 
in Table 3.6. Cultures which received HGG primed spleen cells 
gave slightly higher background responses than cultures with 
u~primed cells, but responses obtained when HCY primed cells 
Table 3.4: Effect of change of medium on the anti-DNP 
response to DNP-HCY 
C lls cultured a ) 
DNP primed 
DNP primed 
+ HCY primed 
DNP primed 
+ unprimed 
DNP primed 
DNP primed 
+ HCY primed 
DNP primed 
+ unpri.m d 
DNP primed 
DNP primed 
+ HCY primed 
DNP primed 
+ unprimed 
DNP primed 
DNP primed 
+ HCY primed 
DNP primed 
+ unprimed 
Medium 
change 
None 
Medium change 
+ antigen day 
Medium change 
- antigen day 
Medium change 
- antigen day 
Anti-DNP PFC per 
culture b) 
319 ± 72 
575 ± 57 
317 ± 29 
111 ± 20 
2 535 ± 27 
237 ± 30 
123 ± 42 
2 490 ± 61 
209 ± 15 
162 ± 25 
3 574 ± 25 
297 ± 52 
a) 2 x 10 6 DNP primed cells were cultured with 4 x 10 6 
carrier primed (6 days previously) or unprimed cells. 
DNP-HCY was at 2.5 µg /ml. 
b) Cultures were assayed on day 4 of culture. Each value 
represents the arithmetic mean of 4 wells± the standard 
error of the mean. 
Table 3.5: The effect of time after carrier priming on the 
ability of spleen cells to help in an anti-DNP 
respo nse 
Days after Anti-DNP PFC per culture b) 
priming Expt. 1 Expt. 2 
DNP primed DNP primed a) DNP primed DNP primed 
+ HCY primed + HGG primed + HCY primed +HGG 
primed 
3 n.d. c) n.d. 201 ± 11 115 ± 11 
5 371 ± 57 199 ± 44 n.d. n.d. 
7 n.d. n.d. 410 ± 28 143 ± 31 
17 558 ± 67 n.d. 524 ± 31 299 ± 67 
22 n.d. n.d. 559 ± 22 374 ± 34 
28 704 ± 30 n.d. 840 ± 70 393 ± 34 
36 734 ± 28 278 ± 54 n.d. n.d. 
a) 2 x 10 6 hapten primed cells and 5 x 106 carrier primed 
cells were cul ured per well. DNP-HCY was at a final 
concentration of 2.5 µg /ml. Cultures were assayed on 
day 4. 
b) Each value is the arithmetic mean of 4 wells± the 
standard error of the mean. 
c) Not done. 
PFC per CULTURE 
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Figure 3.2 The anti-DNP PFC response obtained when 
increasing numbers of carrier (i.e. HCY primed 6 days 
previously) or unprimed spleen cells were cultured 
with DNP primed spleen cells (2xl0 6 per well) 
e - e DNP primed + HCY primed cells 
DNP-HCY at 2 µg/ml. 
0-0 DNP primed + unprimed spleen cells 
DNP-HCY at 2 µg /ml. 
1::.-1::. DNP primed cells + HCY primed cells 
No DNP-HCY in cultures. 
Cultures were assayed on day 4. Each point represents 
the arithmetic mean of 4 wells± the standard error of 
the mean. 
Table 3.6: Specificity of the help effect of HCY primed 
spleen cells in the anti-DNP response to DNP-
HCY 
Cells cultured Anti-DNP PFC per culture a) b) when 
Hapten Carrier carrier primed cells were: 
primed primed HCY primed HGG primed Unprimed 
2 X 10 6 283 ± 79 283 ± 79 283 ± 79 
2 X 10 6 2 X 10 6 418 ± 40 286 ± 13 175 ± 20 
2 X 10 6 5 X 10 6 774 ± 24 351 ± 54 223 ± 38 
2 X 10 6 8 X 10 6 569 ± 40 438 ± 21 224 ± 40 
a) DNP-HCY was at a final concentration of 2.5 µg/ml. 
Cultures were assayed on day 4. 
b) Each value represents the arithmetic mean of 4 cultures 
± the standard error of the mean. 
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were present were clearly better. 
D. Collaboration between DNP primed and HCY primed cell 
populations 
The increase in PFC response when HCY primed cells, 
rather than HGG primed cells, were cultured with the hapten 
primed cells was due to a true collaborative response between 
the hapten and the carrier primed spleen populations as shown 
by some representative experiments in Table 3.7. The additive 
response obtained by either hapten or carrier primed cells 
cultured alone was always at least two fold less than the 
response obtained when the two populations were cultured 
together, and this was 2-3 fold higher than the response of 
DNP primed cells cultured with heterologously primed carrier 
cells. 
E . Effect of treatment of the carrier primed cells with 
anti- 8 and anti-lg and complement 
To show that it was primed T cells in the carrier 
population that were responsible for the collaborative effect, 
the carrier primed population was treated with anti- 8 and 
complement prior to culture with the hapten primed cells. 
However, this treatment had variable effects on the anti-DNP 
PFC response, from complete abrogation of the collaborative 
effect, to partial abrogation, to no effect (Table 3.8). 
There was an indication that the anti- 8 treatment was more 
effective on spleen cells primed for periods greater than 6 
days. Treatment of the carrier primed population with anti-
'immunoglobulin serum prior to culture decreased the collabor-
ative effect (Table 3.8). Thus it appeared that both Band 
T cells in this population were important in the in vitro 
anti-DNP response to DNP-HCY. 
F. Fractionation of carrier primed cells on Isopaque/ 
Ficoll 
A role f or T c ells in the collaborative response 
was further demonstrated following fractionation of the carrier 
primed cells on Isopaque/Ficoll (Chapter 5). These cells were 
depleted of Ig bearing cells and the ability of the upper 
layer (i.e. T cells) to collaborate with the hapten primed 
Table 3 .7: Collaboration between DNP primed and HCY 
primed cell populations 
Cells cultured a) Anti-DNP PFC per culture 
Expt. l Expt. 2 Expt. 3 
DNP primed 234 + 14 133 ± 19 133 ± 21 
HCY primed 94 ± 12 141 + 15 134 ± 38 
DNP primed 
+ HCY primed 604 ± 67 876 ± 57 623 ± 99 
DNP primed 
+ HGG primed 232 ± 4 127 + 2 264 + 30 
b) 
Expt. 4 
120 ± 6 
31 + 5 
593 ± 14 
199 ± 8 
a) 2 x 10 6 DNP primed cells were cultured with 5 x 10 6 HCY 
or HGG primed spleen cells. DNP-HCY at 2.5 µg/ml. 
b) Cultures were assayed on day 4. Each value is the 
arithmetic mean of 4 wells± standard error of the mean. 
Table 3.8: Effect of treatment of the carrier primed cells with anti- 8 or anti-Ig and complement 
on the anti-DNP response 
Cells cultured a) 
D~-P primed alone 
DN? primed 
HCY primed 
D::-P prif"ed 
BCY primed 
DNP primed 
ECY primed 
DNF primed 
ECY primed 
DNP primed 
HGG primed 
Treatment of carrier 
primed cells 
-
Untreated 
NormaJ ascitic fluid 
and C' 
Anti-8 ascjtic 
fluid and c' 
Anti-Ig and CJ 
Untreated 
Expt. 1 
310 ± 45 
643 ± 34 
590 ± 108 
528 ± 39 
312 ± 51 b) 
195 ± 15 c) 
250 ± 31 d) 
356 ± 47 
Anti-DNP PFC per culture e) 
Expt. 2 Expt . 3 Expt. 4 Expt . 5 
205 ± 37 133 ± 19 40 ± 16 141 ± 15 
578 ± 111 n.d n.d. n.d. 
590 ± 127 976 ± 57 411 ± 47 715 ± 62 
566 ± 69 167 ± 34 238 ± 23 303 ± 45 
n.d. f) n.d. 196 ± 43 n.d. 
272 ± 26 127 ± 2 225 ± 17 148 ± 36 
a) 2 x 10 6 DNP primed cells were cultured with 5 x 106 viable carrier primed cells. In experiments 1, 
2 and 3 carrier primed cells were taken 6-8 days post priming and in experiments 4 and 5, more than 
30 days after priming. 
b) 1 x 10 6 , c) 3 x 106 and d) 5 x 10 6 viable anti-Ig treated carrier primed cells per culture. 
e) Cultures were assayed on day 4. DNP-HCY at 2.5 µg/ml. Each value represents the arithmetic mean of 
four cultures± the standard error of the mean. 
f) Not done. 
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B cells examined. It was shown (Table 3.9) that the T cells 
could collaborate to give good anti-hapten responses to 
DNP-HCY. This collaboration was removed by treating the 
upper layer cells with anti-8 and complement. 
T cells, there f ore had a role in the collaborative 
anti-hapten response to DNP-HCY, but the role of the B cell 
remained to be investigated. The small differences with the 
DNP-HCY response hampered further investigations along these 
lines with this system, but using the in vitro response to 
DNP-MON (3.3.2.3) further light on the role of the carrier 
specific B cell in collaboration was obtained (Chapters 6 and 
7) • 
G. Collaboration between DNP primed and HCY primed cells 
ln vivo 
Collaboration between DNP primed and HCY primed 
cells could also be demonstrated in vivo (Table 3.10), when 
these cells were injected into irradiated recipients (850 rads, 
24 h previously) with 100 µ g DNP-HCY. Spleens were harvested 
7 days after the cell transfer and indirect anti-DNP PFC 
measured. There was clear collaboration between the two cell 
populations, as observed in vitro. 
3.3.2.2 Response to DNP-HGG in vitro 
Collaboration between DNP primed and HGG primed 
cells was demonstrated in vitro in the anti-DNP response to 
.DNP-HGG. Responses were lower, however, than the anti-DNP-
HCY responses as shown in Table 3.11, where optimal conditions 
for the response were used. 
3.3.2.3 Response to DNP-MON in vitro 
When spleen cells f rom CBA/H mice were cultured 
with DNP-MON as in 3.3.2.lA, in contrast to the previous 
anti-hapten responses (3.3.2.1 and 3.3.2.2), a large 
Table 3.9: Fractionation of carrier primed cells on Isopaque/ 
Ficoll - ability of pure T cells to collaborate 
with hapten primed B cells in the anti-DNP PFC 
response 
a) Anti-DNP PFC per culture b) Cells cultured 
Expt. 1 Expt. 2 Expt. 3 
DNP primed 120 ± 6 234 ± 14 108 ± 3 
DNP primed 
+ HCY primed 593 ± 14 800 ± 77 583 ± 31 
DNP primed 
+ HGG primed 199 ± 8 232 ± 4 199 ± 8 
DNP primed 
+ HCY primed 738 ± 26 528 ± 7 454 ± 25 
T cells untreated 
DNP primed 
+ HCY primed T 
cells t,reated with 
n.d. c) n.d. 378 ± 16 normal ascitic fluid 
and c' 
DNP primed + HCY 
primed T cells 
n.d. n.d. 74 ± 11 treated with anti-
e and CI • 
HCY primed T cells 
alone < 5 <5 0 
a) 2 x 106 DNP primed cells and 5 x 106 HCY primed spleen 
cells were cultured per well. 5 x 106 HCY primed T cells 
were cultured in Experiments 1 and 2 and 2.5 x 106 HCY 
primed T cells were cultured in Experiment 3. HCY primed 
cells were taken 6 days after priming. DNP-HCY was at 
2.5 µg/ml. 
b) Cultures were assayed on day 4. Each value is the 
arithmetic mean of 4 wells± the standard error of the mean. 
c) Not done. 
d) See also Table 5.3. 
T bl, 3 . 10 : Collaboration L ~ we e n DNP prime d and HCY 
prim ~d sple n c 1 lls in vivo 
C lls transferr d 
a ) 
DNP primed alone 
HCY primed alone 
DNP primed 
+ HCY primed 
DNP prim d 
+ unprimed spleen 
Indirect anti-DNP PFC per spleen 
Expt . 1 Expt. 2 
1400 ± 440 1480 ± 260 
2040 ± 420 n.d. 
11100 ± 2100 19300 ± 4480 
n.d. 900 ± 320 
b) 
a) In experiment 1, 2 x 10 7 DNP primed and 5 x 10 7 HCY primed 
c e lls (6 days after priming) were transferred. In 
experiment 2, 2 x 10 7 DNP primed and 1.5 x 10 8 HCY primed 
c e lls (6 days after priming) were transferred.100 µg DNP-
HCY was given to e ach mouse . 
b) Spleens were assayed on day 7 a fte r cell transfer. 
Table 3.11: Collaboration between DNP primed and HGG primed 
spleen cells in the anti-DNP response to DNP-HGG 
in vitro. 
Cells cultured a) Anti-DNP PFC per culture b) 
DNP primed cells alone 20 ± 5 
HGG primed cells alone 108 ± 12 
DNP primed 
+ HGG primed cells 351 ± 90 
DNP primed 
+ HCY primed cells 194 ± 22 
a) 2 x 10 6 DNP primed and 5 x 10 6 carrier primed cells (6 days 
post priming) were cultured with 100 ng/ml DNP-HGG. 
) PFC wcr assay_d on day 4. 
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lgM response, which peaked on day 3 r esulted whether the 
mice had been deliberately primed be forehand or not (Table 
3 .12). To s ·e , th r f or , if the response to DNP -MON was 
merely a B c )11 effect without T cell involvement, spleen 
cells from nude mice, their littermates, ATxBM mice, 
normal CBA/H mice and deliberately primed CBA/H mice, were 
cultured with DNP-MON. The PFC response on day 3 is shown 
in Table 3.13. It can be seen that ATxBM mice and nude 
mice responded to this antigen in vitro as well as mice 
possessing T cells. There was also little indication that 
deliberate carrier priming could augment this response. 
A. Nature of the antigen 
The results in Tables 3.12 and 3.13 seemed contra-
dictory to reports (e.g. Feldmann , 1972b; Feldmann and 
Basten, 1971) that the response to DNP-MON was dependent on 
T cells. Only the primed groups of mice were expected to 
respond. The antigen being used was further examined in 
some detail because of this discrepancy. 
Dose effect or mitogenic properties 
Spleen cells from nude mice, CBA/H and CBA/J mice 
were cultured with unconjugated MON or DNP-MON at concentrations 
ranging from 10-1000 ng/ml. The anti-DNP response is shown 
in Tabl e 3 .14. Nude mi ce gave as good a r esponse as CBA/J 
1n c) ov r his rang o f anlig .n concentrations . The r e sponse 
o CBA/H mic - , from our colonies , however , was about twice 
that of the nude s or CBA/J mice. Although there was some 
mitogenic effect of this MON preparation (unpurified) it did 
not account for the large response shown by nudes to DNP-MON. 
In addition it was shown (Table 3.15) that the DNP 
had to be chemically couple d to the MON (a necessary require-
me nt in classic hapten-carrier systems (Mitchison et al., 
1970). The MON was not s imply giving "signal 2" to a DNP --
stimulated B cell (Bretsche r and Cohn, 1970; Bretscher, 1972). 
The effect of having both MON and DNP-MON in the 
cultures caused inhibition rather than enhancement of the 
anti-DNP response (Table 3.16) . 
Table 3.12: In vitro anti-DNP response to DNP-MON 
Cells cultured a) Number per Anti-DNP PFC per culture 
culture 
Day 3 Day 4 Day 5 
DNP orimed alone 2 X 10 6 794 ± 52 630 ± 99 350 ± 64 
... 
DNP primed 2 X 10 6 1968 ± 254 1030 ± 56 335 ± 36 
+ MON primed 1 X 10 6 
DNP primed .2 X 10 ~ 2376 ± 138 1920 ± 179 440 ± 60 
+ MON primed 2 X 10b 
n~-rp primed 2 X 10~ 3700 ± 674 2230 ± 332 588 ± 72 
+ MON primed 4 X 10° 
DNP primed 2 X 10~ 2308 ± 342 1245 ± 96 n.d. b) 
+ unprimed 2 X 10 
DNP primed 2 X 10 6 3632 ± 164 2140 ± 184 1068 ± 85 
+ unprimed 4 X 10 6 
a) Cells were cultured with DNP-MON at a final concentration of 2 µg/ml. 
b) Not done. 
Table 3.13: Response of CBA/H and T deficient mouse spleen 
cells to DNP-MON in vitro 
Cells cultured a) Anti-DNP PFC per culture 
Nu/nu 1650 ± 116 
Nu/+ 1485 ± 199 
ATxBM 1003 ± 48 
CBA/H 1785 ± 121 
MON primed CBA/H 2265 ± 142 
DNP primed + MON primed 
CBA/H 1700 ± 138 
a) Unprimed cells were cultured at a concentration of 
6 x 10 6 per well. 
2 x 10 6 DNP primed cells were cultured with 4 x 10 6 
MON primed cells. 
DNP-MON was at a final concentration of 1 µg/ml. 
b) Cultures were assayed on day 3. 
Each value is the arithmetic mean of 4 wells± the 
standard error of the mean. 
b) 
Table 3.14: Effect of antigen dose and MON alone on the anti-DNP response 
Cells cultured a) 
Nu/nu 
CBA/J 
CBA/H 
Antigen 
MON 
DNP-MON 
MON 
DNP-MON 
MON 
DNP-MON 
a) 5 x 10 6 cells per well. 
b) Cultures were assayed on day 3. 
Anti-DNP PFC per culture at different concentrations of 
antigen b) 
Nil lOng/ml lOOng/ml lOOOng/ml 
40 ± 12 
64 ± 10 
75 ± 31 
1150 ± 189 
88 ± 26 
938 ± 122 
656 ± 57 
3363 ± 238 
175 ± 47 
2069 ± 51 
163 ± 26 
1825 ± 68 
581 ± 60 
4888 ± 361 
394 ± 109 
1600 ± 223 
294 ± 36 
1806 ± 139 
956 ± 30 
2769 ± 356 
Each value is the arithmetic mean of 4 wells± the standard error of the mean. 
Table 3.15 : The requirement for chemical union of the hapten 
and carrier 
a) 
b) 
Antigen 
MON 870 
MON 870 
DNP-HCY 
DNP-HCY 
+ MON 870 
DNP-MON 
Each value 
cultures ± 
Concentration 
(ng/ml) b) 
100 
1000 
2000 
2000 
100 
100 
Direct anti-DNP PFC 
per culture a) 
130 ± 25 
150 ± 26 
130 ± 17 
115 ± 44 
140 ± 8 
1065 ± 128 
represents the arithmetic mean of four 
the standard error of the mean (5 X 10 6 CBA/H 
spleen cells per well) . 
DNP-HCY was used at a concentration of 2 µg/ml as this 
had been found optimal for the response of CBA/H spleen 
cells to this antigen in vitro. (3.3.2.1.B). 
Table 3.16: Effect o f exce s s MON on the in vitro anti-DNP 
reseons e to DNP-MON 
Antigen concentration Anti-DNP PFC per culture a)b) 
(ng/ml) 
DNP-MON MON Expt. 1 Expt. 
100 1065 ± 128 1370 ± 
100 100 530 ± 55 905 + 
100 1000 355 ± 48 953 ± 
a) 5 x 10 6 cells were cultured per well. 
b) Cultures were assayed on day 3. Each value is the 
arithmetic mean of 4 wells± the standard error of the 
mean. 
2 
50 
152 
78 
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Degree of substitution of MON with DNP 
Highly substitute d hapten-protein conjugates have 
been reported to be able to yield T independent anti-hapten 
responses (Aird, 1971), pre sumably by presenting an array of 
repeating antigenic determinants to the B cell and activating 
it directly (Feldmann and Basten, 1971). The effect of the 
degree of substitution of the MON with DNP, on the response 
of nude and normal mice in vitro was investigated (Figure 
3.3). At very low coupling ratios, nudes still gave a 
significant response which was again about half that of CBA/H 
mice when equal numbers of spleen cells were compared. 
Possibility o f contaminating DNP-POL 
In most of the e xpe riments r e ported so far the 
antigen was a MON preparation oxidized with chloramine-T 
before dinitrophenylation. This oxidation procedure has been 
shown to prev nt r e polyme r i zation of the MON to POL (Parish 
and Stanle y, 1972). Howe ve r, although the response of DNP-
MON is r e ported to be depe ndent on T cells, DNP-POL is able 
to induce a T cell independent anti-DNP response (Feldmann, 
1972a). The possibility, therefore, that contaminating amounts 
of DNP-POL were responsibl e for the observe d anti-DNP response 
w s inve stigated. 
Samples of both oxidized and non-oxidized DNP-MON 
pre parations were c e ntrifuge d on sucrose gradients (18 hat 
39500 rpm, 5°c). Fractions were analyzed for protein con-
centration spectrophotometrically. Comparable gradients 
. containing markers of known molecular weight were run so that 
the position of MON and aggregates of MON could be predicted. 
Only one protein peak was observed, coinciding with the 
monomeric protein, (although the possibility of contamination 
by dimers cannot b e e xclude d) (Figure 3.4 ). 
At 1 a s t 80 % o f the total ab s orba nc e units app lied 
were recove r e d i n th· s p e ak in both the oxidized and non-
oxidized preparations. Some labelled protein, presumably 
DNP-polymerized flagellin was sedimented at the bottom of the 
tube. The purified DNP-MON was used immediately as the antigen 
in tissue culture and compared with the original non-centri-
fuged preparations (Table 3.17). 
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of MON with DNP on the anti-DNP response of nude 
and normal CBA/H mice (5 x 10 6 cells/well). Each 
point represents the mean of 4 wells± the standard 
error of the mean. The antigen was at a final con-
centration of 100 ng/ml in all cases. 
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Figure 3.4 The protein profile obtained when oxidized 
• - • and non-oxidized D- D DNP-MON preparations were 
spun on sucrose gradients. A single protein peak 
corresponding to the monomer was obtained. 
Table 3.17: Comparison of the anti-DNP response obtained 
with sucrose gradient puri fied DNP-MON and the 
original antigen preparations. 
Antigen a) 
DNP-MON 
DNP-MON (pure) 
DNP-MON (oxidized) 
DNP-MON (oxidized, 
pure) 
Anti-DNP PFC per culture b) 
CBA/H Nu/nu MON-primed 
1878 ± 216 
1548 ± 21 
1613 ± 86 
1503 ± 173 
1548 ± 93 
1000 ± 132 
1503 ± 173 
938 ± 25 
CBA/H 
2520 ± 191 
1985 ± 62 
a) All antigens were at a final concentration of 100 ng/ml. 
b) Cultures were assayed on day 3. Each value is the 
arithmetic mean of 4 wells± the standard error of the 
mean. 
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The results confirmed that both nude mice and 
n.ormal "un.prirned" mice gave good responses to DNP-MON in 
tissue culture, although there had been some contribution by 
DNP-POL in the nude response. There was only a slight effect 
of deliberate carrier priming of CBA/H mice. The purified 
DNP-MON w s stored at a low concentration (10 µg/ml) for 
subsequent use. 
B. Evidence for the importance of T cells in the response 
to DNP-MON 
It was now seriously considered that nude mice might 
possess functional T cells, and that mice in our colonies were 
pre-primed to MON. In this next section the T-dependence of 
the anti-DNP response to DNP-MON is clearly established and 
the presence of MON primed T cells confirmed by a second assay 
for functional T cells, delayed-type hypersensitivity to MON 
injected into the hind-footpad. In the following chapter the 
presence of these functionally active T cells in nude mice is 
shown . 
Effect of anti-8 and complement treatment on the response of 
CBA/H spleen cells to DNP-MON in vitro 
rna:zrr;:r:=__,. 
Spleen cells from CBA/H mice were treated with anti-
G and complement and then cultured with DNP-MON. This treat-
ment was cytotoxic for 20 to 30% of CBA spleen cells when 
compared with cells treated similarly with normal AKR ascitic 
fluid and complement. The PFC responses of such treated cells 
arc shown in Table 3 .18. Anti-8 treatment significantly 
reduced the ability of spleen cells to give an anti-DNP 
response. If the anti-8 ascitic fluid was adsorbed with CBA 
mouse brain (4 brains/ml) prior to use, the cytotoxicity for 
Rormal spleen cells was reduced from 25% to 5%, and this effect 
was paralleled in the tissue culture responses (Table 3.18). 
In addition, when DNP irrunune spleen cells were treated with 
the anti- 8 and complement just prior to assay, no effect on 
the PFC response was observed. 
Restoration of the anti-DNP response of anti- 8 treated spleen 
by the addition of T cells 
The importance of T cells in the response was 
confirmed by their ability to restore the anti-DNP response to 
Table 3 .18: The effect of anti-8 treat.Inent on the anti-DNP PFC response 
Treatment of cells a) Anti-DNP PFC per culture b) 
Expt. l Expt. 2 Expt. 3 Expt. 4 Expt. 5 
Untreated 1193 ± 117 1303 ± 87 1860 ± 194) 1275 ± 78 1073 ± 22 
Normal ascitic 1185 ± 41 1120 ± 68 1403 ± 96 ~d) 1233 ± 39 995 ± 10 
fluid and C' 
Anti- 8 ascitic 365 ± 39 390 ± 48 495 ± 91 217 ± 35 150 ± 23 
fluid and C' 
Anti- 8 {adsorbed) c) e) n.d. 975 ± 40 1068 ± 75 n.d. n.d. 
and C' 
a) In all cases 5 x 106 viable cells were cultured per well with purified, oxidised DNP-MON at a final 
concentration of 100 ng/ml. 
b) Each value is the arithmetic mean of 4 cultures± the standard error of the mean. 
c) The anti- a ascitic fluid was adsorbed for 1 h at o0 c on CBA/H mouse brain slurry (4 brains/ ml fluid ) . 
c) The decrease in the anti-DNP response following treatment with normal ascitic fluid and C' was not 
due to the ascitic fluid but was a property of the batch of C' used. 
e) Not done. 
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anti-8 treated spleen cells. Thymus cells could partially 
restore the response (Table 3.19). On a cell for cell basis, 
cortisone resistant cells gave better restorations than thymus 
cells, but again only partial restorations of the response 
were obtained (Table 3.19). If, however, the cortisone 
resistant thymus cells were cultured with MON for 1-2 days 
prior to their addition to the anti-8 treated spleen cells, 
they were able to restore completely the anti-DNP response 
(Table 3.20). It was shown by radioautography and the nigrosin 
staining procedure (2.2.11) that the cortisone resistant cells 
which proliferated and formed blasts during culture alone with 
MON were T cells, as they were killed by anti-8 serum and 
complement but not by anti-B cell serum and complement 
(2.3.2.4) (see Table 3.21 and Figure 3.5). 
It will be shown (5.3.2.1) that splenic T cells, 
isolated on Isopaque/Ficoll, could also fully restore the 
anti-DNP response to anti-8 treated spleen cells. Hence the 
response to DNP-MON was dependent on T cells primed to MON 
and these were present in normal (i.e. not deliberately primed) 
spleen cells from mice in our colonies. 
Collaboration between MON primed T cells and B cells 
in an nti-hapte n response could also be demonstrated in vivo. 
See Table 5 .7 and 7.6 and 7.7. 
DTH responses in CBA/H mice 
The presence of MON primed T cells in mice from our 
colonies was further substantiated by the ability of these mice 
to give DTH reactions to MON injected into the footpad (Cooper, 
1972a). Similar responses were obtained when MON was injected 
into the hind footpad whether the mice had been deliberately 
primed with MON or not (Table 3.22 and Figure 3.6). The DTH 
response to HCY was negli ible, however, unless the mice we re 
d lib r tely primed, when equally large footpad swellings were 
registered. 
3 .4 DISCUSSION 
This chapter has described the characteristics of 
the in vitro anti-hapten responses to DNP-HCY, DNP-HGG and 
Table 3.19: Restoration of the anti-DNP PFC response of anti- 8 
treated s plee n c e lls by the addition of thymus and 
cortisone resistant thymus cells 
Cells cultured per well Anti-DNP PFC per culture 
Spleen a) Thymus b) CRT b) Expt. 1 Expt. 2 
Untreated - d) 1423 ± 79 1650 ± 31 
Anti-8 and 
C' treated 285 ± 22 438 ± 35 
Anti- 8 and 
C' treated 2 X 10 6 503 ± 19 n.d. e) 
Anti-8 and 
10 6 C' treated 4 X 655 ± 18 825 ± 64 
Anti-8 and 
C' treated 8 X 106 678 ± 33 n.d. 
4 X 106 0 0 
Anti-8 and 
C' treated 3 X 10 6 835 ± 74 950 ± 54 
3 X 10 6 <5 <5 
a) 5 x 10 6 viable cells per well. DNP-MON at 100 ng/ml. 
b) Thymus cells and cortisone resistant thymus cells (CRT) 
were from normal (i.e. not deliberately primed) CBA/H 
mice. 
c) Cultures were assayed on day 3. Each value is the 
arithmetic mean of 4 wells± the standard error of the 
mean. 
d) No cells. 
e) Not done. 
c) 
T ble 3.20: Restoration of the anti-DNP PFC response of anti-8 
tr ted sple n cells by the addition of activated 
!;-h_ymus cells 
Cells cultured pe r well Anti-DNP PFC per culture 
Spleen a) Activated thymus c) 
cells b) Expt. 1 Expt. 2 
Untreated 1435 ± 64 1275 ± 78 
Normal ascitic 
fluid and C' 1315 ± 134 1233 ± 39 
Anti- 8 ascitic 
fluid and C' 238 ± 26 217 ± 35 
Anti-a ascitic 
10 6 fluid and C' 1.5 X 1048 ± 138 780 ± 68 
Anti-8 ascitic 
10 6 fluid and C' 3 X 1280 ± 198 1193 ± 107 
Anti- 8 ascitic 
fluid and C' 5 X 10 6 1403 ± 73 1185 ± 122 
Anti- G ascitic 
10 6 fluid and C' 7.5 X 1128 ± 71 1123 ± 60 
a) 5 x 10 6 viable cells per well. 
b) Cortisone resistant thymus cells were cultured for 2 days 
with MON, harvested, washed , counted and cultured as above 
for a further 3 days. DNP-MON was at a final concentration 
of 100 ng/ml. 
c) Each value is the arithmetic mean of 4 wells± the standard 
error of the mean. 
Table 3.21: The effect of anti-8 and anti-B cell serum and 
complement on proliferating cortisone resistant 
thymocytes 
Treatm nt of Number of cells counted 
cells Labelled Unlabelled 
Live Dea.ab) Live Dead 
Untreated 65 0 221 137 
Normal rabbit 
serum and C' 42 0 159 111 
Anti-B cell 
serum and C' 31 1 50 172 
Anti-8 and C' 5 81 25 245 
a) 3HTdr uptake. See Figure 3.5. 
b) As judged by the nigrosin staining procedure (2.2.11). 
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Radioautographs of MON activated cortisone resistant thymocytes. 
3HTdr uptake. 
a) Cells treated with normal rabbit serum and complement after 
culture. 
b) Cells treated with anti-B cell serum and complement after 
culture . 
c) Cells treated with anti- 8 ascitic fluid and complement after 
culture. 
The labelled cells are unaf f ected in a) and b) but killed inc). 
Dead cells are stained with nigrosin. 
Scale in microns. 
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b 
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Table 3.22: Evidence for MON primed T cells in normal (i.e. 
not deliberately primed) CBA/H mice 
Primary a) Secondary b) Mean percentage increase 
challenge challenge in footpad thickness at 
24 hours c) 
CBA/H None MON 20.9 ± 1.6 
MON MON 23.3 ± 2.7 
None HCY 3.2 ± 1.0 
HCY HCY 20.8 ± 3.0 
a) HCY: 1 mg sub. cut. (flank) in 0.2 ml Freund's complete 
adjuvant (Difeo) plus 1 mg aggregated HCY and 10 9 B. 
pertussis organi s ms, i.p., in 0.2 ml saline. 
MON 870: 100 µg sub. cut. (flank) in 0.2 ml saline. 
b) HCY: 1 mg, MON 870: 100 µg, sub. cut. (right hind foot-
pad) in 0.01 ml saline, 6 days after primary challenge. 
c) Each value is the arithmetic mean of 6 mouse footpads± 
the standard error of the mean. 
See also Figure 3.6. 
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Figure 3.6 
Histological sections (haerna toxylin eosin stained) through 
CBA/H mouse footpads 24 hours after the injection of antigen. 
a) HCY into an unprimed mouse footpad. 
b) HCY into HCY primed mouse footpad. 
c) MON into an "unprimed" mouse footpad . 
d) MON into a deliberately primed mouse footpad. 
b), c) and d) show cellular infiltration and muscle oedema 
giving a DTH reaction (Magnification: approx. 300x). 
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DNP-MON. A PFC assay adapted from Strausbauch et al. (1970), 
was established and used for measuring anti-DNP PFC. The 
responses to DNP-HCY and DNP-MON were characterized in some 
detail. It was shown that for both antigens the anti-DNP 
r sponse was dependent on collaboration between DNP specific 
B cells and carrier primed T cells. A role for the carrier 
primed B cells was also inferred from some preliminary 
experiments with the DNP-HCY system. Treatment of the HCY 
primed population with anti-lg serum and complement severely 
interfered with its ability to help in the response to DNP-
HCY. The role of the carrier primed B cells will be pursued 
in later chapters (Chapters 6 and 7). 
The response to DNP-HCY in vitro was similar to 
anti-hapte n responses reported previously in vivo_, (Mitchison, 
1970 ; Mitchison, 1971; Roelants and Askonas, 1971) - minimal 
r sponses to the antigen being obtained unless populations 
primed to both the carrier and the hapten were present. In 
this case a 2~ to 3 fold increase in the PFC response was 
obtained above background (i.e. the PFC response when hapten 
primed B cells were cultured with heterologously primed T 
cells). This difference appeared to be the limit obtainable 
in culture (3.3.2.1.B). Purified T cells (Isopaque/Ficoll 
procedure , Chapter 5) from the HCY primed population 
collaborated with the hapt e n primed population in the anti-
DNP response. This represented a direct demonstration of 
T-B collaboration in vitro. 
The in vitro response to DNP-MON was much more 
vigorous than the response to DNP-HCY. A larger PFC response 
(2-4 time greater), which arose more rapidly, (peak response 
day 3 compared to day 4 for DNP-HCY) was obtained even without 
deliberate carrier priming and even in mice severely depleted 
or supposedly free of T cells. Nevertheless, it was clearly 
established that this response represented a collaboration 
between carrier-primed T and hapten-primed B cells. The 
difference between this response and the one ro DNP-HCY was 
that animals from our school had become naturally primed to 
flagellin or cross reacting antigens from birth and therefore 
had built up significant numbers of MON primed T cells. This 
w s particularly striking in the response of ATxBM mice and 
the congenitally athymic "nude" mouse mutant which could 
respond almost as well as normal mice to this T dependent 
antigen (see also Chapter 4). 
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Evidence that the response to DNP-MON was due to 
true T-B collaboration (as had been previously reported by 
Feldmann, 1972b) and not due to mitogenic properties of the 
antigen for B or T cells, can be summarized as follows:-
a) Purified MON alone in the culture at concentrations 
used, did not cause an anti-DNP response above back-
ground levels. 
b) The same large response to DNP-MON was obtained with 
5 different DNP-MON preparations. 
c) Rigorous removal of DNP-POL from the preparations 
made little difference to the anti-DNP response. 
d) Chemical linkage between the DNP and MON was required 
for an anti-DNP response. The MON was not simply 
giving a second signal to a DNP activated B cell. 
e) Excess MON in the culture inhibited, rather than 
stimulated, the response to DNP-MON. 
f) The response was dependent on the presenC/l.of primed 
T cells. Anti- 8 treatment reduced it 3-7 fold. 
Thymus cells and cortisone resistant thymus cells 
could only partially restore it but MON activated 
cortisone resistant thymus cells and splenic T cells 
(Chapter 5) could fully restore it. 
Evidence that the CBA/H mice were pre-primed to 
MON was:-
. a) Deliberately priming the mice with MON led to no 
augmentation of the anti-DNP response. In addition, 
maximal DTH to MON was obtained without deliberate 
priming, in contrast to results of Cooper, (1972a) 
using similar mice from these colonies and the same 
antigen preparation. 
b) Newborn mice (1-5 days after birth) did, however, show 
a 3-5 fold increase in the anti-DNP response to DNP-
MON ollowing d0liberat MON priming. (I.Ramshaw, personal 
communication.) CBA/J mice purchased from overseas which 
had spent less time with our colonies, gave consistently 
lower responses than mice bred in the School. (3.3.2.3.A). 
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Thus two in vitro systems for measuring T cell 
helper function were characterized. The response to DNP-HCY 
has been used to investigate collaboration between histoincom-
patible T and B cells, reported elsewhere, (Zinkernagel, 
Kirov and Doherty, in preparation), and in characterizing the 
Isopaque/Ficoll separation procedure (Chapter 5). The 
response to DNP-MON has proved more useful due to its extreme 
sensitivity to T cells. It has been used in some collaborative 
work with Dr. A. Globerson to investigate whether uncommitted 
stem cells in embryonic liver have the capacity to develop 
into T helper cells on passage through the thymus (Kirov 
and Globerson, 1974), in characterizing the Isopaque/Ficoll 
separation (Chapter 5), and in the experiments described in 
Chapters 6 and 7 where it was used in conjunction with the 
cell separation procedure to look at the mechanisms of 
collaboration between T and B cells. 
3.5 SUMMARY 
In vitro culture systems for measuring the anti-
hapten responses to DNP-HCY and DNP-MON were set up and 
characterized. Specific anti-DNP PFC were measured using 
SRBC coated with rabbit anti-sheep Fab-DNP reagent. The 
response to both hapten-carrier antigens was shown to be 
dependent on the presence of carrier primed T cells and this 
was demonstrated directly for both systems. The extremely 
good response obtained to DNP-MON was shown to be due to 
natural pre-priming of the animals to the carrier determinant 
or a cross reacting antige~. A possible role for carrier 
primed B cells in collaboration was also intimated by the 
ability of anti-Ig and complement treatment of carrier primed 
spleen cells to interfere with the anti-hapten response to 
DNP-HCY. 
CHAPTER 4 
Demonstration of functionally active T cells 
in congenitally athymic ("nude") mice 
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4.1 INTRODUCTION 
The congenitally athymic ("nude") mouse mutant 
(Flanagan, 1966) lacks recognizable thymus tissue, at least 
in adult life, and seems to be severely depleted of thymus-
derived lymphocytes by both histological and functional 
criteria. It is grossly depleted of lymphocytes in the 
thymus-dependent areas of lymph nodes and spleen (de Sousa 
et al., 1969), and is deficient in its ability to reject tissue 
grafts (Rygaard and Povlsen, 1969; Rygaard, 1969), to give a 
cell-mediated cytotoxic response in vitro (Feldmann et al., 
1972), to produce antibodies to "thymus-dependent" antigens, 
e.g. SRBC and T4 phage (Kindred, 1971; Wortis, 1971), and to 
react to T cell mitogens, e.g. PHA and Con A (Wortis, 1971; 
Coutinho et al., 1973). In addition, theta-positive lympho-
cytes have been reported few or missing (Raff and Wortis, 
1970), and virtua ly 100% of nud thoracic duct lymphocytes 
h · r;; L J c.; i f ;und to h v a Ll Ct.; ll r <-'~ c e ptor .for antigen-...antibody 
complex s (Bankhurst and Warner, 1972). 
However, recent reports (Loor and Kindred, 1973; 
Loor and Roelants, 1974) have demonstrated precursor T cells 
present in nude mice, detected by a fluorescent anti-8 reagent, 
which can repopulate a thymus graft. It has not been shown 
that nude mice possess functionally active T cells, but as 
reported in the previous chapter (3.3.2.3) nude mice from our 
colonies gave extremely good responses to DNP-MON in vitro. 
Responses to this antigen were shown to be dependent on the 
presence of MON primed T cells (3.3.2.3.B) and in this chapter 
evidence is presented that nude mice do in fact have a small 
percentage of theta-positive lymphocytes which are capable 
of functioning as specific "helper" cells, and which are able 
to mount a delayed type hypersensitivity reaction to flagellin 
inj ·ctcd into the hind footpad. 
4.2 MATERIALS AND METHODS 
4.2.1 Animals 
Mice used were obtained from breeding colonies in 
this School. Nud mice w re rom both heterozygous (nu+ x 
1i-t) · nd h m .cy<JJU I (n x nu/nu) rnaLlng of rn · cc: obtuin~d 
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Figure 4.1 
a) The "nude" mouse littermate (nu/+). 
b) The congenitally athymic "nude" mouse mutant (nu/nu). 
These two mice came from a homozygous mating of a nu/+ 
female with a nu/nu male. 

52 
originally rom Dr. M. Holmes of the Walter and Eliza Hall 
Institute, M lbourne. They had no signs of thymus tissue. 
The heterozygous nudes, originally outbreds, had been back-
crossed in CBA/H and Balb c mice. Mice were used at 7-9 weeks 
of age. (See Figure 4 .1 ). 
4.2.2 Culture conditions and assay procedures 
Antigens, culture conditions, cell treatments and 
assay procedures have all been described in the previous 
chapter (3.2). 
4.3 RESULTS 
4.3.1 Ability of nude mice to respond to DNP-MON in vitro 
As reported in Chapter 3 (3.3.2.3), both nude and 
normal mice gave good responses to DNP-MON without any 
deliberate priming. The response to other DNP conjugates was 
minimal, however, unless cell populations primed to both the 
carrier and DNP were used. In this case normal mice gave good 
anti-hapten responses. These findings are summarized in 
Table 4.1. It can be seen that nude mice responded to DNP-
MON as well as mice possessing T cells. The response, as for 
CBA/H mice (Table 3.15) was a classical anti-hapten response, 
chemical linkage between the hapten and the carrier being 
required (Table 4.2). 
4.3.2 Effect of treatment with anti-8 and complement on 
the response 
In view of these results, the possibility that nude 
mice might contain a proportion of T cells primed to MON 
seemed likely. To investigate this, spleen cells from nude 
mice were treated with anti-8 and complement and then 
cultured with DNP-MON, as had been done for CBA/H spleen cells 
(3.3.2.3.B). 'rhis treatment was cytotoxic for 20 to 30% of 
CBA spleen c~lls but only a small proportion of nude spleen 
cells (estimated to be between 2-4%) were killed when compared 
with cells treated similarly with normal AKR ascitic fluid and 
complement. The PFC responses of such treated cells are 
shown in Table 4.3. Anti- 8 treatment significantly reduced the 
ability of nude mice to give an anti-DNP response. 
Table 4.1: Response of CBA/H and nude mice to DNP 
conjugates in vitro 
Cells cultured a, b) Antigen Anti-DNP PFC per culture 
CBA/H normal DNP-MON 1746 ± 151 
CBA/H MON primed DNP-MON 2265 ± 142 
CBA/H DNP + MON 
primed DNP-MON 1700 ± 138 
Nu/nu DNP-MON 1650 ± 116 
Nu/+ DNP-MON 1485 ± 1 99 
CBA/H normal DNP-HCY 93 ± 4 
CBA/H DNP + HCY 
primed DNP-HCY 819 ± 18 
Nu/nu DNP-HCY 19 ± 6 
CBA/H normal DNP-HGG 40 ± 8 
CBA/H DNP + HGG 
primed DNP-HGG 351 ± 38 
Nu/nu DNP-HGG 10 ± 5 
a) Unprimed cells were cultured at a concentration of 
6 x 10 6 cells per well. 
Antigen concentrations: DNP-MON l µg/ml 
DNP-HCY 2 µg/ml 
DNP-HGG 2 µg/ml 
b) 2 x 10 6 DNP primed cells were cultured with 4 x 10 6 
carrier primed cells. 
c) 
c) Each value represents the arithmetic mean of four wells 
± the standard err or of the mean. 
Table 4.2: The r qui r emen t f or che mi cal union between the 
ha pte n and c arrier for nude mice to respond to 
DNP - MON 
Antigen 
MON 
MON 
DNP-HCY 
DNP-HCY 
+ MON 
DNP-HCY 
+ MON 
DNP-MON 
DNP-MON 
Concentrationb) 
100 ng/ml 
1000 ng/ml 
2 µg/ml 
2 pg/ml 
100 ng/ml 
2 µ g/ml 
1000 ng/ml 
100 ng/ml 
1000 ng/ml 
Anti-DNP PFC per a) 
culture 
20 ± 20 
20 ± 20 
30 ± 30 
20 ± 20 
10 ± 10 
840 ± 128 
620 ± 54 
a) Each value represents the arithmetic mean of four wells 
± the standard error o f the mean (5 x 10 6 nu/nu spleen 
cells per well). 
b) DNP-HCY was used at a concentration of 2 µg/ml as this 
was found optimal for r e sponse of CBA/H mice in vitro. 
(3.3.2.1 B). 
Table 4. 3 : The effec t o f a nt i - 8 treatme nt on the a bi lity 
of nude splee n to respond to DNP-MON in vitro 
Treatment of cells Anti-DNP PFC per culture 
a) Expt. 1 Expt. 2 Expt. 
Untreated ( 828 ± 109 1020 ± 28 1178 ± 
Normal ascitic fluid c) ( 
and C' (705 ± 55 913 ± 47 978 ± 
Anti-8 ascitic fluid 
and C' 335 ± 39 310 ± 30 405 ± 
b) 
3 
117 
42 
28 
a) In all cases 5 x 10 6 viable cells were cultured per well 
with purified, oxidised DNP-MON at a final concentration 
of 100 ng/ml. 
b) Each value is the arithmetic mean of 4 cultures± the 
standard error of the mean. 
c) The d e crease in the anti-DNP response following treatment 
with normal a s citic fluid and C' was not due to the 
ascitic fluid but was a property of the batch of C' used. 
Even after rigorous adsorption, some batches of C' had 
residual anti-thymocyte activity which became important 
when only few T cells were involved. 
4.3.3 Fractionation of nude spleen on Isopaque/Ficoll -
enrichment of functional nude T cells 
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The presence of functionally active T cells in nude 
s plee n was unequivocally shown following f ractionation of 
cells on Isopaque/Ficoll (Chapter 5). When nude spleen was 
depleted of lg-rosette forming cells there was a 10% recovery 
of non-rosetting cells in the upper layer. Of these cells, 
32% were sensitive to treatment with anti-8 and complement. 
There was thus more than a ten-fold enrichment of the theta-
bearing population in the upper layer. These cells were able 
to restore fully the response of an anti-8 treated nude spleen 
(Table 4.4). In addition, the lg-bearing cells recovered from 
the bottom layer, following lysis of the SRBC, gave little 
response when cultured alone, but a normal response following 
re-addition of cells from the upper layer. The upper layer 
cells when cultured alone, gave no plaques at all. 
4.3.4 Ability of nude mice to give a DTH response to MON 
An independent assay, the measurementof delayed 
type hypersensitivity (DTH) to MON injected into the footpads 
(see 3.2.19), confirmed the presence of MON primed T cells in 
nude mice. DTH responses to MON were obtained in nude mice 
and were of the same magnitude as those obtained in CBA/H 
mice (Table 3.22), whether the mice were deliberately primed 
with MON or not (Table 4.5). Nude mice deliberately primed 
to HCY, how - ver , did not develop footpad s we llings , unlike 
thei r hairy littermat s or CBA/H mice (Figure 4.2.). 
4.4 DISCUSSION 
The results reported in this and the previous 
chapter lead to the conclusion that nude mice possess a small 
numbe r o f theta-positive cells, a proportion of which have 
become prime d to MON and can function as helper cells in a 
collaborative anti-DNP r espon se and give a vigorous delayed-
type hypers nsit ivi ty reaction to flagellin injected into the 
footpad . This conclusion rests on the following premises: 
a) The antigen used in the tissue culture was DNP-MON, 
which did not contain any DNP-POL. DNP-MON is known 
to r e quire MON-prime d T cells in order to stimulate 
Table 4.4: Fractionation of functionally active T cells 
on Ficoll gradients 
Cells cultured Anti-DNP 
Unfractionated Bottom Top PFC per 
culture d) Spleen a) layer b) layer c) 
(B cells) (T cells) 
Untreated 800 ± 80 
Normal ascitic 
fluid and C' 558 ± 43 
Anti-8 and C' 168 ± 19 
Anti-8 and C' + 603 ± 84 
+ 0 
+ 285 ± 24 
+ + 791 ± 58 
a) and b) 5 x 10 6 viable cells were cultured per well. 
c) 1.5 x 10 6 viable cells were cultured per well. 
B cells= lower layer from Isopaque/Ficoll 
separation of lg-bearing and 8-positive lymphocytes. 
T cells= upper layer from separation. 
d) Each value is the arithmetic mean of four cultures 
± the standard error of the mean. DNP-MON was at 
a final concentration of 100 ng/ml. 
Table 4.5: The ability of nude mice to give a DTH response 
to MON without deliberate priming 
Mice Primary a) Secondary b) Mean percentage increase 
Challenge Challenge in footpad thickness at 
24 hours c) 
Nude None MON 29 ± 1 
(Nu/nu) 
MON MON 28 ± 1 
None HCY 0 
HCY HCY 0 
Nude 
littermate None MON 29 
(Nu/+) 
MON MON 26 ± 2 
None HCY 3.9 ± 0.75 
HCY HCY 17.3 ± 1.7 
a) HCY: 1 mg sub. cut. (flank) in 0.2 ml Freund's complete 
adjuvant (Difeo) plus 1 mg aggregated HCY and 10 9 B. 
eertussis organisms, i.p., in 0.2 ml saline. 
MON 870: 100 µg sub. cut. (flank) in 0.2 ml saline. 
b) HCY: 1 mg, MON 870: 100 µg, sub. cut. (right hind 
footpad) in 0.01 ml saline, 6 days after primary 
challenge. 
c) 3-4 mice per group. 
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Fi9ure 4.2 
Histological sections (haematoxylin eosin stained) through nude 
mice footpads 24 hours after the injection of antigen. 
a) HCY into an unprimed mouse footpad. 
b) HCY into a HCY primed mouse footpad. 
c) MON into an "unprimed" mouse footpad. 
d) MON into a deliberately primed mouse footpad. 
a) and b) show no DTH response. 
c) and d) show massive cellular infiltration and muscle oedema 
giving a clas sic .orrn reaction. 
(Magnification: approx. 300x). 
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a good anti-DNP response. 
b) Anti- 8 treatment of spleen cells significantly reduced 
the anti-DNP response by specifically killing the T 
helper cells. 
c) Mice in our colonies are pre-primed to the carrier, MON. 
With respect to these premises, firstly, the 
unexpectedly high response of the nude mice to DNP-MON was 
not due to properties of the antigen used, e.g. its concent-
ration in the cultures, non-specific mitogenic properties, 
high substitution ratios of the protein with DNP, or the 
presence of DNP-POL in the preparation (3.3.2.3.A). Secondly, 
the activity of the anti-8 used could a) be adsorbed by CBA 
brain tissue and b) did not affect anti-DNP PFC (3.3.2.3.B). 
In addition fractionation of nude spleen cells on Isopaque/ 
Ficoll enabled confirmation of the importance of T cells in 
the response, showing that B cells alone could not respond 
and that addition of only a small number of T cells could 
completely restore the response of anti-8 treated spleen and 
of the T-depleted B population. 
Evidence for c) was the finding that deliberate 
priming of mice in our colonies with MON had only a slight, 
if any, enhancing effect on two responses to this antigen. 
Thus, such mice were able to mount a vigorous DTH reaction on 
primary challenge with MON. This observation is consistent 
with the very slight effect of deliberate MON priming on the 
anti-DNP response (Tables 3.12, 3.13 and 4.1). 
Mice may well be experiencing continual exposure to 
either flagellar or cross-reacting antigens so that a 
significant population of carrier-primed T cells is acquired 
naturally. It is of interest that mice of the same strain 
kept in this school did not exhibit this pre-priming two years 
ago (Cooper, 1972a). This suggests that the priming in mice 
may be due to an increased susceptibility to a particular 
bacterial infection. 
These results, therefore, show that for functional 
tests nude mice, although depleted of T cells, cannot always 
be regarded as a source of uncontaminated B cells. The 
embryonic nude mouse had thymic epithelium at 13-14 days, 
which has disappeared by birth (M. Moore and A. Szenberg, 
personal conununication). It is probable that the progenitors 
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of the functional T cells found in nude mice arose from this 
rudimentary thymus. 
In addition, these results may be relevant to the 
findings of Morris and colleagues (1971, 1973) who reported 
that lambs thymectomized during foetal life gave undiminished 
humoral responses to three antigens, swine influenza virus, 
chicken red blood cells and Salmonella muenchen. It was 
concluded that in sheep, T cells were not required to give 
normal humoral responses to antigens. However, it is known 
(Cheng and Trentin, 1967) that in mice the background level 
of splenic PFC to SRBC is influenzed by the levels of certain 
bacteria in the gastrointestinal tract. If these three 
antigens used by Morris et al. can be regarded either as 
environmental antigens or related to environmental antigens, 
it seems very likely that at the time of thymectomy, sufficient 
T cells may have already been circulating to serve as a 
progenitor population of primed T cells for these antigens. 
After all, thymectomy cannot be performed unless a visible 
thymus is present. This proposal could be checked if a marker 
similar to theta antigen were available to distinguish Band 
T cells in sheep. 
4.5 SUMMARY 
Spleen cells from con-genitally athymic ("nude") 
mice were found to give a good anti-hapten response when 
cultured with the hapten-carrier, DNP-flagellin, but not when 
cultured with DNP coupled to two other proteins, haemocyanin 
and human gamma globulin. This response to DNP-flagellin was 
anti-theta-sensitive. The evidence indicated that the mice had 
a small population of T cells, a proportion of which had 
become primed naturally to flagellin or to related antigens 
and could function as specific helper cells in a collaborative 
anti-DNP response. The existence of flagellin-primed T cells 
was confirmed by the ability of such mice to mount a DTH 
reaction to flagellin injected into the hind footpad. 
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5.1 INTRODUCTION 
In this chapter a simple, one-step procedure is 
described for separating mouse T and B lymphocytes. A 
similar procedure had been worked out by Parish and Hayward 
(1974 a, b) for the rat and, in collaboration with Dr. 
Parish, was readily adapted to the mouse situation. The 
efficiency of the separation and the functional characteristics 
of the separated cell populations in the anti-hapten response 
to DNP-HCY and DNP-MON (Chapter 3) were looked at. The 
procedure was also adapted for separating and examining Fe 
receptor lymphocytes (FcRL). 
5.2 MATERIALS AND METHODS 
5.2.1 Animals, antigens and tissue culture procedures 
As described in Chapter 3. 
5 .2.2 Radioautographic procedure 
As described in Chapter 2. 
5.2.3 Antisera 
Antisera to mouse IgG and rabbit IgG were prepared 
by Dr. M.J. Crumpton and Dr. C.R. Parish. Briefly, mouse IgG 
and rabbit IgG were obtained from an (NH4)2 S04 precipitation 
(40% saturation) of mouse or rabbit serum respectively. 
After extensive washing the precipitate was dissolved in a 
20mM sodium phosphate buffer, pH 8.0, and passed through a 
DEAE column eluted with the same buffer. The protein eluted 
was then concentrated by pressure dialysis, applied to a 
Sephadex G-200 column, and the IgG fraction from the column 
collected and concentrated. 
Antisera to rabbit Ig were raised in outbred merino 
sheep by injecting into multiple sites 1 mg of rabbit IgG 
emulsified in FCA (1.0 ml/sheep of a 1:1 mixture of FCA and 
antigen). Four to six weeks later the animals were boosted 
with 1mg of rabbit IgG in FIA and the sheep were bled out 
7-14 days after the secondary challenge. The globulin fraction 
of this antiserum was precipitated with (NH4 ) 2S04 at 40% 
saturation and after extensive washing the precipitate was 
redissolved in 0.15 M NaCl. 
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Antisera to mouse Ig were raised in rabbits by an 
identical immunization schedule. 
Anti-SRBC antisera were raised in mice by sub-
cutaneous injection of 10% SRBC in FCA (1:1 mix). Fourteen 
days later the mice were challenged with 0.5 ml 2% SRBC 
intraperitoneally and 7 days later they were bled and sera 
colle cted. The sera was inactivated (56°c, 30 min) and stored 
in separate ampoules at -7o 0 c. A new ampoule was used for 
each experiment as the activity of the sera was decreased by 
freeze-thawing. 
5.2.4 Rosetting Erocedure 
5.2.4.l Surface Ig rosetting 
Mouse lymphocytes were rosetted for surface immuno-
globulin by modifying a procedure previously developed for 
rosetting lg-bearing rat lymphocytes (Parish and Hayward, 
1974b). The procedure consisted of two stages; first, 
reaction of mouse lymphocytes with rabbit anti-mouse Ig and 
second, rosetting of the lymphocytes with SRBC coated with 
sheep IgG specific for rabbit Ig. 
To 2.5ml of spleen or lymph node cells (4 x 10 7 
cells/ml) in PBS/10% FCS was added 10µ1 of a hyperimmune 
rabbit anti-mouse lg antiserum. In preliminary experiments 
this antiserum had been titrated against spleen cells and a 
dilution selected at which the number of lg-rosetting cells 
had reached a plateau level. The cell-antiserum mixture was 
incubated on ice for 30 min and then centrifuged (300g, 5 
min at 4°c). The lymphocyte pellet was resuspended in 2.5ml 
of PBS/10% FCS and 2.5ml of a 20% suspension of SRBC (2 x 10 9 
SRBC/ml) coated, via Crc1 3 , with sheep IgG specific for 
rabbit Ig added (i.e., E anti-lg). The method of coating 
SRBC with IgG preparations has been fully described by Parish 
and Hayward (1974b). In most experiments a control 
preparation was included where 2.5ml of a 20% suspension of 
unsensitized SRBC (E) was added to 2.5ml of lymphocytes. The 
erythrocyte-lymphocyte mixtures were then centrifuged (5 min, 
1200g, 4°C) to enable rosette formation. The cell pellets 
were gently resuspended in their supernatants and samples 
taken, diluted and examined for rosette content. 
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5.2.4.2 Fe rosetting 
Equal volumes of a 5% suspension of washed SRBC 
(E) in PBS and the optimal dilution of mouse anti-SRBC 
antibody (A) in PBS were incubated at 37°c for 30 min. The 
sensitized cells were washed three times (300g, 5 min) with 
PBS, and the EA pellet resuspended by vortexing after each 
centrifuging in order to minimize red cell aggregation. 
After washing,a 20% suspension of EA in Fl5 culture medium 
was prepared and stored on ice. Rosettes were formed with 
lymphocytes as for 5.2.4.1. 
Rosette-forming cells were counted as follows. To 
0.1ml of the rosetted sample (2 x 10 6 lymphocytes/ml, 1 x 108 
red cells/ml) was added 0.1 ml of PBS containing 1% (v/v) 
glutaraldehyde and 2% (w/v) crystal violet. This staining 
solution was clarified of undissolved dye by filtration prior 
to use. With crystal violet the white cells stained violet 
and could be distinguished whether free or binding red cells. 
Thus, this procedure guarded against aggregates of red cells 
being mistaken for rosettes. Preparations were counted 
inunediately after addition of the staining solution as the 
violet colour of the white cells faded in 5-10 min. 
Approximately 300 white cells were scanned from each suspension 
for rosettes. The results were expressed as the percentage 
of rosettes in relation to the total number of nucleated cells. 
Any lymphocyte which bound >5 erythrocytes was classified as 
a rosette. 
5.2.5 Separation of rosetting and non-rosetting cells 
Spleen cells were rosetted for lg-bearing or Fe 
receptor bearing cells as described above. To 5.0ml of 
rosetted lymphocytes (2 X 10 7 white cells/ml, 1 X 109 red 
cells/ml) was added 20 µl 25% (w/v) sodium azide (final 
concentration 0.1%) and the temperature of the mixture raised 
to 20°c in a water bath. The preparation was then layered 
gently on 4.0ml of separating medium which had been prewarmed 
to 20°c and which consisted of 12 parts of 14% (w/v) Ficoll 
(Pharmacia, Uppsala, Sweden) dissolved in distilled water and 
5 parts of 32.8% (w/v) sodium metrizoate (Isopaque; Nyegaard 
and Co., Oslo, Norway), the complete mixture containing 1.0% 
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(w/v) sodium azide. This mixture had a density of 1.09, was 
stored at 4°c protected from light, and will be referred to 
as Isopaque/Ficoll. It was sterilized by Millipore filtration. 
The separations were carried out in 12ml, U-bottomed, 
polycarbonate centrifuge tubes (16 x 100mm; cat. no. 272; 
Ivan Sorvall Inc., Norwalk, Connectic ut, U.S.A.). After 
addition of the rosetting mixtures the tubes were placed in 
a centrifuge prewarmed to 20°c and spun at 2000g (at the 
Isopaque/Ficoll interface) for 20 min. The best separations 
were obtained if the centrifuge accelerated rapidly and 
attained 2000g within 20 seconds. After centrifugation (see 
Figure 5.1) the supernatant above the Isopaque/Ficoll inter-
face was discarded and the white cell layer at the interface, 
together with all the separating medium above the red cell 
pellet, collected. The white cell preparation ("upper layer") 
was then diluted with medium, mixed and the white cells 
pelleted by centrifugation (300g,10 min, 4°C). The pelleted 
cells were washed once more and counted. 
The red cells in the rosette-red cell pellet ("lower 
layer") were lysed by osmotic shock as previously described 
by Dain and Hall (1967). Briefly, each pellet (0.5ml packed 
SRBC) was quickly resuspended in 8.55 ml. of 40% Ringer's 
solution and after all cell clumps had been dispersed 
isotonicity was restored by the addition of 1.0ml of 940% 
Ringer's solution. The white cells were then pelleted by 
centrifugation (300g, 5 min, 4°c), washed once more and 
counted. 
5.3 RESULTS 
5.3.1 Efficiency of the Isopaque/Ficoll cell separation 
procedure 
5.3.1.1 Partitioning of mouse spleen cells on Isopaque/ 
Ficoll 
Table 5.1 summarizes the partitioning of sub-
populations of mouse spleen cells on Isopaque/Ficoll. It was 
found that virtually all red cells (99.7%) sedimented to the 
bottom of the tube whereas the bulk of the white cells floated 
at the Isopaque/Ficoll interface (Figure 5.1). Some white 
Table 5.1: Partitioning of mouse spleen cells on Isopaque/ 
Ficoll. a) 
Cell type 
Erythrocytes 
Leucocytes 
- Mononuclear 
- Polymorphonuclear 
- Stem cells c) 
Upper 
layer 
0.3% 
89(98)b) 
86 
93 
99 
Lower 
Layer 
99.7% 
9 ( 56) 
10 
4 
1 
Recovery 
100% 
98 
96 
97 
100 
a) In this experiment 1 x 10 8 mouse spleen cells were 
applied to the Isopaque/Ficoll. 
b) Values in parentheses represent% viability of cell 
populations as assessed by trypan blue exclusion. 
c) As assessed by morphology. Stem cells were also 
assayed by the spleen colony assay of Till and McCulloch, 
(1961) and were shown to be completely recovered in the 
upper layer (Figure 5.2). 
.~t •. , .. ' ·~, • . C. • 
,-_ ···~· · '..!_,_ ' ,'i·'< 
l' 
· :i~ 
~ .. 
. ~:.. ' ' ;t ( 
i.'11 ' }:\, 
fl• '( 
' t ;~,\ 
1 , , 
f .t>.'C . 
;.,: . 
i. i"• 
,~~i ~ ~ ~ t. f 'i• I 
•'<\, I • ft ,;~ 
! . .. 
~
·~.' . t~, 
t~ ' ' 
:/~\ r' 
,,t.; · l 
k"\ •\ 
l\'; 
1! .'i. ft,.· 
i~ :.~;' 
1\\ 
~I'· 
r1· -~ 
~
~'t ;-
.f 
ltlf~ 
f/' 
,; "l 
.... . 
:. ~· 
\<l • 'i . ft' iJd 
~I . . f i· ~ i~ 
l~J ~ '! 
l(/ 
., ... 
1.,1 . \ i~ ., 
~/\\I 
ll-' .•. 
1\\ t,'{ 
t< ' ~ .(· ·f~ ,·· (~ ... {~ c~ 
ri;\ 
t'>: 
ri 
~·i~· 
ri~ {t 
1~) {!,': ~ . ,t 
• I. 
' ~' /t. ( ~ .. 
[\r. 
'\' ' 
t~: 
~. 
r f.; 
~ ,~ 
:i~ . If 
¥ 
i~ .... 
lt 
t 1:,, J~( 
... f \· 
~F1 
·~~· t:t; 
t·· 
~., 
~·1L 
.r,~ t:~ 
..... , 
t'J ii• 
• f 
ti 
~t; 
11 .,. 
•.t· t,1 . 
i
~;t : 
·I 
" i 
I~·· f, r 
t ~·~ ~ ~~ _e: l:',1 ·~ 
..... 
Ill 
Figure 5.1 
Separation of rosetting and non-rosetting cells on Isopaque/ 
Ficoll. 
a) FlS culture medium. 
b) Isopaque/Ficoll mix. 
c) The non-rosetted white cell layer at the interface ("upper 
layer"). 
d) SRBC and rosetted lymphocytes in the pellet ("lower layer") . 
This was the appearance immediately after centrifugation (2000g, 
20min at 20°c). For photographic purposes, separation was 
carried out in a glass centrifuge tube . 
' 
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cells {9%) sedimented but almost half of these cells were 
dead as assessed by trypan blue exclusion; in fact most of 
the dead cells applied appeared in the red cell pellet. Stem 
cells, mononuclear cells and polymorphonuclear leucocytes were 
identified morphologically and were shown to be quantitatively 
recovered in the upper layer (Figure 5.2). Furthermore, with 
the polymorph population there was no evidence for a selective 
enrichment or depletion of neutrophils, eosinophils or 
basophils. Macrophages were difficult to distinguish 
morphologically in mouse spleen. However, studies with 
peritoneal cells showed that the bulk of the macrophages in 
this cell population were recovered in the upper layer (Parish 
and Davidson, unpublished results). Stem cells were not 
only identified by morphology but were also assayed 
functionally by the spleen colony assay of Till and McCulloch, 
(1961). In both cases it was found that all the stem cells 
appeared in the upper layer (Figure 5.2). It is noteworthy 
that there were excellent recoveries (>95%) of all of the 
subpopulations of cells identified. 
5.3.1.2 Efficiency of the Isopaque/Ficoll system in 
separating Ig-bearing and 8-positive lymphocytes 
The efficiency of the Isopaque/Ficoll system in 
separating rosetting and non-rosetting white cells is 
surrunarized in Table 5. 2. '!'he procedure was >99. 5% efficient 
at depleting mouse spleen cells of lg-rosetting cells. 
Furthermore, 97% of the Ig rosettes were recovered in the 
lower layer in a 76% pure form, i.e., contaminated with 24% 
of unrosetted white cells. The bulk of these unrosetted cells 
(>70%) were dead as assessed by trypan blue exclusion. In 
contrast with the lg-rosettes, virtually all of the 8-
positive lymphocytes (91%) were recovered in the upper layer. 
It is generally accepted that mouse "B" lymphocytes have a 
high density of surface Ig (Raff et al., 1970a; Pernis et al., 
1970; Rabellino et al., 1971) whereas mouse "T" lymphocytes 
carry the theta isoantigen (Raff, 1970a, b). Thus this system 
represents an excellent method for separating mouse T and B 
cells. Subsequent functional studies reported in this chapter 
confirmed this separation. For simplicity, the non-Ig bearing 
(upper layer) cells are henceforward termed T cells and the 
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Figure 5.2 
Upper: 
A smear (Giemsa stained) of the upper layer of an Ig rosette 
depleted sple en cell suspension. (Scale in microns). 
Mononuclear cells and polymorphonuclear leucocytes could be 
identified morphologically and were shown to be recovered 
quantitatively in the upper layer. 60-70% of these cells were 
sensitive to treatment with anti-8 ascitic fluid and complement. 
Lower: 
The colony forming unit (CFU) assay of Till and McCulloch. 
The assay method was based on the fact that the intravenous 
injection of stem cells into syngeneic, lethally irradiated 
(850 rads) hosts led to the formation of colonies of prolifer-
ating cells in the spleens of these animals. The colonies 
appeared as gross nodules in the spleen which could be readily 
counted. They were discrete, round or oval, and greyish in 
colour, embedded in the red mass of the spleen. CFU were 
counted 10 days after cell transfer. Mice received either no 
cells, or lxlo7, lx106 or lxlo5 unfractionated spleen cells or 
upper layer cells ~espectively. 
a) The appearance of a spleen from a mouse which received 
1 x 10 7 upper layer cells . 
b), c) and d) The appearance of spleens from mice which 
received 1 x 10 7 , 1 x 10 6 and 1 x 105 unfractionated 
spleen cells respectively. 
e) The appearance of a spleen from a mouse into which no 
cells were transferred. Note the appearance of a CFU 
(arrowed). There was generally one per spleen of host 
origin 10 days after irradiation. 
• I 50 
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Table 5.2: Ef f iciency o f Isopaque /Ficoll system in 
separating lg-Bearing and 8-positive lymphocytes 
Original spleen cell population: e + lymphocytes - 19.0% 
Ig rosettes - 44.8% 
Fractionations (%) Eb) E anti-Ig b) 
Upper layer c) 
Lower layer c) 
Recovery 
% lymphocytes as Ig rosettes 
in lower layer 
Recovery in Ig rosettes in 
lower layer 
Ig rerosetting of upper layers 
% lymphocytes e + in upper 
layers 
Recovery of a+lymphocytes in 
upper layers 
77.2(98) 
10.5 (52) 
87.7 
46 
24 
98 
26.0(99) d) 
60.0(74) 
86.0 
76 
97 
<0.1 
66 
91 
a) In each fractionation 1 x 108 mouse spleen cells were 
applied to the Isopaque/Ficoll. 
b) E = erythrocytes; E anti-lg= erythrocytes coated with 
anti-lg for Ig rosetting. 
c) Upper layer= non-rosetting lymphocytes; lower layer -
red cells+ rosetting lymphocytes. 
d) Values in parentheses represent% viability of cell 
populations as assesse d by trypan blue exclusion. 
lg-bearing (lower layer) cells are termed B cells. 
5.3.1.3 Radioautography on upper layer cells 
To further substantiate that depletion of Ig-
rosettes removed all lymphocytes with a high density of 
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surface Ig, the undepleted and depleted spleen cell populat-
ions were examined for surface Ig by radioautography (Figure 
5.3). First, it was found that running spleen cells on 
Isopaque/Ficoll with unsensitized red cells resulted in 
little or no change in both the cell surface density of Ig 
and the incidence of lg-bearing cells detected by radio-
autography (compare Fig. 5.3a with 5.3c). However, when spleen 
cells were incubated with the concentration of rabbit anti-
mouse lg used for rosetting some surface lg was blocked and 
so a reduction in both the surface densiti of Ig and the 
frequency of lg-bearing cells detected by radioautography was 
observed (compare Fig. 5.3a with 5.3d). These reductions 
were much less marked if radioautographs were exposed for 
longer periods i.e., 96h rather than 24h. Depletion of Ig-
rosetting cells resulted in a dramatic r~duction in the 
incidence of lg-bearing cells detected by radioautography 
(>97%, compare Fig. 5.3b and 5.3d and inset a and b). 
Furthermore, the great majority of lg-bearing cells which 
escaped depletion possessed a very low density of surface Ig. 
It was estimated that such lymphocytes carried <500 Ig molecules 
on their surface (Ada et al., 1966). 
An experiment was carried out to determine whether 
the low density lg-bearing cells which escaped depletion were 
either T cells or B cells. Spleen cells depleted of lg-
rosettes were labelled with 1251 anti-light chain globulin 
and then treated with anti-8 ascitic fluid and complement. 
Cells lysed by the antiserum were detected on radioautographs 
by the nigrosin staining procedure (2.2.11). It was found 
that from 68-83% of the labelled cells were killed by anti-8 
antiserum and complement. Thus it appeared that the bulk of 
the low density lg-bearing cells which escaped depletion were 
T lymphocytes. 
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Fi9ure _ 5. 3_ 
Estimation by radioautography of the frequency of lg-bearing 
cells in spleen cell populations before and after removal of 
lg rosettes on lsopaque/Ficoll. 
a) Untreated spleen cells - 58.8% lg-bearing cells after 
96h exposure; 54.3% lg-bearing cells after 24h exposure. 
b) Spleen cells depleted of lg-rosettes by lsopaque/Ficoll 
procedure - 1.8%; 0.4%. 
c) Spleen cells run on lsopaque/Ficoll with non-lg-rosetting 
erythrocytes - 52.9%; 46.6%. 
d) Spleen cells pretreated with rabbit anti-mouse Ig -
50.5%; 38.0% . 
The upper inset shows the appearance of radioautographs a) 
and b) after 96h exposure. (Giemsa stained; scale in microns). 
A dramatic reduction in the incidence of lg bearing cells is 
apparent . 
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5.3.2 Immunological responsiveness of separated spleen cell 
populations 
Two antibody responses were used to assess the 
immunological responsiveness of the separated spleen cell 
populations. The first system measured the anti-hapten 
response to DNP-HCY in vitro and the second measured the anti-
hapten response to DNP-MON in vitro and in vivo. (See 
Chapter 3). 
5.3.2.1 Response to DNP-HCY in yitro 
The capacity of unfractionated and fractionated 
spleen cells to respond to DNP-HCY in vitro is summarized in 
Table 5.3. As has been demonstrated (3.3.2.1.D) a mixture 
of carrier (HCY) primed and hapten {DNP-BSA) primed spleen 
cells produced a significantly higher anti-DNP response than 
the two separate cell populations. In contrast, spleen cells 
primed to the heterologous carrier (HGG) did not act 
synergistically with the DNP-BSA primed spleen cells. The 
cell populations primed to DNP-BSA and HCY were then separated 
into Ig and non-Ig bearing cells on Isopaque/Ficoll and 
various mixtures of these subpopulations examined for synerg-
ism. The results can be summarized as follows: 
a) Carrier primed T cells (i.e., non-lg-bearing cells) 
were much more effective than carrier primed B cells 
(i.e., lg-bearing cells) at collaborating with hapten 
primed spleen cells. 
b) Hapten primed T cells were unable to collaborate with 
carrier primed spleen cells. 
c) There was no evidence for synergism between hapten 
and carrier primed B cells. 
d) The greatest synergism occurred when hapten primed B 
c lls were mixed with carrier primed spleen cells. 
These results ar_ consistent with the notion that T 
cells primed to the carrier, HCY, collaborate with B cells 
primed to the hapten, DNP, in the in vitro anti-DNP antibody 
response to DNP-HCY. 
5.3.2.2 Response to DNP-MON in vitro 
It has already been shown (3.3.2.3) that the anti-
Table 5.3: Collaboration between Isopaque/Ficoll purified 
T cells and B cells in the in vitro anti-DNP 
antibody response to DNP-HCY 
Cells cultured a) Number per Anti-DNP PFC per 
culture culture b) 
DNP-BSA primed spleen 2 X 10 6 234 ± 14 
HCY primed spleen 5 X 10 6 94 ± 12 
DNP-BSA primed spleen 2 X 106 604 ± 67 10 6 + HCY primed spleen 5 X 
DNP-BSA primed spleen 2 X 10 6 232 ± 4 + HGG primed spleen 5 X 10 6 
DNP-BSA primed spleen) 2 X 10 6 533 ± 74 + HCY primed T cells c 2.5 X 10 6 
DNP-BSA primed spleen 2 X 10 6 315 ± 44 + HCY primed B cells c) 5 10 6 X 
DNP-BSA primed T cells 2 X 10 6 168 ± 4 + HCY primed spleen 5 X 10 6 
DNP-BSA primed B cells 2 X 106 184 ± 20 
DNP-BSA primed B cells 2 X 10 6 1143 ± 64 + HCY primed spleen cells 5 X 10 6 
HCY primed B cells 2 X 10 6 <10 
HCY primed B cells 2 X 10 6 186 ± 10 + DNP-BSA primed B cells 2 X 106 
a) Cultures were incubated with 2 µg/ml DNP-HCY. 
b) PFC assays were made 4 days after culture. Each value is 
the arithmetic mean of four cultures± the standard error 
of the mean. 
c) B cells= lower layer from Isopaque/Ficoll separation of 
lg-bearing and 8-positive lymphocytes. 
T cells= upper layer from separation. 
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DNP response to DNP-MON was highly T cell dependent, anti- 8 
treated spleen cells giving a 3-7 fold lower antibody response 
in vitro than untreated spleen cells or spleen cells treated 
with normal AKR serum and complement (also see Table 5.4). 
It was found that spleen cells depleted of lg-bearing cells 
by the Isopaque/Ficoll system were unable to produce an in 
vitro anti-DNP antibody response to DNP-MON. However, these 
cells were capable of completely reconstituting the anti-DNP 
response of anti-8 treated spleen cells (Table 5.4), a result 
consistent with the T cell content of this Isopaque/Ficoll 
preparation. 
A second series of experiments measured the response 
of both the upper and lower layer cells from the Isopaque/ 
Ficoll to DNP-MON (Table 5.5). As in the previous experiment 
the upper layer cells (i.e., T cells) produced little or no 
antibody to DNP. However the lower layer preparation (i.e., 
B cells) gave a substantial antibody response, although this 
response was significantly lower than that given by the 
untreated spleen cells. Treatment of the lower layer with 
anti- 8 antiserum and complement significantly reduced the 
anti-DNP response. As a control to test for non-specific 
leakage of some functional T cells through the Isopaque/Ficoll 
mix, the lower layers from control rosetted spleen cells were 
added to anti- 8 treated spleen cells. No restoration of the 
anti-DNP response was obtained. Hence there were no functional 
T cells in these lower laye rs (Table 5.6 ). From these 
results it was concluded that there were some T cells which 
carried e nough surface Ig to form Ig rosettes and which were 
contaminating the lower layer of Ig positive cells. 
Recombination of the upper and lower layers resulted in a 
response equal to or greater than the unfractionated spleen 
cell population. 
5.3.2.3 Response to DNP-MON in vivo 
A similar experiment to the in vitro experiment 
reported in Table 5.5 was carried out in vivo. Unfractionated 
and fractionated cells were transferred intravenously into 
irradiated recipients (850 rads 24 h previously) with 5 µg 
DNP-MON. Six days l a t e r spleens were harvested and the 
Table 5.4: Restoration of in vitro anti-DNP antibody 
response of anti-8 treated spleen cells by 
Isopaque/Ficoll purified T cells 
Cells cultured a) 
Untreated spleen 
Spleen cells treated 
with normal AKR 
ascitic fluid and C' 
Spleen cells treated 
with anti-8 ascitic 
fluid and C' 
T cells d) 
Anti-8 treated cells 
+ T cells 
Anti-DNP PFC per culture b) 
Expt.l Expt. 2 Expt. 3 Expt. 4 
565±59 
635±68 
105±21 
<20 
677±41 
1193±117 1303±87 1275±78 
1185±41 
365±39 
0 
1193±81 
n.d.c) n.d. 
390±48 217±35 
<50 <50 
1120±68 1625±129 
a) 5 x 10 6 viable cells of each type were cultured per well, 
except in experiment 1, where 4 x 10 6 cells were cultured. 
DNP-MON was at a final concentration of 100 ng/ml. 
b) Cultures were assayed on day 3. Each value is the 
arithmetic mean of 4 cultures± the standard error of 
the mean. 
c) Not done. 
d) Upper layer from Isopaque/Ficoll separation of lg-bearing 
and 8-positive lymphocytes (Table 5.2). 
Table 5.5: Collaboration between Isopaque/Ficoll purified 
T cells and B cells in the in vitro anti-DNP 
antibody response to DNP-MON 
Cells cultured a) 
Untreated spleen 
B cells 
Anti-8 treated B cells 
T cells 
B cells+ T cells d) 
Anti-DNP PFC per culture b) 
Expt. 1 Expt. 2 
1193±117 
828±42 
n.d.c) 
0 
1048±38 
1665±115 
885±39 
325±22 
20±15 
2134±159 
a) 5 x 106 viable cells of each type were cultured per well. 
DNP-MON was at a final concentration of 100 ng/ml. 
b) Cultures were assayed on day 3. Each value is the 
arithmetic mean of 4 cultures± the standard error of the 
mean. 
c) Not done. 
d) B cells= lower layer from Isopaque/Ficoll separation of 
lg-bearing and 8-positive lymphocytes (Table 5.2). 
T cells= upper layer from same separation. 
Table 5.6: Control to test for non-specific sedimentation 
of functional T cells. 
Cells cultured a) 
Untreated spleen 
Anti-8 treated spleen 
Anti-8 treated spleen 
+ lower layer control b) 
rosetted cells 
Anti-8 treated spleen 
+ T cells c) 
Lower layer control 
rosetted cells alone 
Anti-DNP PFC per culture d) 
1180±8 
440±18 
415±22 
1185±76 
45±10 
a) 5 x 10 6 viable untreated or anti-8 treated cells and 
approximately 2 x 106 lower layer control rosetted cells 
were cultured per well as described. 
b) Spleen cells+ SRBC were spun on Isopaque/Ficoll, the 
SRBC lysed by hypotonic shock and the recovered cells 
cultured. 
c) T cells= upper layer from Isopaque/Ficoll separation of 
lg-bearing and 8-positive lymphocytes; 4 x 10 6 per well. 
d) Each value represents the arithmetic mean of 4 cultures 
± the standard error of the mean. 
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anti-DNP PFC response measured (Table 5.7). Again the upper 
layer preparation produced little or no antibody to DNP. The 
lower layer produced some, but this was significantly lower 
han that produced by the unfractionated spleen cells. 
Recombination of the upper and lower layers resulted in a 
response equal to that of the unfractionated spleen (see also 
Tables 7.6 and 7.7). 
5.3.3 Fe rosetting lymphocytes 
5.3.3.1 Fractionation of Fe and non-Fe receptor lymphocytes 
on Isopaque/Ficoll 
The rosetting procedure was also adapted for 
depleting and obtaining in pure form Fe receptor lymphocytes 
(FcRL) from mouse spleen cells. 40-50% of spleen cells formed 
Fe rosettes. The separated cell populations were examined 
for their ability to respond to DNP-MON in vitro (Table 5.8 ). 
The non-FcRL gave only a slight response above background but 
the Fe positive (lower layer) gave a significant response, 
2-3~ fold above background. This response was removed by 
treating the cells with anti-8 and complement prior to culture. 
These functional helper cells were specifically forming 
rosettes, as shown by the data in Table 5.6. Hence, it was 
concluded that there was a subpopulation of theta positive, 
helper cells which possessed a receptor for the Fe portion of 
Ig. Recombination of FcRL and non-FcRL populations led to 
anti-DNP responses of the same magnitude as unfractionated 
spleen. 
5 .3. 3 .2 Fer c ptor helper cells 
The presence of Fe bearing, functional helper cells 
was further demonstrated by a double rosetting experiment 
where spleen cells were first depleted of Ig RFC and the 
upper, T layer was then re-rosetted for FcRL. Approximately 
7% of the T layer formed Fe rosettes. On a cell per cell 
basis the Fe depleted T layer was less effective than the 
undepleted T layer at restoring the anti-DNP response to 
anti-8 treated spleen cells. The Fc+Ig- cells were as good 
as Fc+rg - cells as helper cells in the anti-DNP response 
(Table 5.9). Thus these results suggest that a substantial 
proportion of functional helper cells possess an Fe receptor. 
Table 5.7: Collaboration between Isopaque/Ficoll purified 
T and B cells in the in vivo anti-DNP response 
to DNP-MON 
Cells transferred a) Anti-DNP PFC per spleen b) 
Direct Indirect 
None 14±2 4±4 
Untreated spleen 2308±216 3648±640 
B cells 300±53 388±115 
T cells 44±9 84±49 
B cells + T cells d) 2408±384 4332±1330 
a) 107 viable lymphocytes were injected into each mouse. 
b) Anti-DNP PFC were measured on day 6 after cell transfer. 
Each value represents the arithmetic mean of five spleens 
± the standard error of the mean. 
c) Indirect plaques were developed using a rabbit anti-mouse 
Ig serum at an appropriate dilution (1/20) (Cunningham 
and Szenberg, 1968). 
d) B cells= lower layer from Isopaque/Ficoll separation of 
lg-bearing and 8-positive lymphocytes. 
T cells= upper layer from same separation. 
Table 5.8: The response of spleen cells fractionated by Fe 
rosetting and separation on Isopaque/Ficoll to 
DNP-MON in vitro 
Cells cultured a) Anti-DNP PFC per culture 
Expt. 1 b) Expt. 2 
Unfractionated spleen 1375±82 2390±176 
-Fe cells alone 
(Upper layer) 14 3±4 5 365±53 
+ Fe cells alone 
(Lower layer) 650±37 585±142 
Fe-+ Fe+ cells 1450±20 1995±204 
Anti-8 Fe+ cells 283±20 195±40 
a) 5 x 10 6 unfractionated cells and 2.5 x 106 viable 
- + + Fe , Fe and anti-8 treated Fe were cultured as 
described. 
b) In experiment 1, 44.1% of spleen cells were Fe~ 
In experiment 2, 48.9% of spleen cells were Fe~ 
c) 
b) 
c) Each value represents the arithmetic mean of 4 cultures 
± the standard error of the mean. 
Table 5.9: Demonstration of functional helper cells with Fe 
receptors in upper layer of Ig depleted spleen 
(T cell layer) 
Cells cultured Number per Anti-DNP PFC c) 
culture per culture 
Untreated spleen 5 X 10 6 1290 ± 48 
Anti-8 treated spleen 5 X 10 6 355 + 48 
Anti-8 treated spleen 5 X 106 650 ± 45 + T cells a) 0.5 10 6 X 
Anti-8 treated spleen 5 X 10 6 815 ± 87 10 6 + T cells 1.5 X 
Anti-8 treated spleen 5 X 10 6 1000 ± 55 10 6 + T cells 3 X 
Anti-8 treated spleen 5 X 10 6 1185 ± 76 106 + T cells 5 X 
Anti-8 treated spleen 5 X 10 6 455 ± 82 + Fe- T cells b) 0.5 106 X 
Anti-8 treated spleen 5 X 106 660 ± 93 + Fe- T cells 1.5 X 10 6 
Anti-8 treated spleen 5 X 10 6 665 ± 39 + Fe- T cells 3 X 10 6 
Anti-8 treated spleen 5 X 106 690 ± 41 + Fe+ T cells ~2 106 X 
a) T cells= upper layer from Isopaque/Ficoll separation of 
lg-bearing and 8-positive lymphocytes. 
b) T cells were re-rosetted and depleted of Fe receptor 
lymphocytes. In this experiment 6.5% of the lg-cells 
formed Fe rosettes. 
c) Each value is the arithmetic mean of 4 cultures± the 
standard error of the mean . 
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5.4 DISCUSSION 
In this chapter a one step procedure for fraction-
ating and obtaining in pure form lg-bearing cells and an 
enriched population of theta-positive cells from mouse 
lymphoid populations was described. Virtually all theta-
positive lymphocytes (> 90%) were recovered in the non-
rosetting population; few sedimented with the lg rosettes 
(Table 5.2). Helper T cells appeared in the non-rosetting 
population whereas the precursors of antibody forming cells 
(i.e. B cells) were isolated in the preparations of Ig 
rosettes. This was observed in the in vitro anti-hapten 
response to DNP-HCY and DNP-MON (Tables 5.3, 5.4 and 5.5) and 
the in vivo response to DNP-MON (Table 5.7). It was 
demonstrated that a pure population of carrier primed T cells 
could collaborate with a pure population of hapten primed B 
cells to generate an anti-hapten response. There is ample 
indirect evidence for this collaboration (Wigzell et al., 
1972; Raff, 1970b; Mond et al., 1972; Niederhuber and Moller, 
1973), but the above results represented a direct demonstrat-
ion of this phenomenon and confirmed conclusively the T 
dependent nature of the anti-DNP response to DNP-MON 
described in Chapters 3 and 4. 
In these studies some evidence was obtained which 
suggested that a small subpopulation of lg-bearing T cells 
existed. Firstly, a small number (<1%) of T cells were found 
which possessed a low density of surface Ig (Figure 5.3). 
Secondly, the lg-rosettes produced a small antibody response 
to DNP-MON which was sensitive to anti-8 treatment. Other 
workers have detected peripheral T cells with surface Ig 
(e.g. Hanunerling and Rajewsky, 1971; Bankhurst et al., 1971; 
Goldschneider and Cogen, 1973; and see 1.1.1). However, 
whether these cells actively synthesize their surface Ig 
(Roelants et al., 1974) or passively acquire it via an Fe 
receptor (Modabber and Coons, 1972; Yoshida and Andersson, 
1972; Orr and Paraskevas, 1973; Webb and Cooper, 1973; 
Tables 5.8 and 5.9) remains to be established. Certainly the 
results suggested that such cells can act as helpers but it is 
not known whether all helper cells are contained within this 
subpopulation. 
The Isopaque/Ficoll separation procedure is a highly 
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versatile technique as any subpopulation of lymphocytes 
which can be identified by rosetting can be purified using 
this method. The procedure was used to deplete and purify 
Fe receptor lymphocytes. It was shown that there is a 
population of theta-positive, helper cells with Fe receptors. 
Also, functional helper cells with Fe receptors could be 
+ -demonstrated in the Ig depleted T layer. Fe Ig lymphocytes 
have also been found in rat thoracic duct lymph (Parish and 
Hayward, 1974b) but owing to the lack of a reliable T cell 
marker in the rat it had not been demonstrated whether these 
were Tor B lymphocytes. The results with the mouse 
lymphocytes suggest that some, or all, of these cells are T 
cells. 
5.5 SUMMARY 
A procedure for both depleting and obtaining in 
pure form lg-bearing cells from mouse lymphoid populations 
was described. The lg-bearing cells were identified by 
rosetting and the rosettes separated from the non-rosetting 
lymphocytes by centrifugation on Isopaque/Ficoll. The 
rosettes sank with the red cells and the non-rosetting 
lymphocytes floated. The procedure was >99.5% efficient at 
depleting mouse lymphoid population of lg-rosetting cells 
and was also >97% efficient at removing the lg-bearing cells 
detected by radioautography. Furthermore, after lysis of 
the red cells by hypotonic shock the lg-bearing cells were 
recovered in a highly pure form. The total recovery of white 
cells and rosettes applied was >85%. 
This procedure was shown to produce a functional 
separation of T and B lymphocytes. The cell population 
depleted of lg-rosettes behaved as a pure T cell preparation. 
It lacked precursors of antibody forming cells, but contained 
virtually all of the 8-positive lymphocytes, the bulk of the 
helper cells detected in two anti-hapten antibody responses. 
In contrast, the preparation of lg-rosettes expressed B cell 
properties. This population contained all of the antibody 
forming cell precursors. However, there was some evidence 
that there was a small subpopulation of T cells which 
poss ssed surface Ig and were present in the Ig positive 
rosette population. 67 
A modification of the separation procedure enabled 
fractionation of Fe receptor bearing and non-Fe receptor 
bearing lymphocytes. It was shown that there was also a small 
subpopulation of T cells which possessed an Fe receptor. 
The Ig rosetting and separation was used to 
demonstrate formally that carrier primed T cells collaborate 
with hapten primed B cells both in vivo and in vitro to 
generate an anti-hapten antibody response to a hapten-carrier 
conjugate, using the responses to DNP-HCY and DNP-MON. 
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6.1 INTRODUCTION 
The mechanisms by which T and B cells collaborate in 
antibody production are still a matter of controversy. As 
discussed in 1.2, the various models proposed can be divided 
broadly into the contact models, where cell-cell contact is 
a necessary requirement for B cell stimulation and the 
factor models. Variants of this latter model postulate that 
T c e lls, once activated by antigen, release either short 
range non-specific factors which trigger B cells already 
stimulated by antigen, or that T cells activated by antigen 
release specific factors (antigen-receptor complex?) which 
can then activate B cells directly, or that both specific 
and non-specific factors are produced. However, where 
specific factors have been characterized, agreement has not 
been reached as to their chemical nature (Feldmann, 1972c; 
Taussig and Munro, 1974). In addition, in all cases where 
specific factors have been found, the ATC have been primed 
in vivo and hence the contribution of antibody, either 
passively acquired by the ATC (Hunt and Williams, 1974; 
Hudson et al., 1974) or synthesized by contaminating B cells 
from the donor thymus population or the residual radio-
resistent host B cells (Parish and Hayward, 1974 c ; 
Pilarski and Cunningham, 1974) needs to be rigorously 
eliminated. The frequent observation that antibody against 
one antigenic determinant enhances the response to another 
unrelated determinant on the same antigen (e.g. Schierman et 
al., 1969; Pincus et al., 1973; Janeway and Paul, 1973) 
further reinforces the pos sibility that the carrier-specific 
factors r e leased by ATC ma y be B cell derived immunoglobulin. 
The advantage of being able to obtain pure 
populations of T and B lymphocytes (Chapter 5) and the ready 
adaptation of the T dependent in vitro anti-hapten response 
to DNP-MON (Chapter 3) to culture in a double chamber system 
enabled a study of the ability of T cells to collaborate 
with B cells across a cell impermeable Millipore membrane. 
It will be shown in this chapter that T cells alone, 
under the experimental conditions used, were not able to 
collaborate with B cells across a Millipore membrane. 
However, Band T cells together produced a specific 
collaborative factor which passed through the membrane and 
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partially restored the B cell response. In Chapter 7 the 
importance of the carrier specific (i.e. flagellin specific) 
B cells in the production of this collaborative factor will 
be demonstrated. 
6.2 MATERIALS AND METHODS 
6.2.1 Animals 
CBA/H mice, 7-9 weeks of age, obtained from breeding 
colonies in this School were used throughout. 
6.2.2 Antigens 
DNP-flagellin (DNP 1 . 5MON) was prepared as described 
earlier (3.2.3). Sheep red blood cells (SRBC) were 
obtained from Conunonwealth Serum Laboratories, Melbourne, 
and were washed four times in normal saline before use. 
SRBC primed mice were given 2xl0 8 SRBC, i.v., 7 weeks prior 
to use. 
6.2.3 Fractionation of spleen cells on Isopaque/Ficoll 
Spleen cell suspensions were fractionated into T 
and B populations by the one-step procedure described in 
Chapter 5. 
6.2.4 Tissue culture 
Culture medium was as described earlier (3.2.5). 
Cells were cultured in this medium with antigen (usually 
DNP-MON at 100 ng/ml) in 16nun Linbro trays (Linbro Chemical 
Co., New Haven, Connecticut, U.S.A.) or in a modified 
Marbrook - Diener culture system consisting of an inner 
chamber and an outer chamber (Figure 6.1). The bottom end 
of the inner chamber was sealed off from the outer chamber by 
a Millipore membrane (Millipore Corporation, Bedford, 
Massachusetts, U.S.A. - 0.45µ pore size (6.lb) or this type 
of membrane was replaced by a dialysis membrane (Union 
Carbide Corp., New York) fixed on by siliconized rubber 
rings (6.la). Cells were cultured in these double chambers 
with 5 x 10 6 cells in 1.0 ml in the upper chamber and 5 x 106 
cells in 2.0 ml in the lower chamber. Cultures were placed in 
a humidified incubator at 37°c in an atmosphere of 10% CO2, 
7% 02 in N2 for three days and then harvested and assayed for 
a 
o-'---•-_.•A 
Figure 6.l 
Double chamber culture vessels for examining the ability of 
cells to collaborate across cell impermeable membranes. 
a) The bottom end of the inner chamber was sealed off 
from the outer chamber by a dialysis membrane. 
b) The bottom end of the inner chamber was sealed off 
from the outer chamber by a Millipore membrane 
(0.45µ pore size). 
In both cases membranes were fixed on by siliconized rubber 
rings. 
Cells were cultured in these double chambers with 5 x 106 
cells in 1.0 ml in the upper chamber and 5 x 10 6 cells in 
2.0 ml in the lower chamber. 
plaque-forming cells. 
6.2.5 Enumeration of plaque-forming cells 
See 3.2.14 
6.2.6 Treatment of cells with anti- 8 and complement 
See 3.2.16 
6.3 RESULTS 
6.3.1 Sununary of the characteristics of the response to 
DNP-MON in vitro 
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It has already been shown (Chapters 3, 4 and 5) that 
the anti-hapten response to DNP-MON is highly T cell dependent. 
Mice used in these experiments were naturally pre-primed to 
MON and thus spleen cells gave an excellent response to this 
antigen in vitro. Table 6.1 summarizes the T dependent 
nature of the response discussed in previous chapters. Anti-8 
treated spleen cells gave a 3-7 fold lower plaque-forming 
cell response compared to untreated spleen cells or spleen 
cells treated with normal ascitic fluid and complement when 
equal numbers of viable cells were cultured. The response 
could be fully restored by addition of the T cell fraction of 
spleen following removal of the Ig positive rosette-forming 
cells on Isopaque/Ficoll. 
The Ig positive cells, when cultured alone, gave a 
substantial antibody response, although this response was 
significantly lower than that given by the untreated spleen 
cells. Treatment of these cells with anti- 8 ascitic fluid 
and complement significantly reduced the anti-DNP response. 
It was thus concluded that the Ig positive population was 
contaminated with some functional T cells with enough surface 
Ig to form rosettes. Recombination of the T and B layers 
resulted in a response equal to, or greater than, the 
unfractionated spleen cell population. 
It was also demonstrated that DNP-MON behaved as a 
classic hapten-carrier, chemical linkage between the hapten 
and carrier being required for the anti-hapten response to be 
induced (Table 3.15 ). There was no evidence that carrier 
activated T cells released a mitogen which non-specifically 
Table 6.1: T-ce ll dependence of the anti - DNP response to 
DNP-MON. 
Cells Cultured a) 
Unfractionated 
spleen 
Untreated 
Normal ascitic 
fluid and C' 
Anti- 8 ascitic 
fluid and C' 
Anti- 8 ascitic 
fluid and C' 
Bottom 
Layer 
(B) Ce lls 
+ 
+ 
anti- 0 d) 
treated 
Top b) 
Layer 
(T) Cells 
+ 
+ 
+ 
Direct anti-DNP PFC 
per culture c) 
1430±115 
1185±41 
365±39 
1372±98 
< 5 
828±42 
10 48±38 
325±22 
a) 5 x 10 6 viable cells were cultured per well. 
b) Isopaque/Ficoll fractionated cells. 
Bottom layer: Ig positive RFC. 
Top layer: The T enriched layer. 
c) Each value is the arithmetic mean of four cultures ± the 
standard error of the mean . DNP-MON was at a final 
concentration of 100 ng/ml. 
d) Bottom6layer cells were treated with anti- 8 and C' a nd 5 x 10 viable cells cultured per well. 
trigge r e d hapte n-specific B cells. 
6.3.2 Transfer of a T cell replacing factor across a 
Millipore membrane 
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The in vitro response to DNP-MON was used in 
conjunction with the Isopaque/Ficoll separation procedure 
to look at cellular collaboration across a Millipore membrane. 
6.3.2.1 Partial restoration of the anti-DNP response of 
anti-0 tre ated spleen across a Millipore membrane 
Initially normal spleen cells (i.e. Band T cells) 
were cultured in the upper chamber and the response in the 
lower chamber of anti- 8 treated spleen cells (B cells) to 
DNP-MON measured. DNP-MON was present in both chambers 
(Table 6.2). Partial restoration of the anti-DNP response 
was obtained in all experiments, the average restoration being 
around 40% and varying in individual experiments from 30-90%. 
6.3.2.2 The effect of culturing fractionated cells in the 
upper chamber on production of the factor 
The next step was to fractionate spleen cells by the 
Isopaque/Ficoll procedure and culture either pure T cells in 
the upper chamber or anti- 8 treated spleen (B cells) in the 
upper chamber. It was found (Table 6.3) that both Band T 
cells were required in the upper chamber for the collaborative 
factor to be produced. Purified T cells or B cells cultured 
alone in the upper chamber had no, or only a very slight (<2% 
restoration), effect on the anti-DNP response of the anti-8 
treated spleen cells cultured in the lower chamber. However, 
if the T cells were cultured in the lower chamber with the 
anti- 8 treated cells a complete restoration of the response 
occurred. 
6. 3 .2. 3 Collaboration across the membrane in both directions 
If the partial restoration of the anti-DNP re sponse 
was via a soluble factor, it would be expected that the 
collaboration would operate in both directions. Therefore, 
the system was reversed and the anti- 8 treated spleen 
population cultured in the upper chamber and untreated spleen 
or purifie d Tor anti-8 treated (spleen cells) cultured in 
the lower chamber. In this case, even better restorations, 
Table 6.2; Transfer of a T cell replacing factor across a Millipore membrane 
Cells Cultured a) 
Upper Lower 
chamber chamber 
Untreated Untreated 
Anti-8 
treated 
Untreated Anti- 8 
treated 
1. 
650±80 
165±18 
615±102 
Anti-DNP PFC response in lower chamber b) 
2. 3. 4. 5. 
1143±148 1210±150 1733±100 2347±101 
233±13 190±40 295±89 653±24 
563±37 695±157 690±34 1845±238 
a) 5 X 10 6 viable cells were cultured in 1 ml in the upper chamber and 5 x 10 6 
in 2 ml in the lower chamber. 
b) Each value represents the arithmetic mean of four cultures± the standard error 
of the mean. 
Table 6.3: The effect of culturing f ractionated cells in the upper cha mb e r 
on production of the factor. 
Cells Cultured a) 
Upper 
Chamber 
Untreated 
b) 
Untreated 
Tc) 
Anti- 8 
treated 
Lower 
Chamber 
Untreated 
Anti- 8 treated 
Anti- 8 treated 
Anti- 8 treated 
Anti- 8 treated 
+ T 
Anti- 8 treated 
T 
Anti-DNP PFC response in lower chamber d) 
1. 
728±123 
143±29 
335±59 
e) 
n.d. 
635±56 
n.d. 
n.d. 
2. 
1343±83 
295±16 
515±33 
335±52 
1420±20 
318±27 
0 
3. 
1780±83 
440±18 
933±175 
413±113 
1380±170 
n.d. 
< 5 
4 • 
1578±116 
485±54 
830±51 
n.d. 
n.d. 
506±9 
n.d. 
a) 5 x 10 6 viable cells were cultured in 1 ml in the upper chamber and 
5 x 10 6 cells in 2 ml in the lower chamber. 
b) No cells. 
c) T cells= upper layer from Isopaque/ Ficoll separation of lg-bearing 
and 8-positive lymphocytes. 
d) Each value represents the arithmetic mean of four cultures± the 
standard error of the mean. 
e) No t d one. 
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averaging 55% and ranging between 40 and 70% in individual 
experiments, were obtained (Table 6.4). 
This result probably reflected the geometry of the 
culture vessel. Cells in the lower chamber gave consistently 
higher responses (>2 fold) to DNP-MON than the same number 
of cells cultured in the upper chamber, and possibly 
therefore , more factor was produced by cells cultured in the 
lower chamber. Again there was no restoration by purified 
T cells or B cells cultured alone. 
6.3.2.4 Effect of removal of the lg-bearing T cell on 
production of the collaborative factor 
As mentioned earlier (6.3.1) Ig bearing T cells 
sediment to the lower layer in the Isopaque/Ficoll separation 
procedure, and one possibility was that these cells, which 
can act as functional helper cells (Table 6.1), were 
responsible for the production of the collaborative factor. 
To investigate this possibility the upper layer T 
cells (i.e. depleted of the Ig positive T cells) were added 
to anti-8 treated cells, cultured in the upper chamber, and 
the lower chamber response measured (Table 6.5). The 
collaborative factor was once again produced indicating that 
the Ig bearing T cell is not essential for factor production. 
6.3.3 Properties of the collaborative factor 
6.3.3.1 Inability of the factor to pass through a dialysis 
membrane 
Normal spleen cells were cultured in the upper 
chamber and were separated from anti- 8 treated spleen cells 
in the lower chamber by a dialysis membrane, rather than a 
Millipore membrane. DNP-MON was present in both chambers. 
Under these culture conditions no restoration of the response 
of the lower chamber cells was obtained (Table 6.6). From 
this result it was concluded that the collaborative factor 
was non-dialyzable i.e. has a molecular weight >5000-10000. 
6.3.3.2 Specificity 
The specificity of the factor for the antigen DNP-
MON was investigated using another T dependent response, the 
response to SRBC. 
Table 6.4; Restoration of response in upper chamber by factor production 
in the lower chamber. 
Cells Cultured a) 
Upper 
Chamber 
Untreated 
Anti-8 treated 
Anti-8 treated 
Anti-8 treated 
Anti-8 treated 
+ T 
Talone 
Anti- 8 treated 
Lower 
Chamber 
Untreated 
Untreated 
Tb) 
Anti-8 treated 
Anti-DNP PFC in upper chamber c) 
1. 2. 3. 
663±48 285±50 734±38 
141±27 47±18 293±21 
630±90 258±55 545±86 
n.d. d) n.d. 240±20 
n.d. n.d. 608±77 
n.d. n.d. <10 
n.d. n.d. 150±38 
a) 5 x 1 0 ~ viable cells were cultured in 1 ml in the upper chamber and 
5 x 1 0 cells in 2 ml in the lower chamber. 
b) 
c) 
d) 
T cells= upper layer from Isopaque/Ficoll separation of lg-bearing and 
8-positive lymphocytes. 
Each value represents the arithmetic mean of four cultures± the standard 
error of the mean . 
Not done. 
Table 6.5: Effect of removal of lg-be aring T c e lls 
on production of the factor. 
Cells Cultured a) 
Upper chamber Lower chamber 
Untreated Untreated 
b) Anti-8 treated 
Untreated Anti-8 treated 
Tc) Anti-8 treated 
Anti-8 treated 
+ T 
T 
Anti-E) treated Anti-8 treated 
Anti-8 treated Anti-8 treated 
+ T 
Anti-DNP PFC d) 
in 
Lower chamber 
1695±95 
655±93 
1375±93 
580±91 
1387±105 
<5 
815±60 
1227±125 
a) 5 x 10 6 viable cells of each type were cultured in 
1 ml in the upper chamber and 5 x 106cells of each 
type in 2 ml in the lower chamber. 
b) No cells. 
c) T cells= upper layer from Isopaque/Ficoll separation 
of Ig-bearing and 8-positive lymphocytes. 
d) Each value represents the arithmetic mean of four 
cultures± the standard error of the mean. 
Table 6. 6 : Inability of factor to cross a dialysis membrane. 
Cells Cultured a) Anti-DNP PFC in 
Lower chamber d) 
Upper chamber Lower chamber 1. 1. 2. 
Untreated Untreated 1768±54 1150±87 
b) Anti-8 treated 427±22 228±18 
Untreated Anti-8 treated 436±63 398±53 
a) 
b) 
c) 
d) 
e ) 
Anti-8 treated n.d. e) 1405±121 
+ Tc) 
5 x 10 6 viable cells were cultured in 1 ml in the upper 
chamber, 5 x 106 cells in 2 mls in the lower chamber. 
Upper and lower chambers were separated by a dialysis 
membrane. 
No cells. 
T cells= upper layer from Isopaque/Ficoll separation of 
Ig bearing and 8 positive lymphocytes. 
Each value is the arithmetic mean of four cultures± the 
standard error of the mean. 
Not done. 
Table 6.7: Specificity of factor for the DNP-MON response. 
Cells Cultured a) . c) Antigen ?~C response in lower chamber d) 
Upper chamber Lower chamber Upper cha.rnber Lower chamber ... :\.n c.i-DNP PFC Anti-SRBC PFC 
Untreated Untreated DNP-MON DNP-MON 973±132 1078±255 SRBC SRBC 
b) Anti-8 treated DNP-MON DNP-MON 
SRBC SRBC lS0±21 10±6 
Untreated Anti-8 treated DNP-MON DNP-MON 810±49 108±17 SRBC SRBC 
Untreated Anti-8 treated DNP-.MON DNP-MON 540±72 10±6 SRBC 
Untreated Anti-8 treated SRBC SRBC - 78±31 
a) 5 x 10 6 viable cells were cultured in 1 ml in the upper chamber and 5 x 10 6 cells in 2 ml in 
the lower charr~er. 
b) No cells. 
c) DNP-MON was at a final concentration of lOOng/ml and sterile washed LSL SRBC at 5 x 10 6 cells / ml. 
d) Each value represents the arithmetic mean of four cultures± the sta_~dard error of the mean. 
Cultures were assayed on day 4. 
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Spleen cells primed 7 weeks previously to SRBC were 
used so that good in vitro anti-SRBC responses were obtained. 
These cells were cultured in the upper chamber with both 
antigens (SRBC and DNP-MON) or either antigen alone and the 
lower chamber anti-DNP and anti-SRBC responses measured. 
Cultures were assayed on day 4, instead of day 3 as previously, 
as the anti-SRBC response was highest at this time. Results 
of one of a number of similar experiments are given in Table 
6.7. 
Whilst restoration of the anti-DNP response was 
around 45%, no restoration of the anti-SRBC response was 
obtained when DNP-MON alone was the antigen present in the 
upper chamber, indicating that the factor was not simply 
mitogenic for B cells in the lower chamber but was antigen 
specific. 
Slight but statistically significant restorations 
of the SRBC response (6-9%) were obtained when SRBC were 
present in the upper chamber, suggesting that a specific SRBC 
collaborative factor might also be produced. Restoration of 
the anti-SRBC response might not be expected to be as great 
as for DNP-MON as a SRBC-factor complex would be unable to 
cross the Millipore membrane. 
6.4 DISCUSSION 
In the experiments reported in this chapter, the 
ability of T cells to collaborate with B cells across a cell 
impermeable Millipore membrane was assessed. It was shown 
that purified T cells were unable to collaborate with B cells 
in the anti-hapten response when these cells were separated 
by a Millipore membrane. They were, though, excellent 
helpers when cultured together with the B cells below the 
membrane. If both T and B cells were cultured above the 
membrane, however, a collaborative factor was produced which 
was partially able to restore the anti-DNP response of B cells 
cultured below. B cells alone could not produce the factor. 
The possibility of cell leakage through the Millipore 
membrane seemed unlikely for several reasons. 
a) The Millipore membranes were attached by siliconized 
rubber rings which were well beyond the medium inter-
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face. Hence, if the membrane was intact no leakage 
should have occurred. Millipore membranes were 
examined when cells were harvested for any cracks and 
defective chambers were discarded. 
b) The response to DNP-MON is so highly T-dependent that 
the failure of T cells to give any help at all across 
the membrane was a good positive control against cell 
leakage. 
c) The collaborative factor was shown to work in both 
directions, i.e. could diffuse up as well as down and 
to some extent this also argued against cell leakage 
through the membrane, as during culture cells very 
rapidly settled to the bottom of the chambers. 
The factor was shown to be specific and non-
dialyzable. These two properties are reminiscent of the 
factor described by Feldmann and Basten (1972b, c, d) which 
was obtained from ATC. It is of interest, therefore, that 
in our system T cells alone cannot give rise to this factor. 
Whether the factor was a Tor B cell product could not at 
this stage be concluded. The possibility that irrununoglobulin 
bearing T cells were necessary for its production was 
eliminated, however, by the ability of purified T cells (i.e. 
depleted of Ig bearing cells) and anti-8 treated spleen (B 
cells) to still produce the factor. In the next chapter it 
will be shown that the flagellin specific B cell has a role 
in the anti-hapten response to DNP-MON and in particular 
appears to be necessary for production of the collaborative 
factor. 
6.5 SUMMARY 
The in vitro anti-hapten response to DNP--flagellin 
(DNP-MON) was used to examine the ability of T cells to 
collaborate with B cells across a cell impermeable Millipore 
membrane. Pure populations of T and B lymphocytes were 
obtained by the Isopaque/Ficoll separation procedure. It was 
found that T cells alone were not able to collaborate with B 
cells across a Millipore membrane. However, Band T cells 
together produced a T cell replacing factor which passed 
through the membrane and partially restored the antibody 
I 
Ii 
Ii 
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response o . B cells cultured beneath the merrilirane. The T 
cell replacing factor was shown to be non-dialyzable and 
antigen specific. 
...... 
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7.1 INTRODUCTION 
In Chapter 6, it was shown that when either Tor B 
cells were cultured alone above a cell-impermeable Millipore 
membrane, they were unable to restore the anti-DNP response 
of B cells cultured below the membrane. Band T cells 
together however, produced a factor which passed through the 
Millipore membrane and which partially restored the anti-DNP 
response of the B cells below the membrane. This factor was 
non-dialyzable and specific. In this chapter production of 
the collaborative factor is further analyzed and, in 
particular, the role played by carrier specific B cells and 
macrophages in factor production considered. 
7.2 MATERIALS AND METHODS 
7.2.1 Animals, antigens, tissue culture and assay procedures 
were as described in the previous chapter (6.2) and in Chapter 
3 (3.2). 
7.2.2 Irradiation of mice 
Mice received 850 rads whole body ganuna radiation 
from a 60co source over a period of 20-25 minutes. The mice 
were housed (5 per container) in perspex cylindrical containers 
which rotated around the source as well as around their own 
axis during irradiation. 
7.2.3 Irradiation of cells 
Cells were exposed in capped, plastic centrifuge 
tubes (2.5 x 10 7 viable cells in 1.0 ml FlS medium) to the 
gamma radiation of the 60 co source at the rate of 245 rads 
per minute. The cells were rotated, like the mice, both around 
th ir own axis and around the source during exposure to the 
radiation. 
7.2.4 Titration of anti-POL antibody 
POL specific antibody was detected by a haemagglutin-
ation procedure described in detail by Langman (1972). Briefly, 
SRBC or HRBC were coated with POL, via CrC1 3 , and added to 
dilutions of the serum to be tested in V-cupped perspex trays. 
The serum/SRBC mixtures were allowed to settle for 4-6 hat 
room temperature before 50% agglutination was taken as the 
endpoint of each titration. 
7.2.5 Preparation of POL specific rosettes and depletion 
on Isopaque/Ficoll 
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Washed SRBC were coated with POL 870 as follows. 
To 4.0 ml of normal saline 0.25 ml of packed SRBC were added 
followed by 100 µl (1 mg) of POL 870 and 200 µl of 0.1% (w/v) 
CrC1 3 in normal saline. All were mixed well and left for 10 
minutes at room temperature. PBS (5 ml) was then added and 
the red cells centrifuged (300 g, 5 min) resuspended in 5 ml 
PBS and again washed. The red cell pellet was finally 
resuspended in 1.0 ml of Fl5 medium to give 20% E-POL cells 
for rosetting. Rosettes were formed as described in 5.2.4.1 
and separated on the Isopaque/Ficoll mixture as usual (5.2.5). 
A 20% suspension of unsensitized SRBC (E) was used for a 
control rosetted population. 
7.2.6 Radioiodination of POL 
POL was iodinated for the suicide experiments with 
carrier-free iodide -125 (IMS 3 Radiochemical Centre, Amershan, 
U.K.) by a direct oxidation procedure (Byrt and Ada, 1969). 
Preparations of 125 r-POL had a specific activity of 50-120 
µC/µg. POL was also iodinated with the non-radioactive 
iodide-127 by the same procedure, for use as a control. 
7.2.7 Suicide of spleen cells with 12 51-POL 
Cells were incubated at a concentration of 2.5xl0 7 
-lxl0 8/ml in culture medium containing 1-SrnM sodium azide and 
5-20µg/ml 125 1-POL for lh at 37°c. They were then washed 
several times before being counted and subsequently cultured. 
Control suicided cells were treated identically except that 
127 I-POL was added. For some of the in vivo transfers, cells 
were left for 14-19 hat 4°c after the washing stage before 
being injected into irradiated mice according to the method 
of Cooper and Ada (1972). 
7.2.8 Removal of Macrophages 
7.2.8.1 By adherence 
Spleen cells were cultured in FlS with 10% FCS for 
Sh at 37°c at monolayer density in plastic tissue culture 
dishes. This procedure allowed macrophages to adhere and 
spread out on the plastic surface. Most of the non-adherent 
cells were then harvested by gentle pipetting which left the 
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adherent cells on the plastic. The efficiency of this 
procedure at depleting macrophages has been described else-
where (Gardner et al., 1974a). 
7.2.8.2 By carbonyl iron method 
To 5 ml of spleen cells (2 x 10 7 cells/ml) in a 
screw capped McCartney bottle sterile, carbonyl iron powder 
was added until the medium was grey in colour. The bottle 
was sealed tightly and rotated at 37°c for 30 min. The cells 
were then transferred into a sterile glass centrifuge tube 
and a strong magnet run down the sides of the tube several 
times. The supernatant, containing most of the non-phagocytic 
cells was removed and the filings in the bottom of the tube 
were resuspended in a further volume of medium and the 
procedure repeated. Cells recovered in this way were washed 
and depleted of carbonyl iron in the same way (usually 3 
times) until no grey colour was apparent. At least 80% of 
cells were recovered following this procedure and most dead 
cells were removed, the recovered cells generally having 
viabilities >95% as judged by trypan blue dye exclusion. 
7.3 RESULTS 
7.3.1 The effect of removal of the POL specific B cell on 
the anti-hapten response to DNP-MON in vitro 
In these studies two methods were used to remove 
POL specific cells from spleen cell populations. In the first 
method POL specific cells were "suicided" with radioactive 
antigen. In the second procedure POL cells were first rosetted 
with POL coated red cells and then separated from the non-
rosetting spleen cells by centrifugation on Isopaque/Ficoll. 
Before u s ing radioactive POL to suicide specific cells the 
radiation sensitivity of the in vitro anti-DNP response to 
DNP-MON was determined. 
7.3.1.1 The effect of y-irradiation on the anti-DNP response 
to DNP-MON in vitro 
Initially spleen cells were irradiated by exposure 
to a 60 co source for varying time intervals. Cells received 
doses between 250 and 3675 rads of irradiation prior to 
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culture in vitro with DNP-MON. It was found that the anti-
DNP response was highly radiosensitive, radiation doses of 
~ 1000 rads almost completely obliterating the anti-DNP 
response (Figure 7.1). 
The radiosensitivity of the T (helper) cells in 
this system was then determined. Splenic T cells were purified 
by the Isopaque/Ficoll procedure and added to anti-8 treated 
spleen cells. Prior to addition to the anti-8 treated spleen 
the T cells were exposed to irradiation doses ranging from 
600 to 3675 rads (Table 7.1). 
Even after very high doses of irradiation the T 
cells were still able to bring about significant restoration 
(> 40%) of the anti-DNP response. There thus appeared to be a 
radiation sensitive T cell component and a radiation 
resistant component. These findings are consistent with 
those of others (Kettman and Dutton, 1971; Vann and Kettman, 
1972; Hamaoka et al., 1972), and probably reflect the degree 
of differentiation of the helper cells e.g. whether they have 
to divide or not. From Figure 7.1, however, it appeared likely 
that most B cells are damaged by irradiation doses greater 
than about 700 rads. Thus any decrease in the anti-DNP-MON 
response following POL suicide could be due to either 
inactivation of POL specific B cells or elimination of the 
radiosensitive T cells. 
7.3.1.2 The effect of 125 r-POL suicide on the anti-DNP 
response to DNP-MON 
When spleen cells were reacted with 125 r-POL of high 
specific activity (37°c, lh) prior to cell culture with DNP-
MON, a decrease in the anti-DNP PFC response was consistently 
observed. In 9 similar experiments, the average decrease 
was 53% and ranged between 40 and 74% in individual experiments. 
Some typical results are surrunarized in Table 7.2. 
7.3.1.3 The specificity of the 125r-POL suicide in vitro 
To investigate the specificity of the POL suicide, 
spleen cells from mice which had been primed 3 days 
previously with 2xlo5 ORBC, a procedure known to prime helper 
T cells pr ferentially for an anti-SRBC response (Cunningham 
nd Sercurz, 1971), wer _ suicided as usual with POL and 
PFC per CULTURE 
4000 
300 
200 
100 
0 5 10 15 
TIME of EXPOSURE(Minutes) 245 rads . per minute 
Figure 7.1 The effect of 60co irradiation of spleen 
cells on their anti-DNP response to DNP-MON. Approx-
imately 5xlo 6 cells were cultured per well. Each point 
represents the arithmetic mean of four cultures± the 
standard error of the mean. 
Table 7.1: The effect of radiation of T cells on their 
ability to restore the anti-DNP response of 
anti-8 treated spleen cells in vitro 
Cells cultured a) Anti-DNP PFC per culture c) 
Untreated spleen 1193 ± 117 
Normal ascitic fluid 
and C' treated spleen 1185 ± 41 
Anti-8 ascitic fluid 
and C' treated spleen 365 ± 39 
Anti-8 treated spleen + 
T cells untreated b) 1193 ± 81 
Anti-8 treated spleen+ 
T cells 600 rads 1076 ± 70 
Anti-8 treated spleen 
+ T cells 1000 rads 800 ± 47 
Anti-8 treated spleen 
+ T cells 2500 rads 643 ± 27 
Anti-8 treated spleen 
+ T cells 3750 rads 700 ± 82 
a) 5xl0 6 viable cells of each type were cultured per well 
b) T cells= upper layer from Isopaque/Ficoll separation 
of lg-bearing and 8-positive lymphocytes. 
c) Each value is the arithmetic mean of 4 cultures± the 
standard error of the mean. 
Table 7.2: The effect of 1251-POL suicide on the anti-DNP response to DNP-MON in vitro 
Cells cultured 
Untreated 
1251-POL treated 
1271-POL treated 
a) 
Expt. 1 
ll98 ± 98 
648 ± ll8 
1298 ± 33 
Anti-DNP PFC per culture b) 
Expt. 2 Expt. 3 
l228 ± 3.1 .1440 ± 6l 
588 ± l4 758 ± 61 
l075 ± l08 l238 ± ll2 
a) 5xlo6 viable cells were cultured per well. DNP-MON at lOOng/ml. 
Expt. 4 
1935 ± 96 
830 ± 101 
l628 ± 27 
b) Each value represents the arithmetic mean of 4 wells± the standard error of the mean. 
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cultured with both DNP-MON and SRBC. Cultures were assayed on 
day 3 against both DNP coated SRBC and normal SRBC so that 
the response to both antigens in the same culture was measured 
(Table 7. 3) . 
It was shown that the suicide was specific for the 
anti-DNP response as the anti-SRBC response was the same in 
both the POL suicided (125 I-POL) and control (127 I-POL) reacted 
cell populations. 
7 3 1 4 h . f. . f h 12 S . . d . . . . Te specl lClty O t e I-POL SUlCl e in VlVO 
Some of the suicided cells were transferred into 
irradiated recipients which were challenged on days 2 and 5 
with 10 µg POL and 2xl08 SRBC, intravenously. Serum was 
collected and spleens harvested on day 8 after cell transfer 
and the anti-POL haemagglutination titre and anti-SRBC PFC 
response measured. Although the anti-POL antibody titre was 
significantly reduced or abolished following 125 I-POL suicide, 
the anti-SRBC PFC response was only slightly affected, if at 
all, by the suicide procedure (Table 7.4). In two other 
experiments the POL antibody response was only partially 
reduced. These in vivo results showed conclusively that the 
POL specific B cell was eliminated by the POL suicide procedure, 
as the antibody response to POL is T independent (Feldmann 
and Basten, 1971). It was not known however, whether some POL 
specific T cells were also affected. 
7.3.1.5 The cell affected by 12 5 r-POL suicide in vitro 
To investigate further the cell affected by the 
suicide procedure, suicided spleen cells were fractionated on 
Isopaque/Ficoll prior to culture. In some experiments spleen 
cells from low dose ORBC primed mice were used, so that a 
specificity control could be included as previously (7.3.1.3). 
The ability of T cells from suicided spleen to 
restore the response of anti-8 treated spleen cells was compared 
with the restorative capacity of both control suicided and 
untreated T cells. In addition, the ability of B cells from 
either suicided spleen or control spleen to respond when 
mixed with normal T cells was determined. It can be seen 
(Table 7.5) that the T cell compartment appeared to be 
Table 7.3: The specificity of 125 I-POL suicide for the 
DNP-MON response in~~ 
Cells cultured a) Anti-DNP PFC b) Anti-SRBC PFC 
per culture per culture 
Untreated 2043 ± 96 638 ± 46 
1251-POL treated 543 ± 69 463 ± 57 
127I-POL treated 1783 ± 151 415 ± 28 
a) 5xlo6 viable cells were cultured per well. Mice had 
received 2xlo5 ORBC 3 days prior to culture. 
DNP-MON was at a final concentration of lOOng/ml and 
sterile, washed CSL SRBC were at 5xl06/ml. 
b) Each value represents the arithmetic mean of 4 wells± 
the standard error of the mean. 
Anti-DNP plaques were obtained by subtracting the anti-
SRBC plaques from the total number of plaques formed on 
DNP-coated SRBC. 
b) 
h . f. . f 125 . . d Table 7.4: Te specl icity O I-POL SUlCl e in VlVO 
Cells transferred a) Anti-POL 
haemag-
glutination 
titre b) 
Untreated 4.4 ± 0.2 
125I-POL <0.5 
1 27I-POL 4.3 ± 0.3 
No cells <0.5 
a) Each mouse received 107 viable cells. 
Anti-SRBC PFC 
per spleen c) 
26560 ± 3422 
27520 ± 3759 
25920 ± 2080 
70 ± 45 
b) The haemagglutination titre was judged as the last well 
showing positive haemagglutination. Well 1 contained 
a 1/5 dilution of antiserum. Each value is the 
arithmetic mean of 5 serum titrations ± the standard 
error of the mean. 
c) Each value is the arithmetic mean of 5 spleen± the 
standard error of the mean. 
Table 7.5 
Ce lls cultured a) b) 
Untreated spleen 
Anti- 8 treated spleen 
Anti- 0 treated spleen 
+ T cells untreated 
Anti- 8 treated spleen 
+ T cells 125 I-POL 
treated 
Anti- G treated spleen 
+ T cells 127 I-POL 
treated 
125 I-POL treated B cells 
125 I-POL treated B cells c) 
+ T cells untreated 
127 I-POL treated B cells 
127 I-POL treated B cells 
+ T cells untreated 
The cell affected by 125 r-POL 
suicide in vitro 
PFC per culture 
Anti-DNP 
Expt . 1 Expt . 2 
2615 ± 123 2028 ± 93 
395 ± 28 443 + 44 
2215 ± 188 1118 + 228 
2320 ± 95 1054 + 71 
1895 ± 186 1224 ± 44 
30 ± 10 n.d. d) 
260 ± 43 n.d. 
240 ± 52 n.d. 
1010 ± 80 n.d. 
Anti-SRBC 
Expt . 1 
1040 ± 93 
so ± 13 
1560 ± 82 
1565 ± 150 
1560 ± 93 
n.d. 
125 ± 13 
n.d. 
185 ± 40 
a) In experiment 1, Sx10 6 viable cells of each type were cultured. 
6 DNP-MON was at a final concentration of lOOng/ml and SRBC at SxlO /ml. 
b) In experiment 2, 5x10 6 untreated and anti- 8 treated cells and lxl0 6 
T cells were cultured. 
c) B cells= lower layer from Isopaque/Ficoll separation of lg-bearing 
and 8- positive lymphocytes. T cells= upper layer from same 
separation. 
d) Not done . 
81 
completely intact following the suicide procedure. T cells 
isolated from the suicided spleen were as good as T cells 
from the control suicided and untreated spleen at restoring 
both the anti-DNP and anti-SRBC responses of anti-8 treated 
spleen. The lesion in the response was in the lower layer 
(B cells), the suicided population giving a significantly 
lower anti-DNP response than the control population. 
The anti-SRBC response of these lower layer cells 
was rather disappointing, however. B cells were recovered by 
lysis of the SRBC used in the rosetting procedure, and 
residual SRBC and SRBC stroma caused interference of the anti-
SRBC response of these B cells. Even so, there was no 
indication of a non-specific decrease in the anti-SRBC 
response following POL suicide. 
7.3.1.6 The cell affected by 125 1-POL suicide in vivo 
The same experiment as that reported in 7.3.1.5 was 
carried out in vivo. Following 125I-POL suicide of normal 
or DNP-BSA primed spleen cells, the cells were fractionated 
on Isopaque/Ficoll, transferred into irradiated recipients 
and challenged with 5 µg of DNP-MON intravenously. Six days 
later spleens were harvested and anti-DNP PFC measured. The 
response of normal spleen cells is shown in Table 7.6. 
Suicide with 12 51-POL reduced the in vivo direct 
PFC response to DNP by about the same extent as the in vitro 
response (55% reduction). T cells from the suicided and 
control treated spleen cells were equally good at restoring 
the anti-DNP PFC response showing again that the T cell 
function was unaffected by the suicide procedure. It is of 
interest that the T cells from the suicided population 
apparently homed to the spleen unimpeded. The lesion again 
appeared in the B cell compartment, the degree of depression 
of the response being of the same order as for the whole 
spleen (54% reduction). 
A similar reduction in the direct PFC response to 
DNP was obtained when DNP-BSA primed spleen cells were 
suicided with 125 r-POL. In addition, suicide reduced the 
indirect PFC response even more dramatically (85 -90% 
reduction). As with the primary response, the suicide proced-
ure inactivated B cells and not T cells (Table 7.7). 
Table 7.6: The effect o f 1 251-POL suic ide on the in vivo 
r esponse o f normal s pleen ce l ls to DNP-MON 
Ce lls transfe rred a) 
No cells 
Untreated sple en 
1251-POL treated spleen 
1271-POL treated spleen 
Anti- 8 treated spleen 
Anti-8 treated spleen b) 
+ T cells 1251-POL treated 
Anti- 8 treated spleen b) 
+ T cells 1271-POL treated 
1251-POL treated B cells 
+ T cells untreated c) 
1271-POL treated B cells c) 
+ T cells untreated 
Dire ct ant i -DNP PFC 
p e r s pleen d ) 
64 ± 1 0 
3504 ± 566 
1550 ± 307 
2952 ± 228 
298 ± 150 
1888 ± 298 
1924 ± 142 
1024 ± 107 
2256 ± 200 
a) 107 viable cells were injected into each mouse. 
b) 7xlo 6 anti- 8 tre ated cells and 3xl06 T c e lls were injected 
into each mouse. 
c) 7xl0 6 B cells and 3xl0 6 T cells were injected into each 
mouse. B cells= lower layer from Isopaque/Ficoll 
separation of lg-bearing and 8-positive lymphocytes. 
T cells= upper layer from same separation. 
d) Each value represents the arithmetic mean o f f ive spleens 
± the standard error of the mean. Only the direct PFC 
response is quoted as little or no indirect PFC we re 
detected. 
+ 
rrc1 ble 7. 7 £ f 125 . ·a h . Th ef ec t o I-POL suici eon t e in vivo 
Cells transferred 
response of DNP-BSA primed spleen 
cells to DNP-MON 
a) Anti-DNP PFC per spleen d) 
Direct Indirect 
No CC!lls 63 ± 13 <5 
Untr atcd spleen 3106 ± 400 1635 + 290 
125 I-POL treated spleen 1136 + 280 164 ± 110 
127 I-POL treated spleen 2608 + 430 1716 + 342 
Anti-8 treated spleen 
11 . 12 5 + T ce s I-POL b) 
treated 2756 ± 528 1732 ± 228 
.l\nti-0 treated spleen 
+ T cells 127 I-POL b) 
treated 2780 ± 276 1650 ± 430 
125 I-POL treated B cells 
T cells untreated c) 792 + 90 368 ± 214 
127 I-POL treated B cells c) 
+ T cells untreated 1935 ± 488 2075 + 458 
u) 107 viable DNP-BSA primed cells were inj ected into each mouse. 
b) 7xl0 6 anti-0 treated cells and 3xlo 6 T cells were injected into 
each mouse. 
c) 7xl0 6 B cells and 3xlo 6 T cells wer e injected into each mouse. 
B < .... ·J 1 :: =- l<)vJc: r lc..1y r. fcorn C:..: orxiquc / F.i.cr;] 1 f"j C: Ji~ru ·tC>n or 19-
r.) :uCl(I(~ uilU (J- iJO~..:iL.i.Vu lyrn[;b<JCJ'l(,;E:;. '1' C<..:ll o -· U[J(.Jl:r luyc..:.r frurn 
same separat ion. 
d) Each v a lu represents the arithmetic mean of five spleens± the 
standard rror of the mean. 
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7.3.1.7 The effect of removal of POL rosette-forming cells 
on the anti-DNP response to DNP-MON 
The decrease in the anti-DNP response following 
removal of the POL specific B cell by 125 r-POL suicide was 
confirmed by another method of depletion, removal of POL 
specific rosette forming cells on Isopaque/Ficoll. SRBC were 
coated with POL, via CrC1 3 , POL specific rosettes formed and 
this rosetted cell suspension spun on Isopaque/Ficoll as for 
depletion of Ig RFC. The POL specific rosettes sank to the 
lower layer and the remaining cells floated (upper layer). 
These upper layer cells, control rosetted upper layer cells 
(i.e. cells reacted with normal SRBC before centrifugation) 
and untreated spleen cells were cultured with DNP-MON as usual. 
A decrease similar to that observed in the 125r-POL 
suicided population was observed in spleen cells depleted of 
POL RFC (Table 7.8). This result is consistent with the 
rosetting procedure removing POL specific B cells. Further-
more, other workers have demonstrated that antigen specific 
rosettes are preferentially formed by B cells and not by 
helper cells (Elliott et al., 1973). The decrease in 
responsiveness was more variable following rosette depletion 
than following suicide, this result probably reflecting the 
lower efficiency of the rosetting procedure at removing POL 
specific B cells. 
7.3.2 The effect of removal of the POL specific B cells by 
125r-POL suicide on production of the specific T 
cell replacing factor 
Removal of POL specific B cells produced a decrease 
in the response to DNP-MON of the order of 50%. Similarly, 
T and B cells cultured above a cell impermeable Millipore 
membrane produced a factor which passed through the membrane 
and restored the anti-DNP response of B cells below the 
membrane by approximately 50% (Chapter 6). 
It was thought, therefore, that this restoration 
might represent the B cell contribution to the anti-DNP 
response. Hence the effect of 1251-POL suicide on production 
of the collaborative factor was examined. Suicided spleen 
and control suicided spleen cells were cultured above the 
Millipore membrane and the anti-DNP response of anti- 8 treated 
Table 7.8: The effect of removal of POL rosette-forming 
cells on the anti-DNP response to DNP-MON in 
vitro 
Cells cultured a) Anti-DNP PFC per culture 
Expt. 1 b) Expt. 2 c) 
Untreated 860 ± 111 1525 ± 115 
POL rosette 
depleted 450 ± 128 658 ± 62 
Control rosette 
depleted 720 ± 47 1398 ± 80 
a) sx106 viable cells were cultured per well. 
b) Each value 1S the arithmetic mean of 4 wells ± the 
standard error of the mean . 
c) Each value . the arithmetic mean of 8 wells ± the 1S 
standard error of the mean. 
83 
spleen cells (i.e. B cells), cultured below, measured. It 
can be seen that 125 r-POL suicide abolished production of the 
collaborative factor (Table 7.9), highlighting the importance 
of the POL specific B cell in allowing collaboration to occur 
across a Millipore membrane. 
7.3.3 The role of the macrophage in the response to DNP-MON 
in vitro 
Having established the importance of the carrier 
specific B cell in production of the collaborative factor, 
it was of some interest to investigate the means by which the 
factor acted on B cells in the lower chamber. In particular, 
do macrophages play a role as has been reported for other 
specific T cell replacing factors (Feldmann, 1972c; Gisler 
et al., 1973). 
7.3.3.1 The ability of macrophage depleted spleen cells to 
respond to DNP-MON 
Initially, the effect of removal of macrophages on 
the ability of spleen cells to respond to DNP-MON was 
investigated. It was shown that when macrophages were removed 
by either of two procedures - an adherence method or a 
procedure utilizing carbonyl iron powder - a decrease of 40-50% 
in the anti-DNP PFC response was observed (Table 7.10). This 
decrease corresponded to the carrier specific B cell contri-
bution to the response (see 7.3.1.5). 
7.3.3.2 The role of macrophages in both the production and 
action of the collaborative factor 
When macrophage depleted spleen populations (carbonyl 
iron procedure) were cultured above a Millipore membrane 
restoration of the anti-DNP response of B cells cultured below 
was virtually abolished, indicating that macrophages play a 
role in production of the factor (Table 7.11). 
In contrast, it appears that the action of the 
collaborative factor is macrophage independent as it was found 
that the factor restored the response of anti-8 treated 
spleen depleted of macrophages (Table 7.11). It should be 
noted, however, that macrophage depleted anti-8 treated spleen 
gave a lower response than undepleted anti-8 treated spleen. 
Table 7.9: The effect of 125 r-POL suicide on production of the collaborative factor 
Cells cultured a) Anti-DNP response in lower chamber b) 
Upper chamber Lower chamber Expt. 1 Expt. 2 
Untreated Untreated 2625 ± 264 1515 ± 207 
Anti- 8 treated 500 ± 41 435 ± 57 
Untreated Anti- 8 treated 895 ± 123 1125 ± 390 
1251-POL treated Anti- 8 treated 350 ± 66 423 ± 117 
127r-POL treated Anti- 8 treated 1100 ± 114 n.d. c) 
125r-POL treated 1287 ± 98 n.d. 
127r-POL treated 2290 ± 158 n.d. 
a) Sxl0 6 viable cells were cultured in 1ml in the upper chamber and Sx10 6 in 2ml in the lower 
chamber. 
b) Each value represents the arithmetic mean of 4 cultures± the standard error of the mean. 
c) Not done. 
Table 7.10: The effect of removal of macrophages on the 
anti-DNP response to DNP-MON in v itro 
Cells cultured a) Anti-DNP PFC per culture b) 
Expt. 1 Expt. 2 Expt. 3 
Untreated 1168 ± 59 3029 ± 250 1295 ± 208 
Macrophage depleted 
(adherence method) 705 ± 122 n.d. c) n.d. 
Macrophage depleted 
(carbonyl iron 
method) n.d. 1691 ± 89 653 ± 93 
a) 5xlo6 viable cells were cultured per well. 
b) Each value represents the arithmetic mean of 4 cultures 
± standard error of the mean. 
c) Not done. 
Table 7.11 The effect of removal of macrophages on 
factor produc tion and the restoration of 
the anti-DNP r espons e 
Cells cultured a) Anti-DNP PFC in 
Lower chamber c) Upper chamber Lower chamber 
Expt. 1 Expt. 2 
Untreated Untreated 3155 ± 232 1515 ± 207 
b) Anti- 8 treated 970 ± 54 435 ± 57 
Anti- 8 treated Anti-8 treated 1013 ± 18 555 ± 152 
Untreated Anti- 8 treated 1660 ± 102 1125 + 390 
Untreated Anti- 8 treated 1073 ± 103 605 ± 64 (-macrophages) 
Untreated Anti- 8 treated 1147 ± 110 645 ± 83 
(-macrophages ) 
Anti- G treated 420 ± 53 160 ± 83 
(-macrophages) 
Anti - 8 treated 2700 ± 140 n.d. d) 
+ T c) 
Anti-0 treated Anti- 8 treated n.d. 190 ± 71 
(-macrophages ) 
a) 5xl0 6 viable cells were cultured in 1ml in the upper chamber and 
5xlo 6 in 2ml in the lower chamber. 
b) No cells. 
c) T cells = uppe r layer from Isopaque/Ficoll separation of lg-bearing 
and 8-positive lymphocytes. 
d) Not done . 
e ) Each value is the arithmetic mean of 4 cultures ± the standard 
urror of tt~ man . 
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Such a result suggests that macrophages can aid direct 
triggering of B cells by antigen. However, the anti-DNP 
response of anti- 8 treated spleen was restored to a similar 
extent (approx. 25-30% of the total anti-DNP response of 
untreated spleen in these experiments) whether macrophages 
were present or absent. 
The possibility that macrophages in the upper 
chamber supplied a growth requirement to the anti- 8 treated, 
macrophage deficient, population in the lower chamber was 
eliminated as macrophages (i.e. anti-8 treated spleen cells) 
in the upper chamber were unable to reconstitute the lower 
chamber response. Collectively these results suggest that a 
non-phagocytic cell (e.g. K cell) may be able to utilize the 
collaborative factor to stimulate B cells, or the factor and 
antigen may stimulate B cells directly. 
7.4 DISCU SSION 
The results reported in this chapter have established 
a role for the carrier specific B cell in the induction of an 
anti-hapten response to DNP-MON both in vivo and in vitro. 
It was shown that removal of the carrier specific B cell by 
125 I-POL suicide decreased the anti-DNP response of spleen 
cells by 40-50%. Furthermore, following suicide of POL 
specific B cells spleen cells were unable to produce a 
specific T cell replacing factor which could pass through a 
cell-impermeable Millipore membrane and partially restore 
the anti-DNP response of B cells below the membrane. From 
these results it was concluded that production of the collabor-
ative factor which passed through the Millipore membrane 
represented the contribution of carrier specific B cells to 
the anti-DNP response. 
The validity of the above conclusion rests on the 
fact that it was the B cell that was destroyed by the suicide 
procedure. This appeared to be the case, as:-
a) B cells were much more sensitive to radiation damage 
than T cells, some helper T activity remaining after 
doses of irradiation as high as 3675 rads. This has 
also bee n f ound by othe r worke rs (Kettman and Dutton, 
1971; Vann and Kettman, 1972; Hamaoka et al., 1972; 
Anderson et al., 1974). 
b) The anti-POL antibody response in vivo,a T dependent 
b 125 . . d h · response, was removed y I-POL suici e, sowing 
that the POL specific B cell was eliminated by the 
suicide procedure. 
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c) Fractionation of the suicided population on Isopaque/ 
Ficoll showed, both in in vivo and in vitro 
experiments, that the T cells were intact functionally 
following the suicide procedure. Groups which received 
suicided B cells, however, showed significant decreases 
in the anti-DNP response compared to controls. From 
the in vivo suicide experiments it appears that the IgG 
response to DNP is more dependent upon carried specific 
B cells than the IgM response. Such a result reflects 
the relative T cell dependence of these two antibody 
classes and is consistent with the notion that carrier 
specific B cells in some way amplify the efficiency of 
T help. 
d) Removal of carrier specific B cells by POL rosetting 
and subsequent depletion on Isopaque/Ficoll yielded 
similar decreases in the anti-hapten response in vitro. 
Such a procedure has been previously shown to remove 
antigen specific B cells rather than helper cells 
(Elliott et al., 1973). 
Suicide of T cells with 125 r-labelled antigen under 
similar conditions used in the above experiments has been 
reported (Roelants and Askonas, 1971; Basten et al., 1971). 
However, the experiments all involved transfer of suicided 
cells into irradiated animals and it was not known whether 
the radioactive antigen procedure inactivated the T cells or 
merely prevented them from homing to the spleen (Hamaoka et 
al., 1972). There have been no reports of T cell function in 
vitro being destroyed by radioactive antigen suicide. T 
cells from our suicided populations apparently homed to the 
spleen unimpeded. Furthermore, from our observations that 
carrier specific B cells play an important role in T-B 
collaboration it is clear that some of the suicide experiments 
reported in the literature which were believed to represent 
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Tc 11 suicide may have to be re-evaluated. 
From the data presented in this and the pre ceding 
chapter it is clear that interaction between T cells and 
carrier-specific B cells is essential if the specific T cell 
replacing factor is to be successfully synthesized. It is 
uncertain, however, whether carrier specific B cells 
actually produce the factor or merely present antigen to 
antigen-specific T cells which then secrete the factor, i.e., 
the cellular collaboration may be B-T-B or T-B-B. Experiments 
are in progress to discriminate between these two possibil-
ities. 
The chemical nature of the collaborative factor 
remains to be determined and until such information is 
available it is difficult to compare our factor with other 
specific thymus replacing factors already reported in the 
literature (Feldmann and Basten, 1972b; Feldmann et al., 
1973; Gisler et al., 1973; Yu and Gordon, 1973; Taussig, 1974; 
Taussig and Munro, 1974). However, it was established that 
macrophages are required for the production of the factor but 
are not needed for the factor to activate B cells. The latter 
result is in direct contrast to the work of Feldmann who 
isolated a collaborative factor from activated thymus cells 
which was 7s IgM in nature and which had an absolute require-
m_n t for m<lcrophages for its action (F'eldrnann, 1972c) . 
However, Feldmann did not include 2-mercapto-ethanol in his 
cultures as we did and this compound has been shown to be able 
to replace at least part of the requirement for macrophages 
in vitro (Pierce et al., 1974). It may be that non-phagocytic 
cells (e.g. K cells) can also substitute in part for the 
presentation role of the macrophage, or that our factor and 
antigen can act directly on B cells, possibly utilizing the 
Fe receptors on B cells. It is of interest also that the 
small anti-8 resistant response consistently obtained was 
macrophage dependent, as removal of the macrophages reduced 
this response to background levels. Macrophages, therefore, 
do play a role in direct presentation of antigen to B cells. 
Whether this response is due to an amplification by POL 
specific B cells or a direct activation of DNP B cells, or 
both, is not known. 
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7.5 SUMMARY 
In this Chapter it was demonstrated that carrier 
specific B cells play an important role in inducing an anti-
hapten antibody response to the thymus-dependent antigen, DNP 
monomeric flagellin (DNP-MON) both in vivo and in vitro. 
Removal of carrier specific B cells by 1251-polymeric 
flagellin (POL) suicide decreased the anti-IgM response by 
40-50%, reduced the anti-DNP IgG response by 85-90% and 
completely eliminated the production of a specific T cell 
replacing factor described in the preceding chapter. 
Several lines of evidence were presented which 
clearly established that the suicide procedure eliminated 
carrier specific B cells rather than carrier specific T 
(helper) cells. It was also demonstrated that macrophages 
were required for production of the specific T cell replacing 
factor but the action of the factor on B cells was macrophage 
independent. 
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8.1 INTRODUCTION 
The experiments described in this thesis have 
examined some surface and functional properties of thymus-
derived lymphocytes. In particular, the presence and 
significance of Ig on thymus cells was considered (Chapter 2) 
and in vitro techniques developed (Chapters 3, 4 and 5) to 
examine the role of T cells and T cell products in antibody 
production (Chapters 6 and 7). In this chapter an attempt 
is made to reconcile the results presented in this thesis 
with the controversial issues described in Chapter 1 and data 
recently reported from other laboratories. 
8.2 Ig on T cells: presence and functional significance 
Initially attempts were made to detect Ig on the 
surface of thymocytes by radioautographic and cell solubiliz-
ation methods (Chapter 2). It was concluded that the majority 
of mouse thymus cells have <500 molecules of Ig on their 
surface. Only a small proportion (-1%) have greater amounts. 
8.2.1 The Ig positive cells in thymus 
Several other groups, in most cases using different 
methods of detection, have also found a small proportion of 
Ig positive cells in the thymus. All groups have estimated 
that these comprise <2% of the thymus population (Hammerling 
and Rajewsky, 1971; Riethmiiller and Rieber, 1972; Perkins et 
al., 1972; Vitetta et al., 1973). However, there have been 
very few attempts to characterize these cells further although 
it has been proposed that they may represent plasma cells, 
(Vitetta et al., 1973), plaque-forming cells, B cells, 
(Anderson and Dresser, 1972; Basten et al., 1972) or an 
advanced stage in the maturation of thymocytes into T lympho-
cytes. (Hammerling and Rajewsky, 1971; Perkins et al., 1972; 
Unanue et al., 1973). 
In Chapter 2 some characteristics of these cells 
were reported, but the major conclusions to be drawn are:-
a) they are an intrinsic part of the thymus cell 
population and not casual blood-borne cells or 
contaminants from parathymic lymph nodes. 
b) the majority are not typical Tor B cells, although 
a proportion (- 20%), all lightly labelled, were 
89 
~usceptible to anti- 8 and complement treatment. 
The functional significance of these cells was 
briefly considered . They do not appear to be essential for 
thymus cells to carry out T cell functions. Thus their 
removal by rosetting or by 1251-anti-light chain suicide did 
not affect the ability of thymus cells to collaborate with 
B cells in an antibody response either in vitro or in vivo 
respectively. Hudson et al., 1974a,b showed that passage of 
thymus cells through anti-lg columns does not alter the ability 
of the remaining cells to be "educated" to killer cells or to 
carry out the cytotoxic reactions. However, because of the 
nature of the experiments (i.e. times involved may allow 
development of precursor cells), definite proof that these 
cells do not have a role in T cell function has not been 
obtained. Hence exactly what these cells are and their role, 
if any, in the thymus is not known. It seems unlikely 
though, from studies of peripheral T cells that they are 
mature T cells about to leave the thymus. Examination of the 
lg positive cells in thymus by E/M radioautography showed 
that they had a unique morphology not observed in spleen or 
lymph node (Perkins et al., 1971). It may be that they are a 
heterogeneous group of cells, functionally as well as 
morphologically, which share the common characteristic of 
surface lg. Some of the more lightly labelled cells may 
have acquired their surface lg cytophilically from a 
proportion of lg synthesizing cells. Vitetta et al. (1973) 
showed that removal of cells bearing the plasma cell antigen 
removed the small amount of lg synthesis that could be easily 
detected by thymus cell populations. Thus the fact that this 
1-2% of thymus cells is an intrinsic population is relevant 
to reports claiming synthesis of Ig by thymus cells (Moroz 
and Hahn, 1973; Santana et al., 1974) and it may also have a 
bearing on discrepancies between total lg detected in thymus 
extracts by different groups (see 1.1.1). The sensitivity of 
the method of detecting lg and the size of the Ig positive 
population, which Basten et al., (1972) have suggested varies 
in different mouse strains, would influence the amounts of 
lg detected. 
90 
8.2.2 Ig in thymus cell extracts 
The conclusion that thymus cells do not contain 
large amounts of hidden Ig has been supported by most recent 
reports in the literature, with the notable exception of 
Marchalonis and coworkers, who still claim that there are 
large amounts of Ig on T cells (see Marchalonis and Cone, 1973; 
Marchalonis et al., 1974). Their objection to the microprec-
ipitin inhibition results reported in Chapter 2 would be that 
the detergent NP-40 may not be effective at solubilizing the 
T cell membrane and releasing T cell Ig. This objection is 
countered to some extent by:-
a) the study of Grey et al. {1972b) who found it the most 
efficient method of a number examined, including freeze-
thawing and urea-acetic acid (Marchalonis method) at 
releasing cell surface Ig; and 
b) the study of Jensenius and Williams (1973) who claimed 
that non-ionic detergents (e.g. NP-40) led to higher 
r~covcrleF of B ~nd T cell Ig ~han other methods of 
Ho ] ubil.iz.inq rn ' mbrane;z; 
c) the fa ilure of four othe r groups using different 
systems and techniques (some similar, if not identical, 
to those of Marchalonis et al.), who also failed to 
detect large amounts of hidden Ig on thymus cells 
(Grey et al., 1972a; Vitetta et al., 1973; Lisowska-
Bernstein et al., 1973; Jensenius and Williams, 1974). 
Technical reasons for the discrepancy in findings 
between Marchalonis and other groups have been 
suggested by Lisowska-Bernstein et al. (1973) and Ada 
and Ey (1974), but to some extent this controversy of 
inaccessible Ig in T cells still exists although there 
are now 5 negative reports to one positive. 
8.2.3 Ig on peripheral T cells 
As mentioned in 1.1.1, Ig appeared to be more 
easily demonstrated on peripheral T cells. Thus a greater 
proportion (>2%) of purified splenic T cells had detectable 
levels (by radioautography) of surface Ig compared to thymus 
cells. Furthermore, some functionally active splenic T cells 
had enough surface Ig to form Ig rosettes (Chapter 5). 
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However, a proportion (5-10%) of splenic T cells were shown 
to be able to form Fe rosettes and the possibility that the 
Ig positive and Fe receptor lymphocytes are one and the same 
cell is a likely one in view of the recent demonstrations by 
other workers that the Ig detected on peripheral activated 
T cells is mostly acquired, rather than synthesized. 
Most groups did not have procedures for obtaining 
pure populations of splenic T cells so studies have been 
carried out on activated thymus cells, e.g. activated TDL, 
(usually activated to H-2 antigens) , or T-TDL (TDL of F1 
animals given parental thymus cells), where Ig was readily 
demonstrated on T cells using anti-Ig reagents, although still 
in amounts much less than on B cells (Goldschneider and 
Cogen, 1973; Sprent and Hudson, 1973; Hunt and Williams, 1974; 
Hudson et al., 1974.) Hunt and Williams estimated there were 
500-2000 molecules of Ig on "T" cells compared to 20000-
150000 molecules on "B" cells in rat TDL. However, a number 
of lines of evidence have shown that most, if not all, of this 
Ig is cytophilic:-
a) There was no allelic exclusion of surface Ig (Hunt 
and Williams, 1974). 
b) Ig, once removed by capping or trypsinization was 
not resynthesized (Hudson et al., 1974; Pernis et 
al., 1974). 
c) Removal of Ig positive cells from parental thymus 
inoculum before injection into F1 animals led to a 
decrease in Ig detected on T-TDL (Hudson et al., 
197 4) . 
Whether this is indicative that all activated thymus 
cells possess an Fe receptor, or whether the Ig is binding to 
antigen already bound on the T cell surface, as has been 
suggested by Sprent and Hudson (1973) and Hudson et al. (1974), 
is a matter of debate. However, Webb and Cooper (1973) have 
found that B cell Ig on peripheral circulating T cells can 
bind antigen, so that at least one Fab binding site is free 
to react. T cells have also been found to synthesize an lg 
binding factor with specificity for the Fe region of IgG 
(Fridman and Golstein, 1974). 
Hence, from the foregoing results it is clear that 
...... 
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both thymus and peripheral T cell populations can be contam-
inated with Ig of extraneous origin. Thus, for meaningful 
studies of T cell Ig and its synthesis and function efforts 
must be made to obtain purified T populations, free of B 
cells, and extraneous Ig removed from the T cell surface (e.g. 
by capping) and its resynthesis demonstrated by these purified 
T populations. 
Thus in answer to the question posed initially in 
this section of the thesis - Is there Ig on T cells? - it is 
concluded that if there is intrinsic Ig on T cells, it is 
present in very much smaller amounts than on B cells, 
probably <500 molecules per cell. Small numbers of splenic 
T cells with larger amounts of Ig, and Ig detected on 
activated thymus cells, is most likely acquired cytophilically. 
The functional significance of the Ig present on T cells is 
still an open question. Some aspects of this question will 
be discussed in a later section (8.3.2.3). 
8. 2. 4 Alternatives to Ig as the T cell receetor 
A consequence of the lack of readily detectable Ig 
on T cells has been the proposal of alternatives to Ig as 
the T cell receptor. The product of the irrunune response (Ir) 
genes, genes that are genetically linked to the chief 
histocompatibility loci and which have been shown to influence 
T cell responses to a variety of antigens (see reviews: 
McDevitt and Benacerraf, 1969; McDevitt et al., 1971; 
Benacerraf and McDevitt, 1972; Grumet and McDevitt, 1973; 
Lieberman and Paul, 1973; McDevitt and Landy, 1973), or some 
other histocompatibility gene products, or complexes of the 
above components with Ig, have been suggested. There is 
mounting evidence in favour of the involvement of histo-
compatibility gene products in T cell recognition and function, 
(Crone et al., 1972; Shevach et al., 1972; Tada et al., 1973; 
Hammerling and McDevitt, 1974 a,b; Taussig and Munro, 1974; 
ArmEFding and Katz, 1974; See reviews: Warner, 1974; Katz and 
Benacerraf, 1974), but as yet data is still too incomplete 
for conclusions to be made as to the nature of the T cell 
receptor. 
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8.3 The role of the T cell in cellular collaboration 
8.3.l Collaboration between T and B cells in the anti-hapten 
response 
In the second part of this thesis characterization 
of in vitro anti-hapten responses to hapten-carrier antigens 
confirmed that carrier-primed lymphocytes collaborate 
synergistically with hapten primed lymphocytes to give an 
anti-hapten antibody response. The cell separation technique, 
described in Chapter 5, enabled a direct demonstration that 
carrier primed T cells and hapten specific B cells were 
involved in this collaboration. In addition, from a study 
of the anti-hapten response to DNP-MON a number of new findings 
were obtained. Pure populations of splenic T cells could not 
collaborate with B cells across a cell impermeable membrane 
(Chapter 6). The carrier primed B cell had a role in T-B 
collaboration (Chapters 3 and 6) and in particular was 
required for production of a specific T cell replacing factor 
(Chapter 7). Also, the congenitally athymic nude mouse mutant 
was shown to possess a small proportion of functional T cells 
(Chapter 4). These results have a number of implications for 
proposed mechanisms of T-B collaboration (1.2), the nature of 
the T cell receptor and results obtained by other invest-
igators. 
8.3.2 Contact vs. Factor models 
From the study of the anti-hapten response, 
particularly to DNP-MON, the following observations relevant 
to mechanisms of T-B collaboration were obtained. It was 
shown that:-
a) Removal of T cells by anti- 8 and complement treatment 
virtually eliminated the antibody response to DNP-MON. 
There w s a slight residual response resistant to anti-
8 treatm nt which could be reduced to background levels 
by removal of macrophages. 
b) Removal of carrier specific B cells by suicide with 
radioactively labelled antigen or an antigen specific 
rosetting procedure caused a 40-50% reduction in the 
response. 
c) R mov l of macrophages also caused a 40-50% reduction 
in the response. 
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d) Pure splenic T cells, separated by the Isopaque/Ficoll 
procedure, could not collaborate with B cells across a 
cell impermeable Millipore membrane. It is noteworthy 
that the T cell population contained macrophages, and 
T cells are reportedly able to be activated by 
macrophages and antigen (Katz and Unanue, 1973; Klaus, 
1973; Kontianen and Feldmann, 1973). 
e) T and B cells and macrophages cultured together with 
antigen produced a specific collaborative factor which 
could partially ( - 40 % restoration) restore the anti-
hapten response to B cells across the Millipore membrane. 
The B cells did not just supply some cultural requirements 
for T cell activation, as it was shown that it was the 
carrier specific B cell in particular that was necessary 
f or the collaborative factor to be produced. The 
restorations obtained were of the same order as the B 
cell contribution to the response (b). 
f ) The carrier specific B cell had a role both in vitro 
and in vivo, contributing to 40- 50% of the IgM response 
and of the order of 90 % to the IgG response in vivo. 
g) Removal of macrophages abolished production of the 
collaborative factor. 
h) Once produced macrophages were not required for the 
factor to restore the antibody response of B cells. 
Hence the above results indicate that there is more 
than one mechanism of T-B collaboration. Direct interaction 
between antigen stimulated T and B cells, which can occur in 
the absence of carrier specific B cells and macrophages, and 
only when T and B cells are in contact, amounts to 50-60% 
of the IgM response to DNP-MON. It may occur either by very 
short-range factors or cell-cell contact. In addition, there 
appears to be a mechanism which amplifies this help phenomenon 
which involves macrophages and carrier specific B cells. 
Macrophages, carrier specific B cells and T cells in the 
presence of antigen allow production of a specific soluble 
factor which can activate hapten specific B cells. It is 
noteworthy that either carrier specific B cells, macrophages 
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or the Tc 11 replacing factor contribute to a similar extent 
to the in vitro anti-DNP antibody response - i.e. approxi-
mately 50% of the total antibody response. It thus appears 
that the major role of macrophages in antibody formation is 
to aid the release of the specific T cell replacing factor. 
Macrophages, however, can also to a small extent stimulate B 
cells directly when antigen is present. This diversity of 
collaborative mechanisms can account for the rapidity at which 
an immune response is achieved and overcomes the difficulty of 
"rare" cells having to contact each other. Consistent with 
the B cell having an amplifying role in the immune response 
is the observation that synthesis of IgG is highly dependent 
upon the carrier specific B cells. 
8.3.2.1 Specific collaborative factors 
The preceding data does not allow a conclusion to 
be drawn regarding the origin of the specific collaborative 
factor - whether it is produced by the carrier specific B 
cell, or whether the carrier specific B cell is required to 
activate the T cell to produce it. This question is being 
investigated. However, it is tempting to relate the con-
tribution of the carrier specific B cell to the phenomenon 
of antibody mediated enhancement of the immune response 
described in Chapter 1 (1.3), and to speculate that the 
collaborative factor from ATC populations, described by 
Feldmann and Basten (1972b), is also a reflection of this 
phenomenon, the collaborative factor being B cell Ig directed 
against the carrier determinant. A number of observations 
are consistent with this interpretation:-
a) Feldmann (1972c) characterized his specific 
collaborative factor as 7s IgM with specificity for 
the inducing antigen. 
b) ATC probably possess cytophilically acquired Ig 
synthesized by radioresistant host B cells or by the 
Ig positive cells present in the thymus inoculum 
(see 8.2.3). As these cells have been primed in 
vivo with carrier antigen, some of the acquired 
antibody is probably directed against the carrier 
antigen. 
c) Synthesis of the specific collaborative factor by ATC 
96 
has not been demonstrated. Moreover, Lisowska-
Bernstein et al. (1973) showed that detectable synthesis 
ofµ and L chains by ATC resulted from contamination 
of these cells by IgM containing plasma cells. 
Relevant to this finding is the observation that 15% 
of MON ATC formed Ig positive rosettes (Kirov and 
Parish, unpublished results). Hence it is likely that 
there are some carrier reactive B cells in the ATC 
population. Feldmann (1972c) has shown that treatment 
of the ATC with anti-8 and complement abolished production 
of the factor, but this is not sufficient to establish 
that it is actually produced by T cells. As shown, in 
Chapter 6, T cells as well as B cells were required 
for the production of a specific collaborative factor 
from spleen cells. Also, T cell metabolism may be 
required for release of cytophilically acquired Ig on 
the T cell surface, if this is the source of the factor. 
d) Playfair et al. (1974) showed that activated T cells 
coul.d be passively sensitized with antibody and develop 
co-operating properties with the specificity character-
istic of the antibody. Hence collaboration via passive 
B cell Ig on activated T cells would appear to be a 
workable mechanism of collaboration. 
The specific collaborative factor produced by 
activated thymus cells, described and characterized by 
another group, appears to have different properties (Taussig, 
1974; Taussig and Munro, 1974). This factor was produced 
early in the secondary response of primed ATC to antigen in 
vitro (within the first 6 hours of culture). It was reported 
to be non-Ig in nature but was able to react with anti-
histocompatibility antisera. The relationship of this factor 
to Feldmann's specific factor and the splenic collaborative 
factor (Chapters 6 and 7) remains to be established. Further 
characterization of the chemical nature of the splenic 
collaborative factor is necessary before comparisons can be 
made. 
97 
8.3.2.2 Non-specific collaborative factors 
Non-specific collaborative factors were not really 
considered in experiments reported in this thesis and did 
not figure much in the culture system examined. However, 
there was some evidence that an ongoing response to DNP-MON 
had a facilitatory effect on the response to SRBC in the same 
culture (see Table 6.7). Gisler et al. (1973) found that the 
non-specific factor produced by activated thymus cell cultures 
in the presence of the priming antigen was restricted to the 
potentiation of antibody responses against fully or partially 
T independent antigens (e.g. SRBC), and that expression of 
the non-specific effect depended on a macrophage function 
which was replaced by 2ME. As 2ME was present in all 
cultures described in this thesis, possibly the effects of 
non-specific factors in the collaborative response were 
minimized. 
8.3.3 Implications of the results for the nature of the 
T cell receptor 
a) Demonstration that carrier specific B cells were 
required for production of the specific collaborative 
factor casts some doubt on the origin of Feldmann's 
specific factor. Thus the Ig nature of this factor 
cannot be taken as evidence that the T cell receptor is 
Ig (1.1.1), until there is conclusive demonstration of 
its synthesis by pure populations of T cells, 
uncontaminated by extraneous Ig. 
b) Data obtained from "T" suicide experiments will have 
to be re-evaluated in the light of the critical role 
of the carrier specific B cell in collaboration. 
Suicide of T helper populations, in general did not 
cause complete abolition of the antibody response 
being measured (Basten et al., 1971; Roelants and 
Askonas 1971). In addition, in Chapter 7 it was shown 
that even though B cells could be readily suicided, 
there was no evidence that T cells were affected in 
function or in ability to home to the spleen in vivo. 
The possibility exists, therefore, that the decrease 
in antibody response observed by other groups following 
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suicide o f T h e lper cell populations (probabl y alway s 
containing carrier spe cific Band T c e ll s ) wa s due to 
suicide of B cells and subsequent r e moval o f t he B 
cell dependent amplification mechanism. He nce, 
information obtained from these expe rime nts, s uch as 
blocking of suicide with anti-lg (Basten et al., 1971), 
cannot be taken as reliable indications as to the nature 
of the T cell receptor. 
8.4 T cells in nude mice 
Nude mice have been widely used as a source of pure 
B cell populations. Hence, the demonstration of functionally 
active T cells in these mice may have a bearing on many 
studies, particularly where responses to antigens which may be 
cross-reactive with environmental antigens have been examined. 
As an example, the results of Schrader (1973, 1974) may be 
considered. He found nude mouse spleen cells in culture 
were unable to respond to de-aggregated fowl gamma globulin 
(FyG). Also, they did not give a significant anti-FyG 
response when varying amounts (0.01 - 100 µg) POL and no FyG 
were added to the culture. However, when both FyG and POL 
were present in cultures, a significant, though low, anti-
FyG response was observed. He concluded that this was evidence 
that substances like POL, MON and LPS - all of which gave this 
help effect - could substitute for T cells in giving t he 
"second signal" to antigen activated B cells. However, an 
alternative and more likely explanation, is that the small 
proportion of nude T cells, probably well primed to the se 
bacterial antigens, are activated by them. The resulting 
proliferation, possibly leading to presence of T c e ll s speci f ic 
for FyG which may allow B cell mediated enhancement o f the 
response and cell-cell contact T help, and production of non-
specific T cell replacing factors by the activated T cells, 
give rise to the response to FyG. (Of interest, 2ME was not 
present in these cultures). 
The ability of nude mice to respond as well as 
normal mice to DNP-MON is an example of the ef f iciency of the 
amplification mechanism of the help phenome non (8.3.2), as 
only a very few T cells are required to g ive the ma xi mal 
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antibody response. Nevertheless, the T cell has a central 
role as shown by removal of 2-4% of spleen cells by anti-8 
and complement treatment leading to a 60-70% decrease in the 
anti-DNP response. It also appears that the macrophage-
antigen presentation mechanism in nude mice is more efficient 
than in normal mice, as the residual response after anti-8 
treatment was consistently higher than in normal mice. It is 
probably through such mechanisms that nude mice are able to 
survive with their impaired immune system. 
8.5 SUMMARY 
Thus the following conclusions may be drawn from 
the work described in this theses:-
a) The nature of the T cell receptor is still a very 
open one. It can no longer be confidently assumed 
that it is immune-globulin in nature, due to the 
small amounts of Ig present on T cells and the 
relatively weak evidence, mostly indirect, that Ig 
on T cells has functional significance. 
b) There is collaboration between carrier primed and 
hapten specific cells in anti-hapten responses, but 
more than one mechanism is involved, including cell-
cell contact between T and B cells, and production 
of specific and non-specific T cell replacing 
factors. The carrier specific B cell has a role in 
production of a specific T cell replacing factor from 
carrier primed spleen cells. The B cell contribution 
to the response amounts to 40-50% of the IgM response 
both in vitro and in vivo and to more than 90% of the 
IgG response in vivo, suggesting that the B cell may 
be involved in an amplification mechanism of the 
immune response. The nature of the factor and the 
cell responsible for its production remains to be 
established. 
c) Nude mice possess a small proportion of functional T 
cells and hence cannot be regarded as pure populations 
of B cells, especially where responses to environmental 
antigens or antigens cross-reactive with environmental 
antigens are being considered. 
S LTMM AllY 
'rhis thesis has de a lt with some aspect s of 
thymus-derived lymphocytes. 
a) Thymus cells were examined for sur f ace lg by radio-
autography and a microprecipitin inhibition assay of 
detergent solubilized cell extr a cts. Only a small 
• 
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proportion (-1%} of thymus cells were fauna to possess 
significant amounts of Ig and this population was 
characterized. No functional significance could be 
attributed to these cells (Chapter 2). 
b) Functional assays for T cell activity were investigated. 
In particular, in vitro anti-hapten responses to 
several DNP-protein conjugates were characterized 
(Chapter 3). It was demonstrated that congenitally 
athymic "nude" mice possess a small population of 
functional T cells which can collaborate in an anti-
hapten response and mount a DTH reaction (Chapter 4). 
c) A cell separation procedure for fractionating mouse T 
) ) 
and B cells by rosetting and centrifugation ,on Isopaque/ 
Ficoll was characterized using radioautographic 
techniques and the in vitro culture systems. It was 
shown by both morphological and f unctional criteria 
that pure populations of T and B cells could be 
obtained (C~apte~ 5). In addition, the procedure was 
modified to detect Fe rec e ptor l ymphocytes and the 
presence of functional T cells with Fe receptors was 
demonstrated. 
d) Mechanisms of T-B collaboration were e xamined using 
the techniques develope d in b) and c). It was 
-
established that the carrier spe cific B cell has a rol e 
1n cellular collaboration. In in vitro experiments, 
it was shown that pure splenic T c ells were unable t o 
collaborate with B cells across a cell impermeabl e 
mcmtJrune. Carrior primed B Ct:,lls were required for 
production of a specific collaborative factor by 
spleen cells. Removal of the carrier specific B cells 
by antigen suicide decreased the anti~DNP IgM response 
by 40-50% both in vivo and in vitro and reduced the IgG 
response by 80-90% !.!l vivo (Chapters 6 and 7). 
This thesis has dealt wi th some aspects of 
thymus-derived lymphocytes. 
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a) Thymus cells were examined for surface Ig by radio-
autography and a microprecipitin inhibition assay of 
detergent solubilized cell extracts. Only a small 
proportion (- 1%) of thymus cells were found to possess 
significant amounts of Ig and this population was 
characterized. No functional significance could be 
attributed to these cells (Chapter 2). 
b) Functional assays for T cell activity were investigated. 
In particular, in vitro anti-hapten responses to 
several DNP-protein conjugates were characterized 
(Chapter 3). It was demonstrated that congenitally 
athymic "nude" mice possess a small population of 
functional T cells which can collaborate in an anti-
hapten response and mount a DTH reaction (Chapter 4). 
c) A cell separation procedure for fractionating mouse T 
and B cells by rosetting and centrifugation on Isopaque/ 
Ficoll was characterized using radioautographic 
techniques and the in vitro culture systems. It was 
shown by both morphological and functional criteria 
that pure populations of T and B cells could be 
obtained (Chapter 5). In addition, the procedure was 
modified to detect Fe receptor lymphocytes and the 
presence of functional T cells with Fe receptors was 
demonstrated. 
d) Mechanisms of T-B collaboration were examined using 
the techniques developed in b) and c). It was 
established that the carrier specific B cell has a role 
in cellular collaboration. In in vitro experiments, 
it was shown that pure splenic T cells were unable to 
collaborate with B ce ll s a cros s a cell impermeabl e 
rn ·mbr ·1nc . Ca.rrior rimed B cells were req ui red f or 
product ion o f a s pecific c ollabora t i ve f actor by 
spleen cells. Removal of the carrier specific B cells 
by antigen suicide decreased the anti-DNP IgM response 
by 40-50% both in vivo and in vitro and reduced the IgG 
response by 80-90% !_!l vivo (Chapters 6 and 7). 
,, 
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